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 The loss of muscle strength in the elderly is greater than the loss of muscle mass, 
termed specific force (SF) loss, and indicates that a decrease in muscle quality contributes 
to age-related muscular weakness. The present PhD thesis has studied age-related SF loss 
in human skeletal muscle using a skinned single muscle fibre model.   
 A large variation in published skinned fibre SF measurements was found to exist 
in the literature. Therefore, a systematic review and meta-analysis was performed to 
identify factors causing this variability. The majority of publications were objectively 
divided into four research groups based on shared authorship. Methodological differences 
between research groups contributed to ~30% of the variance in the literature, suggesting 
that they are an important contributor to the variance in published SF values.  
 Different research groups use different activating solutions to study skinned 
fibres, and were assessed experimentally. Skinned fibres were exposed to different, but 
commonly used activating solutions (termed A and B).  A significantly higher SF and a 
shorter time to half peak tension (t50) was measured from the same fibres in solution B 
compared with solution A. The use of TES in solution B instead of Imidazole as a pH 
buffer largely caused the SF difference, and a lower Cl- concentration and the use of 
Glutathione in solution B partly caused the faster t50. These findings indicate that the use 
of different activating solutions likely affects the variance of published SF values. 
 The final study in this thesis compared SF between skinned fibres from 
physically active and comparatively frail elderly cohorts to a young, healthy group. MHC 
I fibre SF was significantly higher in solution B than A within all groups. No significant 
differences in SF, myosin content (SDS PAGE) or order (X-ray diffraction) were 
observed between groups. These findings suggest that physical activity does not affect 
age-related skinned fibre SF loss and that SF is related to skinned fibre myosin content.  
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1.1 General introduction  
 
The proportion of elderly people over 60 years of age is increasing in modern 
societies worldwide. However, advances in medicine, science and technology have 
enabled people to live longer with disease or disability, meaning that increased life 
expectancy is not necessarily associated with an increased number of years of healthy 
living (Harper, 2014). The proportion of the budgets of healthcare organisations 
worldwide which is directed towards healthcare for the elderly is expected to increase 
with the growing elderly population. Therefore, the ageing population is considered to be 
a major socio-economic concern (Caley and Sidhu, 2011). 
Maintaining skeletal muscle function with advancing age is associated with the 
maintenance of functional independence in elderly individuals (Foldvari et al., 2000). In 
contrast, age-related muscular weakness and frailty is associated with an increased 
number of falls, which comprise a large proportion of injuries in the elderly population. 
Falling related injuries in the elderly cost the NHS £581 million in the year 2000, 
equivalent to almost 20% of the total NHS expenditure on pharmaceuticals (Scuffham et 
al., 2003). 
The functional properties of skeletal muscle are related to and influenced by 
morphological features such as muscle size. Indeed, a positive proportional relationship 
between human muscle cross-sectional area (CSA) and force has been well documented 
for at least the last seventy years (Haxton, 1944). Given the link between muscle size and 
force generation, considerable attention has been given to interventions such as exercise 
training, which can induce positive morphological adaptations, i.e. hypertrophy, which 
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have beneficial effects on force production (Trappe et al., 2000, Parente et al., 2008). 
Furthermore, environments such as intensive care (Puthucheary et al., 2013) or 
microgravity (spaceflight) (Riley et al., 2000, Widrick et al., 1999, Widrick et al., 2001) 
accelerate muscle adaptations which have a negative effect on force, so have been studied 
to better understand the onset of muscle atrophy, as well as exercise or nutritional 
countermeasures (Trappe et al., 2004, Trappe et al., 2008).  
Much attention has been given to the age-related loss of muscle mass, termed 
‘sarcopenia’ (Rosenberg, 1989). The onset of the reduction in muscle size and force is 
difficult to determine due to a lack of appropriate longitudinal studies, but it is estimated  
that a reduction in muscle mass occurs in middle age (~45 years old) (Janssen et al., 2000). 
Unfortunately, sarcopenia does not fully explain muscular weakness observed in elderly 
people. Studies conducted at the whole muscle level have demonstrated that the decline 
in muscle strength with advancing age is greater than the decline in muscle mass, 
indicating that an age-related decline in muscle quality occurs (Klein et al., 2001, 
Macaluso et al., 2002, Morse et al., 2005). A muscle’s peak isometric force (P0) 
normalised to its CSA yields a measurement of force produced per unit CSA, termed 
specific force, which is regarded as a reflection of a muscle’s intrinsic contractile quality. 
Hence, the reduction in muscle quality, as reflected by specific force, has become a major 
topic in investigations into the cause of age-related muscular weakness.  
The reduction in physical activity which accompanies old age is associated with 
multiple deleterious effects on overall health, and physical inactivity has been strongly 
linked with chronic disease (Mokdad et al., 2004). Analogously, studying sedentary 
elderly cohorts is likely to be an inappropriate model of inherent biological ageing, as the 
negative physiological impact of inactivity will interact with the effects of the ageing 
process. Therefore, physically active master athletes have been proposed as a model to 
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study the effects of ageing, unaffected by the negative effects of physical inactivity 
(Lazarus and Harridge, 2010, Pollock et al., 2015).  
Due to the nature of whole muscle experiments performed in vivo, the mechanism 
of specific force loss in humans is difficult to study and cannot be studied at the level of 
the myofilaments. The chemically skinned fibre method has the advantage of being able 
to isolate and cause a single muscle fibre to contract maximally in vitro under highly 
standardised conditions, offsetting limitations of whole muscle experiments such as 
neural influences, the presence of non-contractile tissue and heterogeneous fibre type 
populations etc. The mechanism of age-related specific force loss, studied using the 
skinned fibre preparation, has been suggested to be a reduction in myosin content 
(D'Antona et al., 2003), which implies that a reduction in the number of acto-myosin 
cross-bridges is responsible for age-related specific force loss. Some evidence also exists 
suggesting that the behaviour of cross-bridges, as well as the number, affect specific force 
in the elderly (Lowe et al., 2001, Ochala et al., 2007).  
The starting aim of the present doctoral work was to assess the impact of physical 
activity on the development of specific force loss in elderly individuals at the level of the 
myofilaments, by studying skinned skeletal muscle fibres. However, before these 
experiments could be performed, the lack of consistency with regard to human skinned 
fibre specific force values reported by different studies needed to be addressed. Thus, a 
systematic review and meta-analysis, in order to identify methodological factors 
contributing to the observed variability was undertaken. This was followed by a detailed 
investigation into the effects of the chemical compositions of the different activating 
solutions used to study skinned fibres, which identified a significant effect of the 
experimental solutions on the skinned fibre contractile response. Therefore, a novel 
approach was taken whereby the effects of two different activating solutions on skinned 
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fibre specific force were used as a tool to probe the potential mechanisms of age-related 
specific force loss with regard to cross-bridge behaviour. Experimentally, two cohorts of 
elderly individuals, one physically active master cyclists, another comparatively frail hip 
fracture patients, were compared to a control group of healthy, young individuals. The 
mechanisms of specific force loss with regard to skinned fibre myosin content as well as 
the position of the heads of the myosin molecule during contraction, obtained through 
preliminary data from X-ray diffraction experiments, were also assessed. 
 
1.2 Skeletal muscle: a brief overview 
 
1.2.1 The relation of muscle force to cross-sectional area 
 
Skeletal muscle functions to convert chemical to mechanical energy, which occurs 
in the basic contractile unit of muscle, called a sarcomere. Among the protein structures 
which comprise a single sarcomere, the heads of myosin molecules constituting thick 
myosin filaments, attach to thin actin filaments to form structures termed ‘cross-bridges.’ 
During a muscle contraction myosin heads are thought to attach to and pull actin filaments 
towards the centre of the sarcomere, causing the sarcomere to shorten. The relative 
distances moved by the thick and thin filaments are greater than the length of a myosin 
molecule, indicating that the myosin head detaches and re-attaches to the thin filament; a 
process known as the cross-bridge cycle (Huxley, 1957, Huxley and Simmons, 1971). 
Muscle force is produced as a result of the cross-bridge cycle, which is driven by the 
hydrolysis of Adenosine Triphosphate (ATP) bound to the myosin molecule, hence the 
conversion of chemical to mechanical energy. 
A myofibril is composed of repeated sarcomere structures, and the force produced 
by a given myofibril is the sum of the force produced by individual cross-bridges arranged 
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in parallel with one another. Therefore, an individual muscle fibre, itself composed of 
approximately two thousand myofibrils, produces force proportional to its cross-sectional 
area (CSA). Hence, the single fibre CSA serves as a proxy to reflect the number of cross-
bridges arranged in parallel throughout the fibre. Indeed, that force measured at the whole 
muscle level in humans is proportional to a given muscle’s anatomical CSA (ACSA) has 
been known for at least seventy years (Haxton, 1944). More specifically, muscle force is 
proportional to the physiological cross-sectional area (PCSA) which is reflective of the 
contractile tissue contributing to force generation, since the angle of pennation of the 
fibres in a given muscle is accounted for. PCSA can be affected by the density of 
myofilament packing, which affects the number of cross-bridges in parallel in a given 
ACSA. The implications of normalising force to the ACSA or PCSA are discussed in 
section 1.5. 
1.2.2 The force-length relation and specific force 
 
The number of cross-bridges which can be formed during a muscle contraction is 
dependent upon the overlap of the thick and thin filaments in a sarcomere, which in turn 
is determined by the sarcomere length. In their classic study, Gordon et al. (1966) 
determined the optimal sarcomere length for force generation in isolated frog skeletal 
muscle fibres. The force-length relation was shown to have characteristic phases, 
including an ascending phase where force increased with increasing sarcomere length 
until a plateau in force was reached, indicating that the optimal range of sarcomere length 
(2.0-2.25µm) had been found. At sarcomere lengths greater than the optimal range a 
decrease in force occurred until no force was produced, due to a complete absence in thick 
and thin filament overlap at very long (3.75µm) sarcomere lengths. In humans, an optimal 
sarcomere length for force development of 2.75µm has since been determined using 
chemically skinned, single muscle fibres (Gollapudi and Lin, 2009). Force-length is 
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difficult to set in humans in vivo due to confounding factors associated with whole muscle 
experiments, which are outlined in section 1.5.  
Given the force-length relation in skeletal muscle, a contraction whereby the 
muscle length is set at an optimum sarcomere length for force production is commonly 
used to obtain maximal force measurements, termed an ‘isometric’ contraction. The word 
‘isometric’ itself has Greek roots, being derived from the words ‘iso’ meaning equal and 
‘metro’ meaning length. Due to the dependence of muscle force on the number of cross-
bridges in parallel, the peak isometric force (P0) normalised to a given muscle’s CSA 
gives a measurement of force per unit CSA, which is regarded to be a reflection of the 
intrinsic contractile quality of a muscle, termed ‘specific force.’ The emphasis of the work 
presented in this thesis is on the specific force generating capacity of human skeletal 
muscle.  
1.2.3 The force-velocity relation 
 
The movement of muscle during a concentric contraction, i.e. the velocity of 
shortening, summates along sarcomeres in series with one another, so is proportional to 
the overall length of a muscle. Force is maximal during an isometric contraction when 
both ends of a muscle are fixed so that no shortening occurs. In contrast, P0 decreases 
with increasing shortening velocity, exhibiting a negative non-linear relationship which 
was first described by Hill (1938). The heat produced by a muscle during contraction was 
also shown to be proportional to the shortening which occurs. The force-velocity relation 
for an individual fibre is calculated by causing a given fibre to perform ‘isotonic’ or 
‘isovelocity’ contractions. The maximal velocity of shortening (Vmax) is obtained via an 
extrapolation of the force-velocity curve, to the theoretical point where P0 is equal to zero 
and shortening velocity is maximal. Alternatively, the velocity of unloaded shortening 












Figure 1.1. The force-length relation as demonstrated by Gordon et al. (1966) in frog 
muscle fibres.  
The peak force was reached at an optimum sarcomere length range of 2.0-2.25um. The 
so called ‘descending limb’ can be seen to the right of the peak, where a decrease in force 
occurs with increasing sarcomere lengths. The ascending limb is immediately to the left 








1.2.4 Power output of concentric muscle contractions 
 
Muscle power is the rate of work performed and is reflective of the force-
velocity properties of a given muscle. Therefore, power is an indication of a muscle’s 
functional performance. The power output of a muscle can be determined by 
multiplying a given P0 with the corresponding Vmax value, obtained from plotting a 
force-velocity curve.  
1.2.5 Muscle fibre types 
 
In the study of skeletal muscle, an early distinction was made between red and 
white muscle fibres by Ranvier (1873). Measuring the myosin ATPase activity of 
different muscles, Bárány (1967) observed a positive relationship between the speed of 
muscle shortening and the myosin ATPase activity. Indeed, the differentiation between 
different muscle fibres based on the pH lability of the ATPase enzyme expressed in thin 
(~10µm) sections of skeletal muscle revealed three distinct fibre types in humans, 
identified as type I, type IIA and type IIB (BROOKE and KAISER, 1970). Subsequent 
work revealed that the histochemical ATPase characteristics of a given muscle fibre were 
determined by the fibre’s myosin heavy chain (MHC) isoform expression (Ennion et al., 
1995, Sant'ana Pereira et al., 1995). Furthermore, the human IIB isoform was shown to 
not express IIB MHC, but actually expressed a human equivalent to the type IIX MHC 
expressed in rat skeletal muscle. Therefore, the three MHC isoforms which exist in human 
skeletal muscle are classified as MHC I, IIA and IIX. The fact that individual fibres can 
co-express multiple MHC isoforms has also been demonstrated (Ennion et al., 1995). The 




The mechanical properties of individual fibres have been shown to be dependent 
on their MHC expression. In humans, that Vmax is faster in fibres containing MHC II than 
MHC I has been reported since the 1990s (Harridge et al., 1996, Stienen et al., 1996, 
Larsson and Moss, 1993, Bottinelli et al., 1996). Furthermore, peak power in human 
skeletal muscle fibres has been shown to be dependent on MHC isoform expression, 
increasing in the order MHC I < MHC IIA < MHC IIX (Widrick et al., 1996b).  The 
dependence of muscle fibre power on MHC isoform expression is not surprising since 
Vmax, a fundamental determinant of the force-velocity relation, is modulated by MHC 
isoform expression. The role of MHC isoform expression with regard to specific force is 
discussed later, in Chapter 2.  
 
1.3 Age related loss of muscle mass and strength 
 
Age related weakness has been attributed in part to a progressive loss of muscle mass, 
a process termed Sarcopenia (Rosenberg, 1989). Generally, elderly individuals are 
classified as sarcopenic if they exhibit a lean body mass measurement more than 2 
standard deviations lower than that of young male or female reference groups, although 
several specific criterion exist (Cruz-Jentoft et al., 2010).  Given the importance of muscle 
mass to force production, studies have tried to identify the age at which sarcopenia begins, 
as well as the rate of reduction in muscle mass and strength. Using cross-sections of 
autopsied whole Vastus Lateralis muscle, Lexell et al. (1988) reported that 10% of muscle 
mass in men had been lost by the age of 50, but muscle atrophy rate increased until almost 
50% of muscle mass had atrophied by the age of 80. Janssen et al. (2000) observed an 
increasing rate of muscle atrophy at ~45 years of age (Figure 1.3), similar to Lexell et al. 
(1988).   
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Figure 1.2. Composite force velocity and force-power curves obtained from MHC I, 
IIA and IIX fibres from sedentary, middle aged men (Widrick et al., 1996b).  
A: The force-velocity curves were obtained using isotonic load step experiments and 
demonstrate the slower velocities observed in MHC I fibres compared to MHC IIA and 
IIX fibres. B: The force-power curve from power normalised to fibre volume. Power is 
calculated from the shortening velocity at a given percentage of P0. As is illustrated, MHC 
I fibres exhibit lower power output than MHC IIA fibres, and MHC IIX fibres have been 






Attempts to accurately quantify the degree of muscle atrophy with age are difficult 
due to the cross-sectional nature of most studies. However, declines in muscle mass of 
~1.2kg per decade in men aged 49-85 (Starling et al., 1999) and 1.7kg in men aged 65 
and above (Baumgartner et al., 1999) have been reported by plotting the relationship 
between skeletal muscle mass and age. This further supports that the rate of muscle 
atrophy increases with age. Further complicating the interpretation of the aforementioned 
findings is the fact that the majority of ageing studies are performed on sedentary 
individuals. Therefore, the relative contributions of long-term inactivity as opposed to 
biological ageing, to the loss of muscle mass and strength, are difficult to determine. The 
issue of selection of participants for ageing research is addressed in section 1.4.  
Numerous causes of sarcopenia have been documented, briefly mentioned here. 
Anatomically, sarcopenia is due to a reduction in the total number of muscle fibres (Lexell 
et al., 1983), and preferential atrophy of type II muscle fibre area has been shown to occur 
with age (Lexell et al., 1988). Fibre type grouping has been shown to occur in elderly 
individuals, and is thought to be caused by the denervation and renervation of fibres in 
the gradual loss of motor neurons (Lexell et al., 1986). Using spike triggered averaging 
from surface EMG recordings, Doherty et al. (1993) reported the age-related reduction in 
number of motor units was proportional to force produced during a maximal voluntary 
contraction, indicating muscular weakness in old age was associated with the reduction 
in muscle mass. As well as reductions in muscle mass and ACSA, alterations in muscle 
architecture via the shortening of fascicles in Gastrocnemius muscle were observed in 
elderly compared to young men using ultrasonography, and contributed to a reduction in 
PCSA (Narici et al., 2003). However, the reduction in PCSA due to changes in muscle 
architecture was shown not to fully account for age-related reductions in plantar flexor 












Figure 1.3. The decline in muscle mass with advancing age. 
The relationship between whole body muscle mass (kg) determined using an MRI scan, 
and age (years). Total muscle mass remains unchanged until the age of 45, at which point 






At the molecular level, ageing is associated with increased variability in the size 
of the myonuclear domain on individual muscle fibres, which may have implications for 
muscle protein synthesis (Cristea et al., 2010). Indeed, although basal rates of muscle 
protein synthesis were similar between young and elderly men, the anabolic response 
following ingestion of essential amino acids was lower in elderly men, suggesting a 
diminished anabolic response to feeding (Cuthbertson et al., 2005). Elderly men were also 
shown to exhibit reduced muscle protein synthesis in response to resistance exercise, as 
indicated by a reduced phosphorylation of anabolic signalling targets (Kumar et al., 
2009), although the anabolic response was improved with increased exercise volume 
(Kumar et al., 2012). Further causes of sarcopenia include, but are not limited to, 
hormonal changes and the action of reactive oxygen species on cellular function, which 
are outlined in comprehensive review articles (Mitchell et al., 2015, Narici and Maffulli, 
2010). 
With regard to muscle function, cross-sectional (Skelton et al., 1994, Baumgartner 
et al., 1999) and longitudinal (Rantanen et al., 1998, Bassey, 1998) studies have reported 
significant annual losses of 1-2% in hand-grip strength with advancing age, which one 
study also reported from the quadriceps muscle (Skelton et al., 1994). The rate of strength 
loss has been shown, like the rate of muscle atrophy, to rapidly increase at a certain age. 
Vandervoort and McComas (1986) observed no significant strength changes until the age 
of 53, when strength rapidly decreased, while  Lindle et al. (1997) reported strength losses 
in the 40s. Therefore, the timing of increased strength loss coincides with the onset of 
increased muscle atrophy (Lexell et al., 1988, Janssen et al., 2000) confirming the loss of 
muscle strength associated with sarcopenia. 
Although strength losses with age are consistently reported in longitudinal studies 
(Aniansson et al., 1986, Kallman et al., 1990, Winegard et al., 1996, Bassey, 1998, 
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Rantanen et al., 1998) attempts to quantify this as annual strength losses are seldom 
performed and comparison between studies is difficult due to the different populations 
and muscle groups studied. These reasons also confound the comparison of the ‘degree 
of strength loss versus rate of muscle atrophy’ relationship between studies.  
However, several studies compared the degree of age-related muscle atrophy they 
observed with the amount of strength loss. In plantarflexors and dorsiflexors 
(Vandervoort and McComas, 1986), the forearm (Kallman et al., 1990), knee extensors 
(Madsen et al., 1997, Lindle et al., 1997), and the whole body in general (compared with 
hand-grip strength) (Baumgartner et al., 1999), a strength decrease was observed which 
was only partially explained by the loss of muscle mass. One study (Greig et al., 1993) 
found that the decline in strength was fully accounted for by sarcopenia. However, Greig 
et al. (1993) performed a longitudinal study using ultrasound scans and then computed 
X-ray tomography in the follow-up study to determine muscle mass, introducing error 
which may explain their finding. Supporting that the rate of strength loss in elderly 
individuals is greater than the loss of muscle mass, Delmonico et al. (2009) reported 
reductions in isokinetic quadriceps torque two to five times greater than the loss of muscle 
CSA, in a large cohort of 1678 elderly individuals over a period of five years. The loss of 
strength relative to muscle mass in the elderly is important, since reductions in strength 
was an independent predictor of mobility limitation in a cohort of 3075 well-functioning 
elderly people (aged 70-79 years old), more so than muscle mass (Visser et al., 2005). 
An important consideration to make when interpreting the aforementioned 
findings regarding the association between skeletal muscle mass and strength with 
advancing age, is that the physical activity levels of the cohorts studied were not 
characterised in detail. The impact of varying levels of physical activity on the 
relationship between muscle mass and strength is illustrated in Figure 1.4, which shows 
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that the loss of strength relative to muscle mass is greater in physically inactive compared 
to physically active individuals. The rationale for studying physically active elderly 
individuals is put forward in section 1.4. 
The observation of a decreased ratio of muscle strength:muscle mass suggests that 
a reduction in muscle quality occurs at the whole muscle level in elderly individuals. 
Interestingly, experiments in rats have demonstrated that specific force is reduced in the 
Plantaris muscle of elderly (25 months old) compared to young (13 months old) rats 
following hypertrophy induced via an overload intervention. Furthermore, P0 did not 
increase despite increased Plantaris muscle mass following overload induced hypertrophy 
in elderly (33 month old) rats and subsequently specific force was non-significantly 
reduced. These findings suggests that specific force loss occurs in elderly muscle even 
when atrophy does not occur (Degens et al., 1995, Degens and Alway, 2003). The 
reduction in muscle quality, as reflected by specific force measurements taken at the 
whole muscle level in humans, is discussed in section 1.5.  
 
1.4 Biological vs Chronological Ageing 
 
The reduction in physical activity which generally accompanies old age leads to 
de-conditioning, reduced fat free mass, increased body fat, and development of clinical 
diseases, which reduce the capacity of elderly individuals to carry out tasks of daily living, 
independent of the ageing process. Therefore, determining the effects of biological ageing 
on functional independence in sedentary humans is difficult (Tanaka and Seals, 2003). 
The link between chronic disease and physical inactivity, given that physical inactivity is 
a leading cause of death (Mokdad et al., 2004), suggests that human studies should use 
subjects with high physical fitness as a control group, instead of sedentary, less healthy 
individuals (Booth and Lees, 2006). While the importance of the relationship between 
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health and physical activity is accepted, the amount of exercise necessary to maintain 
good health is unclear (Blair et al., 2004). Indeed, a ‘set point’ theory has been proposed, 
whereby a minimum threshold of physical activity, specific to a given individual, may be 
required to offset the negative health impact of physical inactivity, after which point the 
effects of ageing as such, will be more clear (Lazarus and Harridge, 2016, Lazarus and 
Harridge, 2010). 
Due to the practical, financial and logistical difficulties of carrying out 
longitudinal studies in humans, there has been a reliance on information obtained from 
cross-sectional studies into the effects of ageing on skeletal muscle function (Harridge 
and Lazarus, 2017). Due to their nature, cross-sectional studies investigating human 
ageing make the assumption that the elderly cohorts studied are representative of the aged 
physiological status of their younger counterparts. In reality, intergenerational differences 
are likely to mean that changes which occur with advancing age, such as physical activity 
patterns, are not reflected by differences observed between the young and elderly cohorts 
studied (Mitchell et al., 2015). Even within the young or elderly population, a continuum 
of differing physical activity levels exists. Furthermore, when categorised based on 
physical fitness, a large overlap occurred between young and elderly individuals, meaning 
that individuals could not be identified by their age (Lazarus and Harridge, 2010). This 
demonstrates the necessity to account for an individual’s level of physical activity, when 
trying to assess the impact of biological ageing.  
Master athletes have been proposed as a model of ageing, free from the 
deleterious, aforementioned effects of inactivity. An examination of the trend in world 
record athletic performances with advancing age indicates that physical performance does 
decline with age, even in elite elderly athletes. However, this trajectory is likely to reflect 









Figure 1.4. The effect of physical activity on the relationship between muscle mass 
and strength in young and elderly populations. 
Knee extensor muscle strength expressed per kilogram of muscle mass in young female weight 
lifters (athletes, 26.3 years old), young non-athletic women (young, 24 years old), elderly healthy 
women (old, 75.5 years old) and elderly inactive patients with a previous hip fracture (inactive 
old, 76,8 years old) (Madsen et al., 1997). There is a significant decline in muscle strength per 
kilogram of muscle mass with physical status as well as age, highlighting the significance that the 









Figure 1.5. A visual representation of the effect of exercise on the preservation of 
muscle mass and quality.  
An MRI scan illustrating the transverse section of the mid-thigh of a 40 year old triathlete 
(top image), compared to a 70 year old triathlete (bottom image) and a 74 year old 
sedentary man (middle image) (Wroblewski et al., 2011). Muscle mass was preserved in 
the elderly triathlete and there was a distinct lack of infiltration of fat. In contrast, the 
sedentary, elderly individual displayed reduced muscle mass and much greater infiltration 
of adipose tissue. The reduction in muscle quality in the thigh of the sedentary, elderly 
man which is visually represented in the above MRI scan supports that the effects of 
physical inactivity mask the effect of ageing as such, on skeletal muscle mass and 
function. In contrast, the thigh muscles of the elderly triathlete are well preserved, 
suggesting that master athletes offer a model of the biological ageing process free from 
the deleterious effects of physical inactivity.  
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study of physically active elderly cohorts likely represents a population in whom the 
effects of ageing have not been masked be health complications relating to physical 
inactivity Figure 1.5. Based on this information, one of the aims of the present PhD thesis 
was to study the development of age-related specific force loss using a group of master 
cyclists whose physiological function had been carefully characterised as part of previous 
work (Pollock et al., 2015). 
 
1.5 Age-related specific force loss observed in whole muscle 
experiments 
 
A reduction in human skeletal muscle specific force as a function of increasing 
age was first reported by Men et al. (1985). Equivocal results have been reported about 
whether there is an age-related decline in specific force at the whole muscle level in 
humans. The inconsistency in observing a loss of specific force with age has been 
attributed to methodological differences between studies (Overend et al., 1992).  Indeed, 
a multitude of methodological factors must be taken into account to obtain a reliable 
specific force value at the whole muscle level, some of which are time consuming or 
expensive and therefore not always measured. With regard to obtaining reliable peak 
isometric force measurements, muscle length, co-activation of antagonist muscles and 
whether maximal voluntary activation occurs must be taken into account. For accurate 
CSA measurements, muscle fibre architecture (angles of fibre pennation) and contractile 
and non-contractile tissue must be accounted for, in order to obtain a reliable PCSA 
measurement. Hence, ranking the studies which examined the effect of age on specific 
force based on the validity of their methods (Table 1.1) and then assessing their results 
may provide a clearer picture. 
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Table 1.1 shows that when methodological factors which remove confounding 
variables of whole muscle specific force measurements are taken into account, age-related 
specific force loss is observed. In particular, studies accounting for PCSA, as opposed to 
ACSA, observed an age-related reduction in specific force. PCSA is the total CSA of all 
muscle fibres in a muscle, which takes muscle volume and pennation angle of muscle 
fibres into account, while ACSA is the area measured from a single cross-section of 
muscle (Klein et al., 2001). Klein et al. (2001) showed that PCSA vs MVC correlations 
(r = 0.86 in elbow flexors and r=0.87 in elbow extensors) were better than anatomical 
cross-sectional area (ACSA) vs MVC correlations (r = 0.83 in elbow flexors and r=0.80 
in elbow extensors), supporting that PCSA is a more valid measurement of contractile 
tissue. 
However, three studies (Jubrias et al., 1997a, Phillips et al., 1992, Bruce et al., 
1989b) which normalized force to ACSA, not PCSA did observe specific force loss in 
elderly individuals. Accurate ACSA measurements which did not largely under-represent 
the PCSA of a given muscle is a likely cause of these findings. Indeed, Phillips et al. 
(1992) and Bruce et al. (1989b) used a method to obtain adductor pollicis (AP) muscle 
CSA, which had been shown to correlate well (r = 0.937) with measurements from 
computed tomography scans. Skin thickness of the hand was also taken into account 
based on measurements from cadaveric dissection  (Bruce et al., 1989a). Furthermore, the 
AP muscle is a parallel fibred muscle, so ACSA measurements would underestimate the 
PCSA less than in a multi-pennate muscle such as the quadriceps. Jubrias et al. (1997a) 
normalized peak isokinetic force to ACSA of the quadriceps muscle, but they used an 
MRI scanner which allowed them to account for non-contractile tissue. 
Frontera et al. (1991) took non-contractile tissue into account but did not observe 
a loss of strength greater than the loss of muscle mass due to advancing age. This can be 
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explained by the fact that they measured muscle mass as opposed to CSA, so their 
measurements do not reflect specific force. Furthermore, they measured urinary 
creatinine excretion under the assumption that it is proportional to muscle mass, which 
may not be reliable in all subjects (Heymsfield et al., 1983). This indirect measure of 
muscle mass was used in 141 subjects, but applied the results to the full cohort of 200 
subjects, indicating that significant discrepancy in muscle mass estimation is likely to 
have occurred. 
Cannon et al. (2001) did not report specific force loss with age, however their 
‘elderly’ cohort had a mean age of 53.9 years, which is relatively young compared to 
other publications. Overend et al. (1992) did not observe specific force loss from 
isometric contractions of elderly individuals but did in isokinetic contractions in the same 
study, while Frontera et al. (2000b) reported specific force loss in permeabilised fibres 
but not at the whole muscle level of the same study. Therefore, only one study assessed 
in Table 1.1 did not report age-related specific force loss having taken non-contractile 
tissue into account (Kent-Braun and Ng, 1999). This strongly suggests that once 
methodological differences are considered, the majority of the research consistently finds 






Figure 1.6. Methodological considerations required for the calculation of PCSA.   
A: The MRI scan of the thigh of a young (aged 24) person (Jubrias et al., 1997b) can be 
used to account for non-contractile tissue, and the thigh volume can be calculated from 
MRI scans taken at regular intervals along the thigh. B: An example of an ultrasound 
image used to measure fascicle length and pennation angle of the triceps brachii 
(Kawakami et al., 1993). The image to the right is a labelled version of the image to the 
left. Adipose tissue (AT) and bone (Humerus) are labelled accordingly. The echoes from 
aponeurosis (APO) and interspaces among fascicles are indicated by the white lines. The 
muscle fibre pennation angles were defined as the angles between the echoes of the 
aponeurosis of the triceps and the echoes from interspaces among the fascicles. The 
pennation angles of the long and medial heads are represented by angles ‘A’ and ‘B’ 



































force loss?   
(p < 0.05) 
Muscle Age (years) 
and sex of 
subjects 
Morse et al 
(2005) 
          Gastrocnemius 74, Male 
Klein et al 
(2001) 
          Elbow flexors 
and extensors 
81, Male 
Macaluso et al 
(2002) 




Kent Braun & 
Ng (1999) 





Cannon et al 
(2001) 
          Knee extensors 54, Male 
Phillips et al 
(1992) 





Jubrias et al 
(1997) 
          Quadriceps 65-80, 
Male and 
Female 
Lynch et al 
(1999) 
          Elbow and knee, 
flexors and 
extensors 



































force loss?   
(p < 0.05) 
Muscle Age (years) 
and sex of 
subjects 
Bruce et al 
(1989) 
          Adductor 
pollicis 
81,    Male 
and 
Female 
Overend et al 
(1992) 
          Quadriceps, 
Hamstring 
71,   Male 
Frontera et al 
(2000) 
          Quadriceps, 
Elbow extensors 
77,   Male 
Frontera et al 
(1991) 






Table 1.1. The observation of age-related specific force loss at the whole muscle level, in relation to the methodological measurements 
accounted for when measuring specific force.  
A given publication is listed in the far left column, and the methodological factors listed in subsequent columns to the right. A green tick or red 
cross indicate that a given measurement was or was not taken respectively. Generally, specific force loss was observed in studies with more valid 
PCSA measurements, suggesting that differences between studies can be explained by methodological differences.
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1.6 The permeabilised skeletal muscle fibre technique 
 
To overcome the limitations of in vivo approaches, researchers have used in vitro 
methods to study human muscle function and specific force. This has been achieved by 
investigating the properties of segments of single fibres, usually obtained from a muscle 
biopsy sample. Pioneered during the 1970s, chemical skinning dissolves the lipid bilayer 
of a single muscle fibre by means of detergents such as Triton X-100, but leaves the 
myofilament lattice functionally intact (Stienen, 2000).  
The confounding variables of whole muscle experiments, such as heterogeneous 
fibre type populations, the presence of non-contractile tissue, neural influences and 
differences in muscle fibre architecture, are offset using the chemically skinned single 
fibre model. The CSA and P0 of an individual fibre can be measured and the MHC 
expression determined, allowing for a detailed characterisation of an individual muscle 
fibre’s intrinsic force generating capacity. Once skinned, the myofilaments are exposed 
to experimental solutions, described in detail in Chapter 4, which control a given fibre’s 
intracellular environment and allow for direct investigation of the activity of the 
myofibrillar proteins during contraction (Larsson et al., 1997, Frontera et al., 2000a).  
The chemically skinned fibre technique is used to model the contractile function of 
the myofilaments for a single muscle fibre in vivo. For practical reasons, intact skeletal 
muscle fibre contractile measurements cannot currently be taken in humans. Therefore, 
the comparison of skinned fibre specific force in humans is limited to a direct comparison 
with whole muscle specific force. As discussed in section 1.5, a multitude of 
methodological factors must be taken into account in order to accurately measure whole 
muscle specific force. O'Brien et al. (2010) measured specific force from the human 
quadriceps muscle with great accuracy and report that specific force was similar across 
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adult men and women and pre-pubertal boys and girls, being approximately 560 kPa in 
each group. In contrast, the highest mean human, skinned fibre specific force value 
reported from young healthy individuals is 331 kPa and 367 kPa for type I and IIA fibres 
respectively, measured at 12°C (Yu et al., 2007). The discrepancy in skinned fibre and in 
vivo skeletal muscle specific force is at least in part due to the sub-physiological 
temperatures used to study skinned fibres, which keep the fibres from breaking, but lower 
the force produced. Methodological factors affecting skinned fibre force measurements 
are discussed further in Chapter 2.  
Currently, the best way of comparing skinned fibre contractile properties with those 
observed in vivo is by comparing skinned and intact fibres from animal models (Curtin et 
al., 2015). However, as will be discussed extensively in Chapter 2, specific force values 
published by different research groups vary greatly, suggesting that the methodological 
practice of a given research group influences the skinned fibre contractile response. 
Therefore, skinned and intact fibre contractile data from the same research group and 
preferably the same animal would be required to provide a direct comparison of data 
obtained using the two techniques.  
In this regard, Curtin et al. (2015) measured skinned fibre specific force and power 
from intact and skinned rabbit skeletal muscle tested at the same experimental 
temperature (25°C), since force and power generation are sensitive to temperature (Rall 
and Woledge, 1990, Woledge et al., 2009). Skinned and intact fibre specific forces were 
similar across a range of CSA values, indicating that the results were not influenced by 
the size of the fibre selected for experimentation. Skinned and intact fibre power 
normalised to volume was also similar between the two preparations. Furthermore, since 
P0 is proportional to the contractile tissue of a muscle fibre, the authors normalised power 
to P0 to eliminate any potential errors in CSA or volume calculations, and observed that 
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the ‘relative power’ was also similar between the two preparations. These findings 
support that the skinned fibre technique can be used to study in vivo muscle function.  
 
1.7 Contractile measurements reported from human, chemically 
skinned skeletal muscle fibres 
 
The methodological factors which must be taken into account when measuring in 
vivo specific force from whole muscle have been discussed in section0. Confounding 
variables of whole muscle experiments such as heterogeneous fibre type populations, 
presence of connective tissue, differences in muscle fibre architecture and neural 
influences, are offset using chemically skinned single muscle fibres. The skinned fibre 
technique allows for direct investigation of the activity of myofibrillar proteins during a 
muscle contraction (Larsson et al., 1997, Frontera et al., 2000a).  
Like the equivocal results in whole muscle experiments, mixed results regarding 
the occurrence of age related specific force loss have been reported from studies using 
chemically skinned single muscle fibres. Given that physical activity is an important 
determinant of the contractile properties of skeletal muscle, the following literature 
review groups discussion points based on the general physical activity profiles of the 
elderly participants studied. Hence, the impact of studying sedentary, physically active or 
mobility-limited elderly cohorts is addressed. Where relevant, results assessing the impact 
of physical activity interventions on skinned fibre specific force from young individuals 
is considered. Furthermore, the mechanism underpinning the observed trends in reported 
specific force between young and elderly individuals is discussed with regard to skinned 





1.7.1 The effect of non-weight bearing on skinned fibre specific force 
 
Interventions which prevent weight bearing on a given limb have been used as a 
model of accelerated ageing, as they enable the study of the acute or chronic effects of 
disuse on the contractile properties of skeletal muscle. Following two weeks of unilateral 
lower limb cast immobilisation, healthy young (n = 9; mean age: 24) and elderly (n = 8; 
mean age: 67) men displayed reductions in Vastus Lateralis MHC I fibre CSA and a 
significant decrease in MHC IIA fibre CSA. P0 and specific force significantly decreased 
in MHC I fibres and particularly MHC IIA fibres in both groups to a similar degree, with 
no significant differences in specific force observed between the two groups (Hvid et al., 
2011). Furthermore, young (n = 11; mean age: 24) and elderly (n = 11; mean age: 67) 
men who underwent four days of unilateral lower limb disuse in a knee brace exhibited 
significant reductions in MHC I fibre specific force, while MHC IIA fibre specific force 
was only lower in young men (Hvid et al., 2013). Importantly, the similar effects of non-
weight bearing on the specific force in skinned fibres from young and elderly individuals 
suggests, that interventions carried out in young individuals can mimic the effects of 
muscle disuse in the elderly. 
However, the validity of the aforementioned results is difficult to determine, since 
sarcomere length and experimental temperature were not formally measured and skinned 
fibre force has been shown to be sensitive to both parameters (Gollapudi and Lin, 2009) 
(Stienen et al., 1996). Widrick et al. (2002) reported that MHC I Soleus fibre CSA, P0 and 
specific force were significantly decreased in young women (n = 4; age = 26) who 
underwent twelve days of unilateral lower limb suspension. This indicates that short-term 




Exposing participants to a 6° head down tilt, bed rest model, hereby referred to 
simply as ‘bed rest,’ has been used to induce non-weight bearing for durations greater 
than two weeks. A seventeen day period of bed rest in middle aged (n = 8; mean age: 43) 
men did not affect Soleus MHC I fibre specific force, since P0 decreased in proportion to 
fibre CSA,  (Widrick et al., 1997). Consistent with their bed rest study, Widrick et al. 
(1999) reported that Soleus MHC I and IIA fibre specific force was unaffected in male 
astronauts (n = 4; mean age: 43), despite significant decreases in fibre diameter and P0 in 
both fibre types following seventeen days of spaceflight. No changes were observed in 
Gastrocnemius fibres (Widrick et al., 2001). Thus, reductions in the morphological 
features of single fibres have been observed due to periods of non-weight bearing less 
than three-weeks, which are associated with a reduced absolute force generating capacity, 
but not reduced intrinsic contractile quality. Potential reasons for the lack of observation 
of reduced skinned fibre specific force from the studies in microgravity is that spaceflight 
is a model of non-weight bearing, but not physical inactivity, as the astronauts’ physical 
activity levels were not controlled for.  
In a bed rest study of long duration, thirty-seven days of bed rest decreased MHC 
I and IIA Vastus Lateralis fibre specific force by 44.6% and 41.5% respectively, in young 
men (n = 3; mean age: 28) (Larsson et al., 1996). The impact of a long duration of eighty-
four days of bed rest was studied in young men (n = 6; mean age: 32), and caused a 
significant reduction in Vastus Lateralis MHC I and IIA fibre diameter and P0. MHC I 
fibre specific force was significantly reduced by 28%, while the same trend was not 
significant in MHC IIA fibres (Trappe et al., 2004). Consistent with these findings, young 
women (n = 7; mean age: 34) who underwent sixty days of bed rest exhibited significantly 
reduced diameter and P0 in Vastus Lateralis MHC I and IIA fibres, and Soleus MHC I 
fibres. Specific force was significantly reduced by 16% and 15% in MHC I Vastus 
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Lateralis and Soleus muscle fibres respectively (Trappe et al., 2007) (Trappe et al., 2008). 
Collectively these findings indicate that specific force loss occurs following a period of 
non-weight bearing greater than one month, primarily in MHC I fibres. 
In contrast to the effect of exposure to bed rest alone, the incorporation of a 
resistance exercise countermeasure in young men (n = 6; mean age: 32) who underwent 
eighty-four days of bed rest prevented decreases in Vastus Lateralis MHC I or IIA fibre 
diameter. Indeed, fibre diameter increased non-significantly in both fibre types. No 
significant differences in P0 or specific force were observed, although these 
measurements were lower in MHC I fibres compared with before bed rest (Trappe et al., 
2004). Young women who underwent sixty days of bed rest with a concurrent resistance 
and aerobic exercise countermeasure did not exhibit changes in MHC I or IIA Vastus 
Lateralis fibre diameter, P0 or specific force (Trappe et al., 2007). Soleus MHC I fibres 
exhibited reduced diameter and P0 but not specific force (Trappe et al., 2008). These 
findings support that physical activity prevents the negative effects of non-weight bearing 
on the contractile properties of skinned skeletal muscle fibres. 
If long-term non-weight bearing studies accurately reflect the effects of 
accelerated ageing on skeletal muscle, the aforementioned results suggest that specific 
force loss occurs at the single fibre level due to prolonged periods of muscle disuse. 
However, these negative effects were ameliorated and muscle function was maintained 
as a result of exercise. In contrast, while negative changes in skinned fibre morphological 
features and absolute force occurred, specific force loss following shorter term non-
weight bearing was not consistently observed. This potentially indicates that a relatively 
extreme non-weight bearing stimulus is needed to induce changes to the intrinsic 
contractile strength of a muscle fibres, as opposed to only morphological changes. 
Furthermore, the fact that young people have been shown to exhibit specific force loss 
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following immobilisation or bed rest suggests that the mechanism of specific force loss 
could be studied in young people. 
 
1.7.2 The effect of ageing on skinned fibre specific force: findings from sedentary, 
elderly cohorts 
 
Studies investigating the effects of ageing on skinned fibre contraction typically 
do not contain a detailed record of the physical activity profile of the young and elderly 
cohorts studied. Therefore, the following sections discuss findings from studies which 
have been grouped based on the general physical activity profiles (i.e. sedentary, master 
athlete etc.) of the cohort studied.  
In sedentary, elderly cohorts, several studies have observed specific force loss in 
both MHC I and IIA fibres. Larsson et al. (1997) reported significantly lower specific 
force in MHC IIA but not MHC I, chemically skinned Vastus Lateralis fibres from 
sedentary elderly (n = 2; age range: 73-81) compared to young (n = 2; age range: 25-31) 
men. Please note, the results from freeze dried fibres are not considered here, since the 
freeze drying process was shown to impair skinned fibre force generation (Larsson et al., 
1997). Frontera et al. (2000a) studied a higher number of subjects and observed that 
compared to young men (n = 7; mean age: 37), specific force was significantly lower in 
both MHC I and IIA Vastus Lateralis fibres from elderly men (n = 12; mean age: 74). A 
later study also showed that specific force was significantly lower in skinned MHC I and 
IIA Vastus Lateralis fibres from elderly men (n = 6; mean age: 66) compared to young 
men (n = 6; mean age: 32) (Ochala et al., 2007).  
Some evidence exists supporting that the onset of specific force at the single fibre 
level may be influenced by gender. No difference in MHC I Vastus Lateralis fibre specific 
force was found between sedentary young women (n = 7; mean age: 27) and two groups 
of elderly women (both groups, n = 7; mean age: 74) (Frontera et al., 2003), in contrast 
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to observations made in men by the same group (Frontera et al., 2000a). Suggesting that 
elderly women may be less susceptible to specific force loss, MHC I Vastus Lateralis 
fibre specific force was found to be higher in elderly women (n = 12; age range: 65-85) 
than men (n = 10; age range: 65-85) (Yu et al., 2007), although specific force was still 
significantly lower in elderly compared with young men (n = 7; age range: 20-43) and 
women (n = 7; mean age: 72). Furthermore, both MHC I and IIA fibre specific force had 
previously been found to be significantly lower in elderly women  compared with elderly 
men (n = 12; mean age: 74) (Frontera et al., 2000a). Therefore, these findings do not 
clearly indicate whether the decline in specific force differs between elderly women 
compared to men, or whether specific force is higher in elderly women compared to men.  
In contrast to the aforementioned findings, several studies have reported no 
significant differences between young and elderly individuals in skinned fibre specific 
force. Trappe et al. (2003) studied life-long sedentary individuals, removing the 
confounding variable of differences in physical activity between the young and elderly 
groups. No significant differences in MHC I or IIA Vastus Lateralis fibre specific force 
were observed, except that MHC IIA specific force was significantly lower in young men 
(n = 6; mean age: 25), compared to young women (n = 6; mean age: 25) and elderly men 
(n = 6; mean age: 80) and women (n = 6; mean age: 78). Consistent with these findings, 
no differences were observed in Vastus Lateralis MHC I and IIA specific force between 
non-exercising young (n = 9; mean age: 21) and elderly women (n = 6; mean age: 85) 
(Raue et al., 2009), or healthy young (n = 9; mean age: 24) and elderly (n = 8; mean age: 
67) men (Hvid et al., 2011).  
Overall, clear disparity exists in the literature regarding whether or not specific 
force loss occurs in human MHC I and IIA skinned skeletal muscle fibres from the elderly 
vs young sedentary or non-exercising population. These equivocal results contradict the 
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consistent observation that specific force loss occurs in young individuals following non-
weight bearing interventions of long duration. Therefore, the models of accelerated 
ageing in skeletal muscle in young participants may not accurately reflect the effects of a 
sedentary lifestyle. Another possibility is that the level of physical activity required to 
maintain healthy muscle function, or at least prevent the deleterious effects of an inactive 
lifestyle, differs between different individuals (Lazarus and Harridge, 2016). This would 
be expected to result in the onset of specific force loss at the myofilament level in some 
but not all elderly individuals. The equivocal results reported by different authors have 
also been attributed to the varying physical activity levels of the individuals studied. 
Indeed, neuromuscular activity has been shown to affect the contractile properties of 
human skinned fibres in young (Meijer et al., 2015) and elderly subjects (D'Antona et al., 
2007), the physical activity level of the individuals comprising an experimental group is 
likely to affect the specific force results.  
 
1.7.3 The effect of physical activity on skinned fibre specific force in elderly cohorts 
 
D’Antona et al. (2007) studied the impact of varying levels of physical activity on 
the development of specific force with advancing age. Vastus Lateralis fibres were 
studied from young subjects (n = 5; mean age: 30) who were recreationally active and 
compared with fibres obtained from three elderly groups (mean age: 73) with distinct 
physical activity patterns: 1) sedentary but functionally independent elderly subjects (n = 
3); 2) elderly subjects who walked at least two hours per day (n = 4); 3) elderly endurance 
trained subjects (n = 3). Specific force was not significantly different in the elderly 
endurance trained group compared to the young controls. In contrast, MHC I fibre specific 
force in the elderly control group was significantly weaker than in young controls, and 
both MHC I and IIA specific force was significantly lower in the sedentary elderly group 
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compared to those in young controls. Furthermore, specific force measurements from 
MHC I and IIA fibres of elderly immobilised subjects (n = 2; aged 70 and 72) from their 
previous work (D’Antona et al, 2003) were included for comparison and the specific force 
loss observed was greater still (Figure 1.7). These data suggest a clear trend exists 
between the level of daily physical activity and the regulation of specific force in old age. 
Consistent with these findings, specific force from Vastus Lateralis MHC I and IIA fibres 
was not significantly different between young (n = 8; age range: 18-33) and elderly (n = 
9; 53-77) individuals who had a long-term sprint training background and who were still 
sprint-training at the time of study (Korhonen et al., 2006). 
Interestingly, the higher specific force observed in endurance trained compared to 
sedentary elderly individuals is not reflected in results observing no difference in skinned 
fibre specific force between endurance trained and untrained young (Harber and Trappe, 
2008, Fitts et al., 1989) and middle aged (Widrick et al., 1996a) men. However, specific 
force measured from skinned MHC I and IIA Gastrocnemius fibres from young, 
recreationally active individuals and trained runners, increased due to endurance running 
training (Harber et al., 2004, Trappe et al., 2006). This suggests that endurance training 
does improve specific force, supporting the findings that skinned fibre specific force is 







Figure 1.7. Age-related, skinned fibre specific force loss is ameliorated by physical 
activity.  
Specific force from MHC I fibres (left) and MHC IIA fibres (right), obtained from young 
controls (CTRL), elderly endurance trained (EL-END), elderly controls (EL-CTRL), 
elderly sedentary (EL-SED), and elderly immobilized subjects (EL-IMM). Data are 
means ± SEM and specific force significantly (p < 0.05) different from the young control 
group is marked using the black dot. Specific force was not significantly different in 
elderly endurance trained individuals compared to young controls in either MHC I or IIA 
fibres. No significant difference was observed in MHC IIA fibre specific force from 
elderly control subjects compared to young controls. Otherwise, MHC I and MHC IIA 
fibre specific force was significantly lower in all other groups compared to young 
controls. These data suggest that physical activity prevents the onset of specific force loss 







Results from some studies contradict the hypothesis that maintenance of physical 
activity in old age will maintain skeletal muscle fibre specific force. Frontera et al. 
(2000a) estimated the average weekly energy expenditure of their participants using a 
questionnaire, which revealed that the elderly men (n = 12; mean age: 74) averaged 1,431 
± 1,455 kcal/wk compared with 657 ± 747 kcal/wk (means ± SD) in the young men (n = 
7; mean age: 37). Even though their average weekly energy expenditure was double that 
of the young men, specific force was significantly lower in MHC I and IIA skinned Vastus 
Lateralis fibres from elderly men compared with young men. However, the large standard 
deviation in physical activity levels for both young and elderly groups suggests that the 
physical activity profiles differed considerably between individuals in each experimental 
group. Therefore, the findings are unlikely to reflect the impact of physical activity on 
skinned fibre specific force. 
MHC I and IIA Vastus Lateralis fibres from elderly individuals (n = 2; age range: 
73-81) who had maintained an exercise programme for at least three to six days per week 
produced similar specific force to elderly controls (n = 2; age range: 73-81) and 
significantly less than young subjects (n = 4; 25-31) (Larsson et al., 1997). This suggests 
that physical activity does not prevent age induced specific force loss, although a 
weakness of this study is the low number of participants studied. A more strongly 
powered study of similar design measured specific force from Vastus Lateralis fibres of 
young adults (n = 6; mean age: 23), non-athlete elderly adults (n = 5; mean age: 78) and 
elite masters track and field athletes (n = 6; mean age: 79) (Power et al., 2016). P0 and 
specific force were significantly higher in the young group compared with both elderly 
groups, while no significant differences were observed between the elderly groups, 




1.7.4 Skinned fibre specific force measured from mobility-limited elderly cohorts 
 
Supporting that the level of physical activity maintained in old age does not affect 
skinned fibre specific force, some research also suggests that muscle disuse does not have 
a negative impact on skinned fibre contractile properties. For instance, specific force, P0 
and CSA of MHC I and IIA Vastus Lateralis fibres were similar between elderly male (n 
= 12; mean age: 79) and female (n = 13; mean age: 77) subjects classified as mobility-
limited based on the Short Physical Performance Battery test, healthy elderly males (n = 
16; mean age: 74) and females (n = 7; mean age: 74), and healthy, middle aged males (n 
= 12; mean age: 47) and females (n = 11; mean age: 48) (Reid et al., 2012).  
Interestingly, Venturelli et al. (2015) compared specific force from two muscles 
which in theory, undergo different degrees of disuse with advancing age, by comparing 
Vastus Lateralis and Biceps Brachii skinned fibre specific force. As age-related declines 
in physical activity are primarily associated with lower limb disuse, the Vastus Lateralis 
was expected to have undergone a greater degree of disuse than the Biceps Brachii, 
relative to the same muscles from young individuals. Vastus Lateralis and Biceps Brachii 
MHC I and IIA specific force was similar between healthy, young women (n = 8; mean 
age: 25), elderly mobile women (n = 8; mean age: 87) and elderly immobilised women 
(n = 8; mean age: 88) who had been wheelchair bound for two years and were unable to 
walk independently (Venturelli et al., 2015). These observations that mobility-limited and 
wheel chair bound elderly individuals do not exhibit specific force loss are surprising, 
given the reports in young cohorts that immobilisation causes a reduction in skinned fibre 





1.7.5 Observations of improved skinned fibre specific force with advancing age 
 
Different still to the findings previously presented, recent research has suggested 
that the specific force generating capacity of Vastus Lateralis fibres improves with 
advancing age. In a three year follow up study on a mobility-limited elderly cohort (n = 
22; mean age: 77) and healthy elderly cohort (n = 26; mean age: 74) MHC I and IIA 
Vastus Lateralis fibre specific force was significantly higher in both groups (Reid et al., 
2014) compared with previously reported measurements (Reid et al., 2012). Consistent 
with these findings, Grosicki et al. (2016) reported Vastus Lateralis MHC IIA fibre 
specific force in eighty-eight year old men and women which was 42% greater than 
twenty year olds and 19% greater than younger octogenarians previously studied in their 
lab. MHC I fibre specific force was 31% greater in the eighty-eight year olds compared 
with the healthy twenty year olds. The authors attribute these findings to a maintenance 
of the highest quality muscle fibres in very elderly people.  
 
1.7.6 Potential causes of the equivocal findings reported as to the occurrence of 
age-related specific force loss in skinned fibres 
 
The equivocal results reported as to the occurrence of age-related specific force 
loss at the skinned fibre level are epitomised by the report of two different conclusions 
from skinned fibres form the same individuals, in the same study. Elderly men and women 
(n = 16; mean age: 71) who suffered from knee osteoarthritis, which substantially reduces 
weight bearing activity on the affected limb, exhibited similar MHC I and IIA Vastus 
Lateralis fibre specific force measured at 25°C, compared to healthy controls (n = 15; 
mean age: 68). However, MHC IIA specific force measured at 15°C, a lower experimental 
temperature, was significantly lower in the osteoarthritic group compared with healthy 
controls (Callahan et al., 2014). This suggests that experimental conditions are a factor 
which influence the results from experiments on skinned fibres. 
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Another example of a methodological factor affecting the conclusion from a given 
study was demonstrated by Toth et al. (2012). No change in MHC I and IIA Vastus 
Lateralis fibre specific force measured at both 15°C and 25°C was observed in sedentary, 
elderly men and women (n = 14; mean age: 72) as a result of an eighteen week resistance 
training programme. Electron microscopy (EM) images revealed that the myofibril area 
fraction was reduced following resistance training. Therefore, P0 was normalised to the 
myofibril area (~74-84% of CSA) as opposed to the CSA, which revealed that skinned 
fibre specific force measured at 25°C was significantly increased in MHC I and IIA fibres 
following resistance training. The authors suggest that skinned fibre CSA may not be 
stable proxy of the area of contractile machinery. Indeed, this may be the case, given the 
variable change in skinned fibre CSA which occurs as a result of swelling due to the 
chemically skinned procedure (discussed in section 2.1.6). However, these data must be 
interpreted with caution because the myofibrillar fraction was extrapolated using the EM 
data from a sub-set of the participants studied.  
If skinned fibre CSA does not accurately represent the myofibrillar proteins 
contributing to force generation, then this could explain why shorter duration (twelve 
week) resistance training studies have not reported increased specific force. However, 
Toth et al. (2012) only observed a different trend when normalising force data obtained 
at 25°C, not 15°C, to the myofibrillar fractional area. Based on the fact that the other 
studies considered thus far were conducted at 12°C or 15°C, normalising P0 to 
myofibrillar fractional area may make no difference. 
Relatively few studies (Larsson et al., 1996, Trappe et al., 2003, D'Antona et al., 
2003) have attempted to quantify the myofibrillar protein content of the elderly and young 
cohorts used to study the onset of specific force loss. This is likely due to the numerous 
technical considerations (outlined in sections 3.12 and 5.3.4) which must be taken into 
55 
 
account when quantifying protein content using Sodium Dodecyl Sulphate 
Polyacrylamide Gel Electrophoresis (SDS PAGE), one of the most commonly employed 
methods (Geiger et al., 2000). Given that the skinned fibre preparation is used to represent 
the interaction of the myofilaments during a muscle contraction, the myofibrillar protein 
content is one of the primary factors influencing skinned fibre specific force. Therefore, 
information about the myofibrillar protein content in a given experimental group could 
provide important information regarding the trends in reported results (discussed in 
section 1.7.7.1). 
 
1.7.7 Mechanisms of human skinned fibre specific force loss 
 
Published reports have shown that physical activity maintains specific force and 
immobilisation causes a decrease in specific force (D’Antona et al., 2007), while other 
studies observed a lower specific force in master athletes (Power et al., 2016), or no 
change following prolonged muscle disuse (Venturelli et al., 2015). Contrary to all the 
aforementioned trends, increases in specific force have been observed with advancing age 
(Grosicki et al., 2016). Clearly, even when results are considered in the context of a given 
physical activity profile of the cohorts studied, considerable disparity is observed. 
However, despite the equivocal results regarding a) the occurrence of specific force loss 
in sedentary elderly people, b) the maintenance of specific force by maintaining physical 
activity and c) whether elderly people are actually left with fibres which are capable of 
producing higher specific force values than young people, the mechanism of specific 
force production with regard to the myofibrillar proteins is relatively consistent. The 
following section discusses the published findings regarding the association between 




1.7.7.1 The association between skinned fibre myofibrillar protein content and 
specific force 
 
The generally accepted view that the observation of age-related specific force loss 
is inconsistent in the skinned fibre literature is summed up by D’Antona et al. (2007): 
“Notwithstanding the large body of information on single muscle fibre contractile 
properties in old age, contradictory results have still been reported in the two most recent 
and detailed studies performed so far (D'Antona et al., 2003) (Trappe et al., 2003).”  
However, while some studies have reported reduced specific force in elderly individuals 
and others have not, the reported mechanism regulating specific force with regard to 
skinned fibre myofibrillar protein content appears to be consistent. 
Skinned skeletal muscle fibre myosin concentration has been quantified by 
measuring the optical density of a given fibre’s MHC bands on SDS PAGE. A lower 
myosin concentration in Vastus Lateralis fibres from young men (n = 3; mean age: 28) 
was associated with reduced specific force, as a result of thirty-seven days of bed rest, 
although the myosin concentrations of the different fibre types were not specified 
(Larsson et al., 1996). D'Antona et al. (2003) correlated the myosin concentration of 
Vastus Lateralis fibres from young (n = 7; mean age: 30), healthy elderly (n = 7; mean 
age: 73) and immobilised elderly (n = 2; age 70 and 72) men with specific force measured 
from a separate set of fibres from the same individuals. The myosin content of each group 
displayed a positive linear relationship with skinned fibre specific force, meaning skinned 
fibres exhibiting the lowest or highest specific force also had the lowest and highest 
myosin concentrations respectively. These findings clearly demonstrated that specific 
force loss is associated with a reduced myosin content.  
In contrast to the aforementioned findings, no difference in myosin and actin 
concentrations in homogenate muscle samples were observed between life-long sedentary 
young (n = 6; mean age: 25) and elderly (n = 6; mean age: 80) men, or between young (n 
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= 6; mean age: 25) and elderly (n = 6; mean age: 78) women. The lack of difference in 
myofibrillar protein concentration mirrored the lack of a difference in skinned fibre 
specific force between the young and elderly groups (Trappe et al., 2003). Furthermore, 
in middle aged (n = 8; mean age: 43) individuals who underwent seventeen days of bed 
rest, no change in Soleus myosin thick filament density occurred, as indicated by electron 
microscopy (EM) images (Widrick et al., 1997). The lack of difference in myosin thick 
filament density pre- and post-bed rest was associated with no difference in specific force.   
The relationship between skinned fibre specific force, myofibrillar protein content 
and cross-bridge behaviour, has been examined in healthy individuals and compared to 
models of specific force loss in pathological conditions other than ageing. Ochala and 
Larsson (2008) observed significantly lower specific force in MHC I and IIA Vastus 
Lateralis fibres from a group of three patients suffering from acute quadriplegic myopathy 
(AQM) and one from small cell lung cancer (n = 4; age range: 22-77) compared with 
healthy age matched controls (n = 7; age range: 26-67). The specific force loss was 
associated with a reduction in the ratio of myosin:actin, indicating a preferential 
degradation of myosin in the patients compared to the healthy controls. Furthermore, 
when specific force was divided by the ratio of myosin:actin, no differences in specific 
force per unit of myosin/actin was observed between either group in MHC I and IIA 
fibres. This supports that skinned fibre specific force is modulated by myofibrillar protein 
content (Ochala and Larsson, 2008).  
The aforementioned studies indicate that there is a strong relationship between 
myofibrillar protein content and the intrinsic force generating capacity of skinned fibres, 
irrespective of whether specific force loss occurs in one group relative to another. 
Therefore, data quantifying the skinned fibre protein content provide a mechanistic basis 
to support the observed trends in specific force between groups. Some studies indicate 
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that a reduced myosin content can be caused by physical inactivity such as cast 
immobilisation (D'Antona et al., 2003) or thirty-seven days of bed rest (Larsson et al., 
1996), whereas others have not observed reductions in myosin content or specific force 
due to inactivity of shorter duration, i.e. seventeen days of bed rest (Widrick et al., 1997). 
 
1.7.7.2 The relationship between protein content and instantaneous stiffness in 
human skinned fibres 
 
The ‘stiffness’ of a muscle fibre is used to reflect the number of bound acto-
myosin cross-bridges during an isometric contraction, and refers to the dependence of P0 
on fibre length at a given moment (Huxley and Simmons, 1971). Furthermore, evidence 
indicates that cross-bridges can be bound in high force or low force producing states 
(Lowe et al., 2001, Ostap et al., 1995), indicating that the behaviour, as well as the number 
of cross-bridges, can influence force production.  
The association between reduced skinned fibre specific force and myofibrillar 
protein content suggests that the mechanism of specific force loss is a lower number of 
available cross-bridges during an isometric contraction. Indeed, skinned fibre stiffness, 
representing the number of bound acto-myosin cross-bridges during an isometric 
contraction, was significantly lower in both MHC I and IIA fibres from AQM patients 
compared with healthy, control participants. The reduced stiffness corresponded to the 









Figure 1.8. The relation between skinned fibre specific force and myosin 
concentration.  
Myosin concentration and specific force of MHC I (clear symbols) and IIA 
(filled symbols) single skinned fibres from young individuals (circles) (specific 
force measurements: MHC I, n = 60; MHC IIA, n = 45), sedentary elderly 
individuals (squares) (specific force measurements: MHC I, n = 49; MHC IIA, 
n = 28) and elderly individuals whose leg had been immobilized for 3.5 months 
in a cast (triangles) (specific force measurements: MHC I, n = 28; MHC IIA, n 
= 21). A clear linear relationship between skinned fibre specific force and 
myosin content was observed between the experimental groups studied. The sloe 
of the regression lines for MHC I (0.185 ± 0.006) and MHC IIA (0.314 ± 0.41) 
were both statistically different from zero (p < 0.05). This relationship suggests 
that skinned fibre specific force is strongly related to myosin content.  
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A strong linear relationship was observed between relative stiffness and relative force for 
both MHC I and IIA fibres from both groups. This indicates that skinned fibre force is 
proportional to the percentage of available cross-bridges which are bound during an 
isometric contraction in both patients and healthy controls. Furthermore, the ratio of 
specific force:fibre stiffness at a given pCa was similar between healthy controls and 
patients, suggesting that the force produced by each cross-bridge was similar between the 
two groups (Ochala and Larsson, 2008). Collectively, these findings support that skinned 
fibre specific force is modulated by the number of bound acto-myosin cross-bridges, 
which are in turn modulated by the concentration of myofibrillar protein in a given 
skinned fibre. 
  
1.7.7.3 Evidence that specific force is affected by cross-bridge behaviour 
 
Evidence suggests that even when there is no reduction in skinned fibre 
myofibrillar protein content, cross-bridge behaviour, as opposed to the number of bound 
cross-bridges, can reduce force production (Toth et al., 2013). Myosin and actin content 
in cancer patients (n = 11; mean age: 59), quantified from homogenate muscle samples 
run on SDS PAGE gels, was similar to age matched healthy controls (n = 6; mean age: 
65). Accordingly, MHC I Vastus Lateralis fibre specific force did not differ between 
groups, but MHC IIA fibre specific force was 14% lower in cancer patients despite the 
lack of difference in myofibrillar protein content. This was attributed to a significantly 
reduced number of bound cross-bridges in MHC IIA fibres from cancer patients, as 
indicated by stiffness measurements (Toth et al., 2013). When considered in the context 
of ageing, these results suggest that specific force loss could occur due to a lower number 
of bound cross-bridges, even when myofibrillar protein content is not diminished.  
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Interestingly, some evidence exists to suggest that acto-myosin cross-bridge 
behaviour can, in fact, compensate for a lower myofibrillar protein concentration i.e. 
fewer total cross-bridges available, in order to maintain specific force. MHC I Vastus 
Lateralis fibres from a mixed-sex cohort of heart failure patients (n = 10; mean age: 72) 
displayed lower specific force, lower myosin content and subsequently lower acto-
myosin cross-bridge stiffness compared to age matched controls with a similar daily 
physical activity profile (n = 10; mean age: 69) (Miller et al., 2009). Thus, the results for 
type I fibres were consistent with the idea that reduced skinned fibre specific force was 
due to a lower total number of cross-bridges. In contrast, MHC IIA fibre specific force 
and fibre stiffness was not significantly different in heart failure patients despite a 
significantly lower myosin content compared to young controls. The maintenance of fibre 
stiffness was explained by a higher proportion of the available cross-bridges being in a 
bound state, as indicated by the higher ratio of fibre stiffness to in rigor fibre stiffness, the 
latter representing the total cross-bridges available in a given skinned fibre (Miller et al., 
2009). Therefore, although outside the context of ageing, these results suggest that acto-
myosin cross-bridge behaviour can compensate for reduced myofibrillar protein content. 
 
1.7.7.4 Evidence that specific force is affected by the force producing ‘state’ of an 
actomyosin cross-bridge 
 
In the context of human ageing, some evidence suggests that there is an alteration 
in the force producing ‘state’ of bound acto-myosin cross-bridges which causes a reduced 
specific force in elderly compared to young individuals. Ochala et al. (2007) calculated 
the ratio of skinned fibre stiffness and specific force (K/SF) to provide an indication of 
the cross-bridge stiffness per unit of force. K/SF was significantly higher in MHC I and 
IIA Vastus Lateralis fibres from elderly men (n = 6; mean age: 66) compared with young 
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men (n = 6; mean age: 32), despite the fact that MHC I and IIA specific force was 
significantly lower in elderly men. Skinned fibre myosin content was not quantified, but 
the results suggest that there are a higher number of acto-myosin cross-bridges bound in 
a low force state in skinned fibres from elderly men, thus increasing the fibre stiffness in 
the presence of reduced specific force (Ochala et al., 2007). These findings indicate that 
specific force can be modulated both by the number and behaviour of bound acto-myosin 
cross-bridges. 
That cross-bridges can be in low-force generating states is supported by more 
direct evidence from rodent models of ageing. Lowe et al. (2001) observed a 27% 
reduction in specific force produced by small fibre bundles from elderly rats (n = 6; age: 
32-36 months) compared to young rats (n = 6; age: 8-12 months), which corresponded to 
a 30% reduction in myosin heads attached in a strong-binding structural state, as indicated 
by electron paramagnetic resonance.  
 
1.7.7.5 Other proposed mechanisms of age-related specific force loss 
 
The simplest explanation for a reduction in specific force would be an impaired 
ability of elderly individuals to fully activate their muscles, either due to poor motivation 
or reflex inhibition. This would indicate that for a given amount of muscle mass, fewer 
individual fibres would be recruited, resulting in reduced force output. However, Phillips 
et al. (1992) used electrical stimulation on the Adductor Pollicis muscle in elderly subjects 
who exhibited specific force loss to test whether they could fully activate their muscles, 
and found that they could. 
At the molecular level, Thompson et al. (2006) demonstrated that MHC content 
was significantly reduced with age but actin content remained the same in the Semi-
membranosus muscle of rats. The preferential reduction in myosin content may alter the 
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stoichiometry of the myofibrillar proteins relative to each other, contributing to the 
reduction in specific force. Furthermore, alterations in the myosin molecule may occur 
via non-enzymatic glycosylation, as myosin contains several potential targets for 
glycation (Ramamurthy et al., 2001). Indeed, an 18-25% ageing related slowing was 
observed in the speeds at which actin filaments were propelled (Vf) by the MHC I myosin 
isoform in an in vitro motility assay (IVMA) preparation of rat soleus muscle fibres (Hook 
et al., 2001).  
In humans, significant reductions in both MHC I and IIA motility speeds which 
were associated with post-translational modifications of the myosin molecule were 
observed in IVMA preparations of fibres from elderly compared to young individuals. 
Furthermore, a higher disorder of myosin molecules during isometric contraction in 
skinned fibres was observed, based on the lower intensity of the low angle X-ray 
diffraction reflection (MM1 reflection). The MM1 reflection corresponds to the 14.3nm 
axial repeat of the myosin filament head and an increase in reflection intensity is 
indicative of a higher order in the arrangement of the myosin heads, discussed further in 
Chapter 5 (Li et al., 2015). The aforementioned findings suggest that kinetic changes in 
the myosin molecule may affect interaction with actin and subsequent formation and force 
production of cross-bridges.  
Canepari et al. (2005) did not observe a clear effect of ageing on Vf in myosin 
isoforms extracted from MHC I and IIA Vastus Lateralis fibres from young and elderly 
individuals. Interestingly, an increase in Vf was observed in MHC IIA isoforms following 
resistance training in both young and elderly groups, suggesting a positive effect of 
exercise on the motility speed of fast myosin isoforms. However, the rate of cross-bridge 
cycling as measured by a slacken-restretch procedure was found to be lower in skinned 
fibres from non-athlete and master athlete elderly individuals compared to young, healthy 
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controls. These findings suggest that an age-related slowing of cross-bridge kinetics 
occurs, irrespective of exercise (Power et al., 2016).  
1.7.7.6 Summary of mechanisms 
 
Evidence suggests that skinned skeletal muscle fibre specific force is modulated 
by myosin concentration, with low and high myosin concentrations associated with low 
and high specific force values respectively (D'Antona et al., 2003). The number of bound 
acto-myosin cross-bridges during an isometric contraction, which is strongly related to 
the specific force generated, has been shown to be largely dependent on the skinned fibre 
myofibrillar protein content (Ochala and Larsson, 2008). Evidence also indicates that 
cross-bridges can be bound in a low force producing state (Ochala et al., 2007, Lowe et 
al., 2001), or can compensate for a lower myosin concentration (Miller et al., 2009). 
Therefore, cross-bridge behaviour affecting the force produced per cross-bridge, as well 
as the number of bound cross-bridges, has been shown to affect skinned fibre specific 
force. 
Given the equivocal results which have been previously discussed (sections 1.7.2, 
1.7.3, 1.7.4, and 1.7.5), it is not possible to draw firm conclusions as to whether age-
related specific force loss occurs at the skinned fibre level. The most reliable conclusions 
that can be drawn are from data which are supported by measurements of myofibrillar 
protein, since specific force and the occurrence of specific force loss has consistently been 
observed to be related to myofibrillar protein content (D'Antona et al., 2003, Trappe et 
al., 2003). However, even within these studies, differences in observations of whether 
age-related specific force loss occurs suggest that factors determining myofibrillar protein 
content are more important than chronological age, for the development of skinned fibre 




1.7.8 Power measured from chemically skinned skeletal muscle fibres 
 
Studies investigating the power output of skinned fibres have demonstrated that 
MHC IIX fibres produce the highest power output, followed by MHC IIA fibres, with 
MHC I fibres exhibiting the lowest power output (Widrick et al., 1996b). The interaction 
of P0 and Vmax, as described by the force-velocity curve, results in the generation of 
power, which is how muscle fibres would be expected to behave in vivo. Few studies have 
reported power from elderly individuals compared to young cohorts (Trappe et al., 2003, 
Reid et al., 2014, Reid et al., 2012, Callahan et al., 2014, Grosicki et al., 2016). Any 
differences reported between groups are dependent on differences in P0 and/or Vmax, 
which have been discussed previously. Reductions in skinned fibre peak or normalised 
power in response to different interventions have been attributed to decreased P0 in 
several investigations (Widrick et al., 1999, Widrick et al., 1998, Widrick et al., 2001). 
This supports that identifying the onset and mechanism of skinned fibre force loss is 
important in elucidating the cause of reductions in skinned fibre power which may be 




1.8 Summary and aims of the present thesis 
  
The literature review aimed to introduce the concept of age-related skeletal muscle 
weakness and highlight the fact that muscle quality, as opposed to quantity, is a prevalent 
factor causing the decline in muscle strength with advancing age. The importance of 
recruiting physically active, healthy elderly individuals for research investigating age-
related specific force loss was discussed, and the chemically skinned fibre preparation 
was introduced as a means of probing the mechanism of age-related specific force loss. 
Given the equivocal findings from experiments studying skinned fibres from young and 
elderly cohorts, and the proposed mechanisms of age-related specific force loss at the 
level of the myofilaments, the aims of the present thesis were to: 
1. Systematically investigate the variation in skinned fibre specific force values 
reported in the literature, identify causative factors and where possible, quantify 
their contribution to the variability in published specific force values. 
2. Address the impact of using different activating solutions to elicit force from 
chemically skinned skeletal muscle fibres on the variability in reported specific 
force values, as well as the equivocal conclusions drawn by different studies as to 
the occurrence of age-related specific force loss at the level of the myofilaments.  
3. To measure and compare skinned fibre specific force between a carefully 
characterised cohort of physically active master cyclists, comparatively frail hip 
fracture patients, and a healthy, young control group. The mechanism of specific 
force with regard to skinned fibre myosin content was assessed and potential 
differences in cross-bridge behaviour between the young and elderly cohorts were 
probed by comparing specific force results from two different activating solutions, 
and from low-angle x-ray diffraction patterns of the myosin meridional reflection.   
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2 Addressing the variance in specific force 
measurements from single, chemically skinned 
human muscle fibres: a systematic review 
 
2.1 Introduction 
In human skeletal muscle, assessing specific force in vivo is complicated by a 
number of factors, which relate to both the measurement of force and cross-sectional area, 
as outlined in section 1.5 (Haxton, 1944, O’Brien et al., 2010). Attempts to address the 
limitations of in vivo approaches have been made using the chemically skinned fibre 
technique in vitro, in order to study human muscle function and specific force (section 
1.6).  
Despite the advantages of being able to study the contractile properties of a single 
skeletal muscle fibre, there appears to be considerable variation in human skinned fibre 
specific force reported by different publications. This observation contradicts the well 
accepted idea that a reliable experimental technique will yield reproducible results across 
different investigations. The variability in reported skinned fibre specific force values 
makes comparisons of results from different studies difficult and raises questions as to 
the validity of the skinned fibre technique with regard to reflecting in vivo function. 
Therefore, the aims of this chapter were to: 
1. Systematically evaluate the degree of variability in published specific force 
values from human, skinned skeletal muscle fibres. 
2. Identify factors causing the variation in published results.  






A systematic search of the human skinned skeletal muscle fibre literature was 
undertaken and methodological differences between studies which may cause the 
variation in reported specific force results were identified. The effect of each of the 
identified methodological factors was quantified. The analysis of specific force was 
performed on data obtained from control or pre-intervention groups, in order to exclude 
the effects of disease, any interventions and the effects of ageing, thereby enabling the 
comparison of results from different studies. Analysis was constrained to fibres 
containing MHC I and MHC IIA isoforms, excluding MHC-IIX and hybrid fibres. 
2.2.1 Search strategy 
A systematic search was carried out in ‘Medline,’ ‘Embase Classic + Embase’ and 
‘Web of Science.’ Each database was searched from the earliest to most recent year or 
week of publication available. Criteria adapted from the Cochrane Collaboration 
guidelines for conducting a systematic search were used, which included consulting an 
IT specialist who had expertise in systematic review methodology, in order to optimise 
the search strategy. Once the search had been conducted (June, 2014) the 1,876 search 
results were compiled into an EndNote reference library. From this library, two people 
independently selected studies to be included in the review and compared their decisions, 
in order to decrease the probability of omitting relevant papers.  
The inclusion criteria were: (1) published in English; (2) using chemically skinned 
fibres from the muscle biopsies of human lower limb muscles; (3) reporting 
measurements of skinned fibre specific force and/or both maximal isometric force and 
cross-sectional area; (4) having a control or pre-study intervention group; (5) having a 
subject group not consisting solely of highly trained athletes; (6) subjects included males 
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and/or females under 45 years old. Some studies which contained groups of older or 
unspecified age were also included, discussed in section 2.2.9. A total of 73 studies met 
the inclusion criteria and were used for a meta-analysis. Their dates of publication span 
the period 1989 to 2013, but only 3 studies were published before 1996.  
Specific force and, where available, fibre peak isometric force (P0) and cross-
sectional area (CSA) data were extracted from each publication, using pre-intervention 
or control groups where appropriate, thus eliminating the impact of any training or other 
intervention effect. Data were taken from numerical tables where possible. When numeric 
data were not available, values were measured from enlarged versions of the figures using 
purpose written MatLab software. Professor Roger Woledge wrote all Matlab software 
used in this study. A second investigator cross checked the compiled data against the 
original source to minimise the chance of errors occurring. 
2.2.2 Data collection, sub-grouping and assessment of variability 
The 73 publications which met the inclusion criteria were objectively divided into 
research groups based on shared authorship using a purpose written Matlab programme. 
Many of the 73 publications included several sets of data which corresponded to specific 
force measured from different fibre types, skeletal muscles, experimental groups 
composed of males, females or both genders, etc. 153 sets of specific force data were 
obtained, of which 132 also had corresponding CSA and/or P0 data. Where only CSA or 
P0 was provided, the missing measurement was calculated using the reported specific 
force value. The 153 data sets were divided into 3 groups based on the temperatures at 
which the experiments were conducted: 12⁰C, 15⁰C and >18⁰C. The relative numbers of 
data sets in each temperature group are shown in Table 1.  
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The compiled specific force data were plotted by temperature group in Forest 
Plots to observe the heterogeneity in reported values for MHC I and IIA fibres within 
each temperature range. A relatively large and relatively homogenous group of data (the 
15⁰C group) was used for examining the influence of specific methodological factors. 
The data for MHC I and MHC IIA fibres were initially kept separate, but were combined 
later during the analysis. 
2.2.3 Adjustments made to published data based on methodological differences 
between studies 
The variability in reported specific force data was assessed using scatter diagrams 
of the mean P0 against the mean CSA reported by a given study, for both MHC I and 
MHC IIA fibres. The effect of methodological differences between studies was assessed 
by adjusting the individual P0 or CSA values from the compiled data sets for a given 
methodological difference, re-plotting the scatter diagrams using the adjusted data and 
observing any change in the P0 vs CSA relation. How the adjustments for each 
methodological difference were made is described below, and the impact of each 
adjustment on the variance in the data is summarised in Table 2.2. The combined effect 
of all the adjustments for methodological differences on the dispersion of the data is 
illustrated in the Figure 2.3E and F for MHC I and MHC IIA fibres respectively. 
2.2.3.1 Adjustment for skinned fibre swelling 
 
Some, but not all authors “corrected” their specific force measurements either by 
multiplying the specific force by 1.44 (=1.22) or 1.56 (=1/0.82), to account for the swelling 
which increases a fibre’s CSA and occurs as a result of chemical skinning. 56 of the 73 
publications specified whether or not they had adjusted their skinned fibre CSA values 
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for swelling. To examine any effect on the dispersion of the data, the correction for 
swelling was removed and the P0 vs CSA relationship was replotted. 
17 of the 73 studies did not clearly state whether their reported mean skinned fibre 
CSA measurement had been adjusted by a factor of ~1.5, to account for the reported 20% 
increase in fibre diameter which occurs due to fibre skinning. Therefore, determining 
which publications reported specific force when fibre swelling had or had not been taken 
into account needed to be clarified. In most cases, whether or not CSA values had been 
corrected for swelling could be determined by calculating CSA using the corresponding 
P0 and specific force measurements. The reported CSAs agreed with the calculated CSAs 
in three publications. The reported CSAs were ~1.5 times greater than the calculated 
CSAs for 7 publications, so in these cases the reported CSA values were “uncorrected” 
for swelling. 7 publications remained which reported mean CSA and specific force were 
reported, but not mean P0. Therefore, one author from each of the remaining 7 
publications was contacted for clarification, the conclusion being that all 7 papers 
reported CSAs corrected for fibre swelling. In one publication (Larsson and Moss, 1993) 
the force values in the tables are ten times the likely values, which was assumed to be a 
typographic error and corrected. Overall, 35 of the 153 data sets, mostly in the 15°C 
group, had corrected for swelling, so an adjustment was applied to undo this ‘correction.’  
2.2.3.2 Different CSA measurement techniques 
 
Three different methods had been used for measuring CSA: 
CSAE: Measuring the major (‘width’) and minor (‘depth’) axes of the fibre and assuming 
an elliptical cross section. 64 of the 153 data sets used this method. 
CSAC: Measuring only the width of the fibre and calculating CSA assuming a circular 
cross section. with the width value used as diameter. Whether the ‘width’ represents the 
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major axis of the generally elliptical shape of the fibre, or an average of the minor and 
major axes is not clear with this method. 39 of the 153 data sets used this method. 
CSAA: Measuring the fibre diameter while the fibre is suspended in air, and thus 
presumably compressed to a circular shape by surface tension, and assuming a circular 
cross section. 50 of the 153 data sets used this method. 
The three aforementioned CSA calculation methods have been compared by Degens and 
Larsson (2007) who show that: 
CSAE=Q
AE * CSAA and CSAE = Q
EC * CSAC 
Where QAE = ~0.7 and QEC = ~0.4 
Several other authors using method CSAE have noted the aspect ratio of the fibres 
they used, and the values are generally larger than in the experiments of Degens and 
Larsson’s (2007) experiments. Therefore when considering all of the included studies 
together the values of QEC and probably also QAE should be less than Degens and 
Larsson’s (2007) values. To find how these different methods might have caused 
dispersion among the data, CSAA and CSAC values were converted to CSAE using Q 
values chosen to maximise the correlation between P0 and CSA for the 15⁰C data.  
2.2.3.3 Adjusting data based on sarcomere length 
 
An optimal sarcomere length (SL) of 2.75µm yields maximum P0 development in 
human skinned fibres (Gollapudi and Lin, 2009). However, 54% of the studies included 
in this systematic review used a sarcomere length of 2.5µm, while other studies used SLs 
ranging from 2.1-2.8µm. Altering SL affects both P0 and CSA of skinned fibres, as is 
described below.  
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P0 falls to 76% of maximum in an essentially linear manner in the SL range 2.75-
2.1µm as shown by the red line in Figure 2.4. The reported data from each study were 
adjusted to represent the specific force which would have been obtained had an optimal 
SL been used, by using the previously published data on the force-SL relationship in 
human skinned fibres (Gollapudi and Lin, 2009). 
Published data on the effect of skinned fibre CSA as a function of SL could not 
be found, and whether skinned fibres exhibit constant volume behaviour is not known. 
The filament lattice of mechanically skinned frog single fibres did not display constant 
volume behaviour, but CSA decreased as the fibres were stretched, more so when in 
propionate solution than in chloride solution, as indicated by the dashed and dotted green 
lines in Figure 2.4 (Matsubara and Elliott, 1972). In contrast, the filament lattice of 
skinned crayfish muscle displayed constant volume behaviour on stretching (April and 
Brandt, 1973). If, as in intact fibres, skinned fibres maintain a constant volume, CSA 
would vary as the reciprocal of SL (full black line in Figure 2.4). Since the filament lattice 
occupies ~80% of the volume of muscle fibres, the different SLs used by different studies 
could be accounted for by adjusting the reported skinned fibre CSA. However, applying 
several corrections to the compiled data sets, up to the full constant volume factor, yielded 
no improvement in correlation between P0 and CSA. Therefore, an adjustment of CSA 
based on SL was not implemented in the present investigation. 
2.2.4 Assessing variability within studies 
 
In order to determine whether specific force measured using skinned fibres was 
consistent within studies, a paired comparison was made between MHC IIA fibre and 
MHC I fibre specific force using both a scatter diagram Figure 2.5A and a Bland Altman 
plot (Figure 2.5B). 60 of the 73 publications reported specific force values for both of 
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these fibre types. This comparison would also reveal whether the specific force of MHC 
I and MHC IIA fibres is consistently found to be different. Furthermore, using the mean 
difference between MHC I to MHC IIA specific forces, the P0 vs CSA relationships from 
different fibre types could be combined by multiplying the reported MHC I specific force 
values by 1.19. 
2.2.5 Adjustment for temperature differences 
 
Four publications (Bottinelli et al., 1996, Stienen et al., 1996, Brenner et al., 2012, 
Godt and Lindley, 1982) report P0 measured from skinned fibres at two or more 
temperatures, which when compared with force data measured at different temperatures 
in whole muscle (Ranatunga et al., 1987), shows that the average temperature sensitivity 
of human skinned fibres is similar to that in vivo. These data are plotted for comparison 
in Figure 2.6. The in vivo experiments provide a continuous function for the effect of 
temperature on specific force, which was used in the present study to adjust measurements 
from skinned fibres made at temperatures other than 15⁰C, to the expected values at 15⁰C. 
Thus, the specific force data from the three temperature groups could be combined, 
accounting for all previous adjustments (CSA swelling, CSA shape, SL, fibre type) made. 
2.2.6 Differences in the activating solutions 
 
Whether differences in the concentration of PCr, ATP, free Ca, pH buffer or ionic 
strength showed any correlations with reported specific force in the included studies was 
tested. There was only a trend between the concentration of PCr in the activating solution 





2.2.7 Date of publication 
 
Whether there was a relation between a study’s year of publication and the 
reported specific force was examined by relating the date of publication with the corrected 
specific force values. 
2.2.8 Variability between research groups 
 
An analysis of variance comparing the different publication groups was carried 
out to determine the probability that the groups’ reported specific force values were from 
the same population. 
2.2.9 Differences in subject populations 
 
Publications which studied participants with a wide range of ages were included 
for analysis in the present investigation. To be certain that the inter publication group 
variability was not due to cohorts of different ages being studied by the different 
publications, the analyses were repeated excluding publications which studied 
participants over 40 years old or where the age was not specified. Studies in which biopsy 
samples were frozen in liquid Nitrogen before skinning were also excluded, for reasons 
which are described in the discussion. The total number of data sets included in the sub-
analysis was reduced from 153 to 117.  
2.2.10 Statistical analysis 
 
A two-way ANOVA was used to assess whether skinned fibre specific force was 
significantly different between genders and/or different muscles. In order to ensure that 
any differences reported were not due to the fact that the data was measured by different 
research groups or at different experimental temperatures, comparisons were limited to 
specific force data which was measured by the same research group at the same 
temperature for a given fibre type (MHC I or IIA).  
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Forest Plots were made using OpenMeta freeware and accounted for the standard 
deviation (SD) of each included data set, as well as weighting individual data sets based 
on the n number of fibres of each data set. Regression lines relating P0 and CSA were 
fitted with a Model II method (York et al., 2004). In Model II regressions, both CSA and 
P0 are assumed to contain some measurement error. 
Box and whisker plots were made using the MatLab boxplot function. The central line 
in each box represents the median value, and the lower and upper edges of each box 
represent the 25th and 75th percentiles respectively. The whiskers extend to the most 
extreme data points not considered outliers. Any specific force data approximately ± 2.7 
times the standard deviation of the data was considered an outlier and plotted individually. 
Specifically, data points were considered outliers if they were larger than q3 + 1.5(q3-q1) 
or smaller than q1 – 1.5(q3 – q1), where q1 and q3 are the 25th and 75th percentiles, 
respectively. To compare results between different groups of sources the Kruskal-Wallis 
Anova (a non-parametric, rank order method) implemented in MatLab was used. Results 
are given as means ± SEM except where stated otherwise. Correlation values (R) are 









2.3.1 Objective grouping of publications 
 
The 73 publications which met our inclusion criteria were objectively divided 
into research groups based on shared authorship. 59 of the 73 publications formed four 
research groups, exhibiting substantial shared authorship within each group and 
minimal shared authorship between groups (Figure 2.1). 14 of the 73 publications did 
not fall into any shared authorship grouping so were not included in the comparisons of 
research groups, but were included in all other analyses. 
 
2.3.2 Variability in reported specific force 
 
The two way ANOVA output indicated that specific force results measured from 
skinned fibres by the same research group at the same temperature were not significantly 
different (p > 0.05) between males and females or between skinned fibres of the same 
MHC isoform expression from different muscles. Therefore, all one 153 compiled data 
sets were used for further analysis. 
All the forest plots of the MHC I and IIA data sets in each temperature group 
(Table 2.1) had a significant χ2 (p < 0.01), indicating that there was heterogeneity present 
in all groups of compiled specific force data. This is illustrated in the Forest Plot in Figure 
2.2, which displays the variability of specific force data measured at 15°C from MHC IIA 
fibres, the group of data which exhibited the lowest range of specific force. The I2 value 
for this group of data was 98%, indicating that even in where the range of specific force 
values is lowest, the heterogeneity is still extremely high. The Forest Plots for all other 
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(52) Larsson 1997; (53) Larsson 1996; (54) Frontera 1997; (55) Ochala 2007b 
(56) Ochala 2008;  (57) Yu 2007;         (58) Larsson 1993;  (59) Larsson 1995 
(60)Korhonen 2006;  (61) Degens 1999; (62) Gilliver 2009; (63) Eskine 2011 
Ungrouped 
 sources: 
(1) Tavernier 1996; (2) Adnet 1996; (18)Campbell 1999; (42) Claﬂin 2011       
(64) Hvid 2011;      (65) Hvid 2013; (66) Kohn 2013;       (67) Malinchik1997 
(68) Malisoux 2007; (69) Malisoux 2006a; (70) Malisoux 2006b; 
(71) Miller 2013;     (72) Ruff 1989;  (73) Seebohm 2009 
 
Figure 2.1. Publication groups formed based on shared authorship.  
Each box around the circle represents one of the 73 publications included in the 
systematic review. A blue line between two boxes indicates that a given pair of 
publications shared one or more authors. The publications are arranged around the circle 
in an order that minimizes the crossover of the blue lines. The different publication groups 
are illustrated by the different coloured markers and have been named group P, Q, R or 
S. Publications which did not form a publication group are indicated by the white squares, 














Temperature group 12⁰C 15⁰C >18⁰C 
Numbers of data sets providing values for specific force 
Type 1 20 44 16 
Type 2A 18 38 15 
Total 38 82 31 
 
Numbers of data sets providing corresponding force and area measures 
Type 1 16 45 10 
Type 2A 14 38 9 
Total 30 83 19 
 
 
Table 2.1. Numbers of data sets which contributed to the analyses displayed Figure 






The box and whisker plots in Figure 2.3 represent the range of reported specific 
force values in each of the 3 temperature groups. Even after eliminating outliers the range 
of values was substantial, exhibiting a high degree of variability in published specific 
force values. The largest variation was more than 8-fold for MHC I fibres at 12⁰C, while 
the lowest variation was 2.4-fold in MHC IIA fibres at 15⁰C. Given that specific force is 
the ratio of fibre P0 and CSA, the relationship between these two variables was plotted 
(Figure 2.3C and D). Each data point in the scatter diagrams represents the mean specific 
force reported from an individual publication. For reasons of clarity error bars are not 
shown. The standard errors of both P0 and CSA were 3.8% of the mean. Significant 
correlations (p< 0.01) between CSA and P0 were observed for both MHC I and IIA fibres 
in the 15⁰C group (black, filled symbols) but not the 12⁰C and >18⁰C groups. Therefore, 
only the regression line for the 15⁰C group is displayed.    
 
2.3.3 P0 vs CSA relation following adjustments to data for fibre swelling, shape and 
SL. 
 
As expected, removing the correction for the 20% swelling of fibre diameter 
which was applied by some, but not all studies, improved the correlation between P0 and 
CSA, significantly so in the case of the 15⁰C group. Converting CSA measurements from 
CSAA to represent the value which would have been obtained if CSAE had been used by 
using QAE = 0.9, significantly increased the P0 vs CSA correlation. No improvement in 
correlation was achieved for converting CSAC to CSAE. Correcting specific force values 
to represent the specific force which would have been measured at a SL of 2.75µm 
improved the P0 vs CSA correlation slightly but not significantly for both MHC I and IIA 
fibres Table 2.2. 
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The extent the methodological adjustments made in the present investigation 
reduced the variation in published specific force data which can be seen by comparing 
the filled (after adjustments) and unfilled (before adjustments) box and whisker plots in 
Figure 2.3A and B with the open box (before adjustments). Furthermore, a tighter 
clustering of the data points in the 15⁰C group following adjustments can be seen for both 
MHC I and IIA fibres by comparing Figure 2.3E and F with Figure 2.3C and D. This 
mirrors the improved consistency in data for the 15⁰C group but not the other temperature 
groups, displayed numerically by the correlation coefficients for each temperature group 
in Table 2.2. The improvement in the coefficient correlation in the 15⁰C group indicates 
that ~30% of the variation was accounted for by the methodological factors considered. 
 
2.3.4 Comparison of MHC I and IIA fibres 
 
Figure 2.5A displays the mean difference between MHC IIA fibre and MHC I 
fibre specific force, as reported by the individual studies included in the present 
investigation. The data are scattered around a line expected for MHC IIA specific force 
being 19% greater than MHC I specific force, indicating that on average MHC IIA fibres 
are consistently found to be ~20% stronger than MHC I fibres, within studies. Figure 2.5 
includes data for all temperatures, so includes data from groups (12⁰C and >18⁰C) in 
which there was very little correlation between P0 and CSA, but nevertheless, the scatter 
around the mean line is modest. Furthermore, the Bland Altman plot in Figure 2.5B 
indicates that there was no significantly proportional bias (p > 0.05), showing that there 










Figure 2.2. A Forest plot of the published specific force data measured from MHC 
IIA fibres from young humans at 15°C.  
Up to 2.4-fold variability in specific force was observed in MHC IIA fibres at 15C, which 
was the lowest degree of variability observed among the 6 different groups of data sets 
compiled in the present systematic review. Nevertheless, the reported heterogeneity was 










Figure 2.3. The variation in published, human MHC I and MHC IIA fibre specific 
force, before and after methodological corrections were applied.  
A:  MHC I fibres: box and whisker plots of published, mean specific force values for 
different temperature groups. See section 2.2.10 for the specifications of plotting the box 
and whiskers plots. The open boxes are the data as published, and the filled boxes are the 
data after the adjustments for methodological differences described in the section 2.2.3. 
B: the same as A, for MHC IIA fibres. C:  MHC I fibre scatter diagram of P0 against CSA. 
Each point is the mean result from a separate study. D: as C, for MCH IIA fibres. E: the 
data presented in C following methodological adjustments described in section 2.2.3. F: 
as D following methodological adjustments. Specific force data are from 12°C (blue), 
15°C (black) or >18°C (red). 










Figure 2.4. Changes with sarcomere length, in P0 (red), CSA (black) and P0/CSA 
(green).   
All values are shown relative to values at SL of 2.75µm, the optimal length for force 
development in human skinned fibres (Gollapudi and Lin, 2009).  Full lines show constant 
volume behavior, as observed in crayfish skinned fibres (April and Brandt, 1973). The 
dotted and dashed lines are from observations on frog mechanically fibres in chloride and 







  MHC I MHC IIA 
Temperature groups 12⁰C 15⁰C >18⁰C 12⁰C 15⁰C >18⁰C 
Data as published 0.459 0.378 0.003 0.115 0.523 0.098 
After removal of 
swelling correction 
0.390 0.510 0.003 0.014 0.666 0.098 
+ conversion of 
CSA-A to CSA-E 
0.390 0.523 0.003 0.014 0.705 0.098 
+ correction for 
sarcomere lengths 
0.313 0.558 0.002 0.099 0.725 0.090 
 Type 1 & Type 2A combined 
 12⁰C 15⁰C >18⁰C 
All above 
adjustments 
0.116 0.631 0.028 
 All temperatures and both fibre types 
After all the above 
adjustments and 




Publication Groups Group P Group Q Group R Group S 
After all the above 
adjustments 




(18    0    6) 
0.651 
N=47 




(0   13   5) 
0.439 
N=23 
(10   13   0) 
Table 2.2. The correlation coefficients of the mean P0 and CSA values reported in 
different publications for MHC I and IIA fibres tested at 12C, 15C or >18C.  
The correlation coefficients of each adjustment made in the present study, described in 










              
Figure 2.5. Comparison of specific force in MHC I and IIA fibres within studies 
included in the present systematic review.  
A: Each point is the mean result from one publication, measured at 12°C (blue circles), 
15°C (red circles) or >18°C (red circles). The dashed line is the line of identity (y=x) and 
the full line is y=1.174 * x.  1.174 is the geometric mean of the ratios of the 62 matched 
pairs of measurements. B: The Bland Altman plot indicates the mean difference between 
MHC I and IIA fibre specific force (19%, blue line), and upper (61.8%, upper black line) 
and lower (-24.4%, lower black line) confidence intervals. There was no significant (p > 
0.05) proportional bias, indicating that there is a good level of agreement in the difference 
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2.3.5 Compilation of data from different fibre types and temperature groups 
 
When specific force data from MHC I and MHC IIA fibres were combined, the 
correlation between P0 and CSA was intermediate, between that reported for the two 
groups separately (Table 2.2). When the data from all three temperature groups were 
combined, accounting for all previous adjustments, the correlation between P0 and CSA 
was dramatically reduced compared to that from the largest of the single temperature 
groups (15⁰C) (Table 2.2). However, when the data were separated based on research 
group the correlation within each of the four groups was restored to a considerably 
stronger level Figure 2.7.  
The analyses were repeated, excluding data sets which were obtained from 
publications which studied cohorts over 40 years of age. Figure 2.8 demonstrates that 
the difference in results published between research groups is a valid conclusion even 
with the smaller sample of data sets. 
The fact that a good correlation between P0 and CSA exists within publications 
but not in the combined data implies that different specific forces are being reported by 
the different publication groups. An analysis of variance comparing these groups 
confirmed that there was essentially zero probability that all groups’ reported specific 
force values (Figure 2.3) were from the same population Figure 2.8. 
2.3.6 Differences in the activating solutions 
 
Of the chemical constituents present in the activating solutions used by studies 
included in the present investigation, a correlation between PCr concentration in the 
activating solution and the reported specific force values was observed. This is illustrated 
in Figure 2.9, where results are grouped into 4 categories based on the concentration of 










Figure 2.6. Temperature dependence of force in human muscle.   
The black line is from in-vivo experiments (Ranatunga et al., 1987), and the coloured 
lines are observations in which individual skinned human fibres were observed at two or 
more temperatures.(blue: Bottinelli et al. (1996); red: Godt and Lindley (1982); green: 
MHC I from Stienen et al. (1996); pink : MHC IIA from Stienen et al. (1996); cyan: 
































Figure 2.7. Relation of fibre force to fibre CSA after all adjustments described in 
the text. 
Adjustments for methodological differences were made, MHC I and MHC IIA results 
were combined (by increasing the MHC I specific force values by a factor 1.17), and all 
data were adjusted to 15⁰C as described in the text (sections 2.2.3 and 2.2.5). The different 
coloured markers refer to the different publication groups, as shown in  














Figure 2.8. Comparison of MHC I and IIA fibre specific force by publication group. 
A: Box and whisker plots were plotted as described in section 2.2.10. A Kruskal-Wallis 
one way Anova gave a Pnull value of ~10-9 for the hypothesis that all specific force values 
are drawn from the same population. B: The same as A, but for a restricted subset of the 












Figure 2.9. Comparison of MHC I and IIA fibre specific force in studies grouped 
by the Creatine Phosphate (CP) concentration in the activating solution.  
In a few cases PEP was used instead of CP.  The group boundaries have been chosen so 
that each group contains data from at least two of the publication groups (P through S). 
A Kruskal-Wallis one way Anova gives a Pnull value of about 10-5 for the hypothesis 
that all specific force values are drawn from the same population.  The median value for 
the 15mM group is significantly different from all the others, but there are no significant 





concentration groups. There is a significant trend for the median value of specific force 
to be less when the PCr concentration is greater. 
 
2.3.7 Date of publication 
 
No significant relationship was observed between the date of publication and the 
adjusted specific force reported. Dividing the sources into quartiles by year of publication 
showed no difference in either the mean or the standard deviation of specific force 




A high degree of variability in specific force reported in the human skinned fibre 
literature was observed in the present investigation, for example, a greater than 8-fold 
difference was observed in MHC I fibres studied at 12°C. The variability was shown to 
occur between, but not within publications and, on a broader scale, between but not within 
research groups. Methodological factors were identified that reduced the variability, 
which suggests that relatively consistent data can be obtained using the skinned fibre 
technique, compared to the initial variability reported. The impact of unknown factors 
such as the true amount of swelling are also discussed. 
 
2.1.1 Inclusion of 153 data sets based on 2 way ANOVA results 
Specific force measured from skinned fibres of different muscles and from either males 
or females was not found to be significantly different (p > 0.05). These findings are 
supported by data from two studies (Miller et al., 2013, Reid et al., 2012) which report 
specific force measurements for both male and female groups of participants, observing 
no significant differences. In contrast, Yu et al. (2007) state that specific force from 
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skinned fibres was significantly higher in females compared with males. However, that 
skinned fibre specific force data from males and females was grouped together in fourteen 
publications for both MHC I and MHC IIA fibres suggests that they are not significantly 
different. Furthermore, reliable specific force measurements from whole muscle show no 
significant difference between males and females (O’Brien et al., 2010). Therefore, 
analysis was carried out in the present investigation assuming that male and female 
skinned fibre specific force data are not significantly different. With regard to the muscle 
studied, the vast majority (64%) of publications measured specific force from Vastus 
Lateralis fibres with a minority using soleus (15%), gastrocnemius (12%) or another 
muscle (<10%). Based on the two-way ANOVA results, data sets obtained from different 
muscles were combined for analysis in the present investigation.  
 
2.1.2 Specific force variability 
A large heterogeneity (Figure 2.2) and variation in specific force values reported 
in the literature for human skinned skeletal muscle fibres was demonstrated (Figure 2.3). 
The high degree of variability in published MHC I and IIA fibre specific force is highly 
unlikely to be due to differences in physiological specific force generating capacity in the 
human muscles that were biopsied. Clearly, factors in the preparation, in the measurement 
and in the data analysis have caused the results to vary across such a wide range. 
 
2.1.3 Effect of standardising methodological factors on specific force variability 
Eliminating the influence of three methodological differences between studies 
reduced the large variability observed in specific force values reported in the literature 
Figure 2.3. This finding supports that differences in specific force measurements between 
studies are not due to differences in participants from control groups or their muscle 
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biopsy samples, but are due to methodological differences in how skinned fibres are 
treated by different publication groups. If the variance had been unaffected by accounting 
for methodological differences, the implication would have been that using a similar 
method produces inconsistent results, questioning the validity of the skinned fibre 
technique. 
Removing the correction for fibre swelling known to occur, unifying the 
assumption made regarding fibre shape among all included studies, and adjusting reported 
P0 based on the SL-force relationship significantly increased the correlation between P0 
and CSA. The improved P0 vs CSA correlation coefficients following data adjustments 
indicate that ~30% of the variation in reported specific force values is explained by the 
methodological differences between studies accounted for in the present investigation. 
Hence, the findings of the present study support that more consistent data can be obtained 
using the skinned fibre technique than could originally be discerned from the large 
variation which exists in published specific force values. Furthermore, this shows that 
there are additional, and major reasons for the dispersion of data other than the differences 
in technique and data processing which have been considered so far. 
No improvement in P0 vs CSA correlation was observed when fibre shape 
assumed was converted from CSAC to CSAE, potentially because the ‘width’ was not the 
major axis, as is assumed in the present investigation. The P0 vs CSA correlation was 
stronger for MHC IIA fibres than MHC I fibres in the data as originally reported and after 
adjustments for methodological factors. This may be due to the fact that there is an 
unknown amount of error in the CSA measurements (discussed later), so the higher P0 
produced by type IIA fibres reduces the impact of any error in CSA measurement on the 
P0 vs CSA relationship. 
95 
 
O’Brien et al (2010) measured specific force in vivo and accounted for all 
confounding methodological factors, yielding reliable measurements. A high correlation 
of 0.98 is observed between the mean P0 and CSA value from whole quadriceps muscle 
across the experimental groups. The significantly improved P0 vs CSA relation following 
adjustments for methodological differences between studies is closer to that observed in 
vivo. This implies that the P0 vs CSA relation of skinned fibres is more representative of 
that in vivo, than could be discerned when visually inspecting the published specific force 
data as originally reported (Figure 2.3A and B). This suggests that the skinned fibre 
technique can be used to study the contractile properties of skeletal muscle, however, 
unknown factors which contribute to the variation of specific force data between studies 
persist. 
Quadriceps muscle specific force measured in different groups of humans in vivo 
has been shown to be ~565 kPa (O’Brien et al., 2010). The average specific force 
measurement taken from MHC IIA fibres at 15°C was 154 kPa. Given the temperature 
sensitivity of skinned fibre specific force, even adjusting this value to that which would 
be obtained at a physiological temperature would yield a lower specific force than that 
observed in vivo. Therefore, while the present study has shown that the skinned fibre 
technique is more representative of in vivo specific force production than could initially 
be understood there is clearly a need to optimise this technique.  
 
2.1.4 Comparison of MHC I and MHC IIA fibres 
Figure 2.5 displays MHC IIA fibre specific force against MHC I fibre specific 
force measured by the same individual study. The fact that the scatter of data points 
around the mean line is modest indicates that the factors causing the variation in the P0 vs 
CSA relationship are not prevalent within the individual studies, but between individual 
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publications. This implies that specific force results from individual studies are valid, 
something which has not previously been demonstrated, and could not be understood 
from the huge variation observed in specific force measurements reported in the literature 
(Figure 2.3). Therefore, conclusions drawn from specific force measurements in a given 
study may represent the effects of a given intervention or physiological condition while 
comparison of results between studies remains difficult. That variation exists between, 
but not within studies supports that differences in specific force measurements are largely 
due to methodological differences between studies.  
That MHC IIA fibres are intrinsically stronger than MHC I fibres is well accepted 
(Schiaffino and Reggiani, 2011). This is supported by an analysis demonstrating that 
investigations which study a higher n number of fibres are more likely to observe that 
MHC IIA fibres have a greater specific force than MHC I fibres (Miller et al., 2015). The 
present investigation shows that MHC IIA fibres appear to consistently be 20% stronger 
than MHC I fibres on average, across 62 publications Figure 2.5. 
 
2.1.5 Adjustment for temperature differences 
Data from different temperature groups which had been adjusted for 
methodological factors (fibre swelling, shape, SL and type) were combined by converting 
specific force measured at temperatures other than 15⁰C to the expected value at 15⁰C. 
The combined specific force data exhibited a greatly reduced P0 vs CSA correlation 
compared with that from the 15⁰C group. A possible reason is that the combined data 
contain more publication groups that the 15°C group, since each temperature sub-group 
does not contain the same number of publication groups.  
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When the combined specific force data were separated by publication group 
(Figure 2.7) the correlation within each of the 4 groups was restored to a much stronger 
level (Table 2.2), even though most of the groups contained data from more than a single 
temperature. Therefore, the variability in specific force data does not only occur between 
but not within individual publications, but occurs on a broader scale between but not 
within publication groups. This indicates that methodological practices of research groups 
as a whole and not just individual publications, influence the variation in specific force 
measurements observed in the present investigation. The finding that within research 
groups there is a reasonable concordance between studies is in agreement with the result 
of Krivickas et al (2011) who combined individual fibre results from six studies made in 
the same laboratory to obtain a large and consistent data set. 
 
2.1.6 Swelling of skinned fibres 
When skeletal muscle fibre segments are mechanically skinned or chemically 
permeabilised, they swell (Matsubara and Elliott, 1972). Fibre swelling upon skinning is 
thought to be an osmotic phenomenon caused by the removal of soluble proteins from the 
environment of the myofibrils. The exclusion of these proteins from the filament lattice 
draws water out from it. The swelling after permeabilisation can be reversed by providing 
a similar osmolar environment to that before skinning, for example by using dextran 
(Andrews et al., 1991, Godt and Maughan, 1977). The publications included in the present 
investigation commonly refer to skinned fibre swelling as “the 20% swelling that is 
known to occur during skinning,” although the amount of swelling measured has been 
found to vary. Therefore a possible reason for the large variation in specific force is that 
skeletal muscle fibres swell by a variable amount when skinned.  
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The two references most commonly cited to support the fact that skinned fibre 
diameter swells by 20% following skinning do not provide strong evidence to support this 
statement. Moss (1979) studied frog muscle fibres at 5⁰C and does contain a single 
sentence in the method section that the fibre diameter ‘increases by about 20%’ upon 
skinning. However, no data is presented from which the range of the diameter swelling 
can be determined, and the number of observations is not specified. Godt and Maughan 
(1977) studied frog fibres at lower temperatures and note the amount of swelling 
observed. The mean increase in CSA is 2.32 fold (± 0.54 SD), which corresponds to an 
approximate diameter increase of 52% (± 18% SD), much higher than the 20% this work 
is cited for. This suggests that reference is being systematically misquoted and skinned 
fibre CSA may be being adjusted by an incorrect amount. Furthermore, the fact that Godt 
and Maughan (1977) are cited as the source first observing that skinned fibres swell by 
20% is surprising, since they explicitly state that the swelling observed in their study was 
greater than that observed by other investigators: “…We observed much more swelling 
than did other workers.” 
The significance of knowing precisely how much swelling occurs is evidenced by 
Blauuw et al (2009) who quantified the amount of swelling of skinned fibres by 
comparing the CSA of skinned mouse fibres to the CSA of fibres in histological section. 
An 11% increase in fibre CSA due to skinning related swelling was observed in their 
experimental group compared with a 25% increase in fibre CSA in their control group. 
Such a variable amount of swelling has serious implications for the interpretation of the 
effect of any intervention or condition on muscle quality, as indicated by specific force 
measurements. Furthermore, the fact that the amount of swelling is likely to be variable 
in different skinned fibres shows that correcting specific force by a constant factor is 
inappropriate. However, these swelling measurements should be interpreted with caution 
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since the amount of swelling was calculated by comparing skinned fibre CSA to that of 
fibres in histological sections where an unknown amount of CSA shrinkage occurs.  
The reasons for the large variability in the swelling are unknown, although 
Matsubara and Elliott (1972) observed different amounts of swelling at different 
sarcomere lengths. If similar variations in swelling occur in mammalian fibres and if 
slight differences in technique in different labs influence the amount of swelling then it 
would be a likely cause of the differences reported in specific force. This suggests that an 
investigation into the magnitude and variability of skinned fibre swelling should be 
conducted. Alternatively, another method could be used as an index of fibre size, which 
is itself a proxy measurement for the number of crossbridge sites in parallel with one 
sarcomere. 
 
2.1.7 Other methodological factors potentially contributing to the inter-research 
variability 
 
The single fibre skinning procedure often includes treatment with detergent, 
usually either Triton X100 or Brij 58. Triton was used in 16 of the 17 studies from 
publication group P and by only 4 other investigations across the other publication groups.  
The adjusted specific force was significantly lower in studies which used Triton (121 ± 
8, n = 50) compared to those which used Brij-58 (186 ± 6, n = 201). However, the effect 
of Triton could not be isolated and attributed to the reduced reported specific force using 
systematic review methodology, and experimental work would be required to test this 
hypothesis. Indeed, the lower specific forces reported by publications which used Triton 
could be due to other methodological factors causing lower specific force values to be 
reported by a given publication group. The same principle applies to investigating the 
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effects of different skinning solutions used by different publications, which are 
distinguished by the anion used in solution, either Chloride or Proprionate.  
In the present systematic review, four publications included immediately froze 
their biopsy samples in liquid Nitrogen, or isopentane cooled in liquid Nitrogen. In one 
study, from Group P, the adjusted specific forces were very low (below 75 kPa), although 
forces from two other studies from Group S were above 150 kPa. However, two 
comparative studies compared the effects of immediate freezing with immersion of the 
muscle biopsy in cold skinning solution and observed that freezing reduced skinned fibre 
force by ~60-70% (Frontera and Larsson, 1997, Larsson and Moss, 1993). Therefore, 
immediate freezing seems to reduce skinned fibre force development.  
 
2.1.8 Differences in the activating solutions 
A trend for the median value of specific force to be lower when the CP 
concentration was greater, was observed when data were grouped into four categories 
based on the concentration of CP used (Figure 2.9). This result must be interpreted with 
caution, since the papers using a particular CP concentration are likely to share other 
technical details which are unreported. Nevertheless, a possible mechanism of high CP 
concentrations which might cause lower specific force, considered below, is that higher 
contaminating concentrations of inorganic phosphate (Pi) may be generated by higher CP 
concentrations, reducing specific force.  
A linear relationship between skinned fibre force and the log of Pi concentration 
at concentrations above 0.1mM has been reported in rabbit muscle (Karatzaferi et al., 
2004). Based on this relationship, the Pi contamination in the activating solutions used by 
Garner and Widrick (2003) and Pathare et al. (2005) can be calculated from their 
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observations of force to Pi concentration, which are 0.25 and 0.55mM respectively. Both 
publications used activating solutions containing ~20mM CP and reported specific force 
values less than 150kPa. Assuming a reduction in the CP concentration to ~10mM would 
reduce the Pi contamination by 50%, an approximate 10% increase in specific force 
would be expected, which is too small an effect to explain the trend observed in Figure 
2.9. Therefore, hypothesis that contaminating Pi which lowers specific force is generated 
as a result of higher CP concentrations is rejected.  
Using systematic review methodology the impact of individual chemical 
constituents of a given activating solution could not be assessed. Factors such as the salt 
used to adjust ionic strength or the pH buffer may also affect the skinned fibre contractile 
response but would need to be tested experimentally, as will be discussed in Chapter 4.  
 
2.1.9 Summary and Conclusion 
The aim of the present investigation was to assess the variability in published 
specific force values from human, skinned skeletal muscle fibres, in order to better 
understand the reliability of data obtained using this technique. Greater than 8-fold 
variability was observed in reported specific force values for a given fibre type tested at 
the same experimental temperature, suggesting that the skinned fibre technique does not 
yield reproducible data across different labs. However, the MHC I:MHC IIA specific 
force ratio was consistent within individual studies, demonstrating that variability occurs 
between but not within publications. This trend was shown to occur on a broader scale, 
with consistent specific force results obtained within but not between research groups 
(Figure 2.7). The consistency within individual studies and research groups suggests that 
reported results are reliable. This important finding was not previously known and is not 
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conveyed by the large and previously unexplained variability in published specific force 
data. 
 Accounting for methodological differences between studies reduced the variance 
in specific force reported, supporting the hypothesis that the large variation was not due 
to physiological differences between control groups from different studies.  Furthermore, 
the P0 vs CSA relationship (at 15°C) was significantly improved when methodological 
differences were accounted for, indicating that ~30%, but not all of the variation was due 
to the factors considered. The improved P0 vs CSA relation also demonstrates that the 
skinned fibre technique is considerably more reflective of the relation between muscle P0 




3 General Methods 
 
The experiments conducted in the present thesis were carried out on human skinned 
fibres. The steps taken to obtain and prepare a biopsy sample for measurements of 
individual skinned fibre specific force will be described in the following Methods section. 
The procedures used for identification of skinned fibre MHC isoform expression and 
quantification of myosin content will also be presented.  
 
3.1 Ethical approval 
 
The experimental work in the present thesis was conducted on Vastus Lateralis 
skeletal muscle samples from participants who were either, 1) Young, healthy controls, 
2) Frail hip fracture patients, or 3) Highly physically active elderly individuals. Ethical 
approval was granted by the Fulham Research Ethics Committee in London, to obtain 
muscle samples from young, healthy individuals and from physically frail hip fracture 
patients (Ethics ID: 12/LO/0250). Muscle biopsy samples were obtained from highly 
physically active elderly individuals as part of a different investigation (Pollock et al., 
2015), previously approved by the Wandsworth Research Ethics Committee in London 
(Ethics ID: 12/LO/0457). All procedures ran in accordance with the declaration of 
Helsinki (1964). 
Professor Stephen Harridge was responsible for taking muscle biopsy samples from 
young, healthy participants and highly physically active, elderly individuals. Participants 
visited the Centre of Human and Aerospace Physiological Sciences at King’s College 
London to undergo this procedure.  Muscle samples from hip fracture patients were 
collected by registrars working with Mr Marc George at St Thomas’ Hospital in London. 
The different muscle sampling procedures which were utilised are outlined in section 3.3. 
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3.2 Participant inclusion and exclusion criteria 
 
Participants from all experimental groups were fully informed of any associated 
risks and provided informed consent. Healthy, young participants who were between the 
ages of 18-40 completed a health questionnaire (Appendices section 8.1). Grounds for 
exclusion, included if they were taking any medication, had any musculoskeletal, 
cardiovascular or neurological problems. The participants who volunteered their muscle 
sample for a given study are outlined where relevant in each chapter of this thesis. 
 
3.3 Skeletal muscle tissue sampling 
 
The muscle biopsy samples for the young, healthy participants and physically 
active, elderly participants were obtained using the same biopsy procedure. A portion of 
the mid-thigh of the participants’ preferred leg was shaved and the skin was cleaned using 
chlorhexidine gluconate. Two percent lidocaine was used as an anaesthetic prior to a 5mm 
incision in the skin overlying the biopsy site, made with a scalpel. A Bergstrom biopsy 
needle was inserted through the incision and a biopsy was taken using suction, yielding a 
sample of approximately 200mg in weight. Approximately 60mg of the biopsy sample 
was prepared for experiments examining the contractile properties of single, skinned fibre 
segments. 
Muscle tissue samples were obtained from hip fracture patients who were 
scheduled to undergo dynamic hip screw insertion surgery. During the routine exposure 
of the hip during surgery, a portion of the Vastus Lateralis muscle inevitably becomes 
detached. Rather than discarding this muscle sample, the surgeons placed the sample into 
a relaxing solution which had been cooled on ice. The muscle sample was collected 
immediately following surgery and prepared for skinned fibre experiments. The number 
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of biopsies used for the studies described in the present thesis is specified in each 
experimental chapter.  
 
3.4 Membrane permeabilisation of fibre bundles 
 
The portion of the muscle biopsy sample to be used for skinned fibre experiments 
was immediately placed into a petri dish containing relaxing solution (Table 3.1), which 
had been cooled on ice to approximately 4°C.  The muscle sample was then dissected into 
bundles of muscle fibres under a stereo microscope (Zeiss, Stemi 2000-C) with a separate 
light source (Zeiss SteREO CL 1500 ECO). Custom-made dissection needles were used 
to separate a bundle of approximately 50-100 fibres from one end of the tissue sample, 
before gently pulling the bundle off from the rest of the sample using forceps, ensuring 
not to overstretch the fibres.  The fibre bundles were tied at each end to glass capillary 
tubes using surgical silk (LOOK SP102) and were extended to approximately 110% of 
their slack length.  
Still attached to capillary tubes, the fibre bundles were placed into tubes 
containing relaxing solution with 50% v/v glycerol (Table 3.1), in order for the 
sarcolemma to be chemically skinned at 4⁰C for 24 hours. Following skinning of the 
sarcolemma, the bundles were transferred into a -20°C freezer while still in skinning 
solution and stored for up to three weeks until they were processed for long term storage 
using a sucrose cryo-protectant. 
 
3.5 Long-term storage of fibre bundles 
 
Bundles were incubated in standard relaxing solutions containing concentrations 
of 0.5, 1, 1.5 or 2M sucrose (Table 3.1), in order of increasing concentration, for thirty 
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minutes in each solution. Immediately following incubation, bundles were snap frozen in 
isopentane (GPR - RECTAPUR) cooled to -80⁰C using dry ice and subsequently stored 
at -80°C in cryo-viles . On the day of an experiment a bundle would be de-sucrosed by 
incubating it for 30 minutes in each sucrose solution in reverse order (2M  0.5M) before 
placing the bundle in relaxing solution. All skinned fibres studied in the present thesis 
underwent sucrose treatment for long term storage in order to standardise the treatment 
of the fibres prior to experimentation. 
 
3.6 Preparation of skinned fibres for mechanical experiments 
 
Following the de-sucrosing of a fibre bundle, fine forceps were used to dissect 1-
2mm permeabilised fibre segments from the bundle under a stereo microscope with a 
separate light source. Individual fibres were dissected when a bundle was in relaxing 
solution cooled on ice to approximately 4°C. Aluminium t-clips (Photofabrication Ltd, 
Cambridgeshire, England) were attached to both ends of each of the fibres using custom-
made dissection needles, before a single fibre was transferred to relaxing solution (pCa 
9.0) in an experimental chamber. Each t-clip was connected to a hook, one of which was 
attached to a force transducer (Kronex, AE-801), thus suspending the fibre in solution 
between two hooks. The main components of the experimental apparatus used for 





















Relaxing 4.05 2 2 10 100 
Skinning Same as relaxing solution but with 50% v/v glycerol. 
Sucrose Same as relaxing solution but with either 0.5M, 1M, 
1.5M or 2M of sucrose in solution. 
 
Table 3.1.The chemical constituents of solutions used to prepare a muscle biopsy 
sample for mechanical experiments. 
The chemical compositions of the relaxing solution used to prepare bundles of skinned 
fibres for chemical skinning, the skinning solution, and the sucrose solution used as a 






3.7 Permeabilised fibre test system 
 
Measurements of the contractile properties of skinned fibres were carried out 
using a custom-made skinned fibre test system, which was set up, and a working protocol 
to collect skinned fibre specific force measurements was developed. As previously 
described, once prepared for an experiment a single fibre was suspended between two 
hooks in an experimental chamber containing relaxing (pCa 9.0) solution. The solution 
changing system consisted of six separate, clear plastic bottom chambers embedded in a 
custom-made, temperature regulated metal trough (NMR, Mill Hill, London, England) 
(Figure 3.1). The transparent floor of the metal trough was connected using waterproof 
silicone sealant to prevent the movement of experimental solutions between the different 
chambers. Furthermore, hydrophobic ink was applied to the grooves in which the hooks 
suspending the fibre were positioned, using a custom-made miniature paint brush. This 
prevented the solution in a given chamber from leaking out through these grooves, which 
would alter the amount of solution surrounding the fibre. 
A light microscope (Olympus, BXFM-F) with both a x10 (BECK, x10/0.17) and 
x40 (Carl Zeiss, 40/0.75W 160/-) objective lens was connected to the base of the skinned 
fibre test system and was used to view the skinned fibre from above. A small mirror was 
used to deflect light from an external light source (SCHOTT, KL1500 LCD) through the 
bottom of the transparent floor of the metal trough and into a given microscope lens. The 
x10 lens was used for measuring fibre length while the x40 lens was immersed in the 
solution surrounding the fibre and used for measuring the diameter and depth of 
individual fibres, as well as for adjusting the sarcomere length. Measurement of skinned 
fibre sarcomere length and dimensions are described in section 3.8. 
In order to transfer a skinned fibre from solution to solution during an experiment 
the metal trough could be manually moved up, down and sideways in either direction. 
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Hence the trough was moved to surround the fibre with a specific experimental solution 
contained in a given chamber. The upwards and downwards movement of the trough was 
activated by an air pressure system. The sideways movement was controlled by a system 
based on ball bearings which allowed movement of the trough over a fixed distance, 
corresponding with the distance between the different chambers. The temperature of each 
solution a skinned fibre was placed in was maintained at 15°C by a water cooler (Neslab 
RTE-300) which was connected to the side of the trough with silicone tubing, in order for 
water to be circulated around the hollow trough interior. The solution temperature was 
monitored during each experiment using a thermocouple (HANNA, HI93530).  
In order to cause a skinned fibre to contract, the fibre was immersed in an 
activating solution (pCa 4.5) (Table 3.2) and the contraction was recorded using a force 
transducer which was connected to a signal amplifier (NMR, Mill Hill, London, England; 
Model EE2588). The amplifier was in turn connected to a data acquisition device 
(National Instruments, USB 6008) to convert the analogue (voltage) signal to a digital 
signal which was visualised in real time as a skinned fibre force trace using a custom 
written LabView programme (National Instruments, Newbury, England). Measurement 
of skinned fibre contractile properties is described in section 3.9. 
 
3.8 Measuring sarcomere length and skinned fibre dimensions 
 
Once mounted onto the skinned fibre test system, the overall fibre length was 
adjusted until an optimal sarcomere length (SL) of 2.75µm was obtained. The SL was 
cross referenced using two separate methods: 1) An eyepiece graticule which had been 
calibrated using a stage micrometer (Graticules LTD, Tonbridge, Kent) was used to 
measure adjustments to the SL when muscle fibre striations were plainly visible at x40 
magnification in solution. 2) A video sarcomere length (VSL) camera (900B, Aurora 
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Scientific) mounted to the microscope of the skinned fibre test system was used to 
measure the SL at three points along the fibre at x40 magnification. This was to ensure 
that the SL was uniform along the whole length of the fibre. Once the SL measurements 
between the two methods were in agreement and the skinned fibre SL was optimal, the 
morphometric measurements of the fibre were taken. 
The diameter of the fibre was measured in solution at x40 magnification using the 
VSL camera, at three points along the fibre, as is routine practice in the skinned fibre 
literature. The mean of the three diameter measurements was used to estimate the fibre 
cross-sectional area (CSA) assuming a cylindrical fibre shape. No correction was applied 
to the fibre CSA for the swelling which occurs during the skinning process, since the 
exact amount of swelling in each fibre is not known (discussed in section 2.1.6). The dial 
used to move the microscope objective up and down indicated the vertical distance moved 
in µm, with one full rotation of the dial in either direction equal to a movement of 200 
µm. Fibre depth could therefore be measured by recording the vertical displacement of 
the x40 microscope objective, which was used to focus on the top and bottom of the 
skinned fibre. Fibre length was classified as the portion of the fibre between the t-clips 






              
          
Figure 3.1. The skinned fibre test system. 
A: The whole set up. The individual components are labelled and described in the text box. 
B: The skinned fibre test system the fibre was mounted to. The micromanipulators used to 
adjust the position of the force transducer (i) or hook (ii) on either side of the bath trough which 
contains the experimental solutions (iii).  
C: A zoomed in image of the skinned fibre test system. The force transducer hook (i) and 
stationary hook (iii) are pictured with the x10 microscope objective (ii) above the two hooks. 
D: A single fibre (black arrow) suspended between the two hooks using t-clips (white arrow).   
  
A 
i -  The mounting microscope, 
used to place an individual fibre 
into the set up. 
ii – The thermocouple used to 
monitor experimental 
temperature. 
iii – the external light source 
used to pass light through the 
bath trough into the microscope 
lens in order to view a given 
fibre. 
iv – the skinned fibre test system 
where a given fibre was 
mounted. 
v – the cooler which maintained 


















3.9 Measurements of contractile properties 
 
Fibres were transferred from a relaxing (pCa 9.0) to a pre-activating solution where 
they were incubated for one minute before being transferred to an activating solution (pCa 
4.5). The pre-activating solution had a lower Ca2+ and EGTA concentration than the 
activating solution, the reason for which is discussed in section 4.1. The chemical 
compositions of the two primary activating solutions used in the present experimental 
thesis are detailed in Table 3.2. As will be described in chapter 4, modified versions of 
the two primary activating solutions were made for experimental purposes, so their 
chemical composition is detailed in Table 4.1. 
Force produced during a muscle contraction was recorded until a plateau in force 
production was reached. Peak isometric force (P0) was classified as the baseline force 
signal of the fibre in the activating solution subtracted from the maximum force signal 
recorded. The P0 was measured and time to half peak isometric force (t50) was calculated 
using custom written Matlab software, the principles of which are described in section 0. 
Specific force was calculated as the P0 normalised to the cross-sectional area (CSA) of 
the fibre. The time to 50% P0 (t50) was used as an indirect, approximate indication of the 
rate of force development. In order to obtain a direct measurement, reflective of the rate 
of cross-bridge cycling during a contraction, a slacken-restretch manoeuvre would need 















Imidazole 20 TES 60 
Glutathione 0 Glutathione 10 
KCl 62.7 K-propionate 20 
CaCl2 7 CaEGTA 24.8 
EGTA 7 EGTA 0.17 
CrP 14.5 CrP 20 
ATP 4.7 ATP 4.65 
pH 7.1 pH 7.1 
Ionic Strength 180 Ionic Strength 200 
 
Table 3.2. The concentrations of the chemical constituents comprising the two 
primary activating solutions used in the present PhD thesis to elicit isometric 
contractions from skinned skeletal muscle fibres.  
The primary differences are the use of different pH buffers (Solution A: Imidazole; 
Solution B: TES), the use of Glutathione in solution B but not in solution A, and the use 
of a different compound in each solution to adjust the ionic strength (Solution A: KCl; 
Solution B: Potassium Propionate). Solution A is widely used by research groups which 
have published measurements of specific force from human skinned skeletal muscle 
fibres (Larsson and Moss, 1993, Trappe et al., 2003). Solution B is used by a research 
group which routinely measures specific force from  non-human mammalian skeletal 




3.10 Measurement of the baseline in activating solution 
 
The movement of the metal trough when transferring a skinned fibre from one 
experimental solution to another, caused a brief, 300ms fluctuation in the force trace 
signal upon entry of the fibre into a new experimental solution. The fluctuation in signal 
occurred when a skinned fibre entered any new experimental solution, irrespective of 
whether or not the fibre was contracting. Therefore the 300ms signal fluctuation was 
classified as an artefact, which masked the baseline force signal of the skinned fibre 
response at the start of a muscle contraction. In order to accurately determine the ‘true’ 
zero point from which to calculate P0 a custom written Matlab programme was developed 
by Professor Roger C. Woledge, the principles of which are described below. 
On a given force trace, the point at which the fibre entered the activating solution 
was selected and classified as the start point of a fibre contraction (Figure 3.2). The P0 
was then selected to give the Matlab programme two reference points for the start and 
end of the contraction. As the signal artefact lasted for approximately 300ms, the first 300 
data points, each corresponding to 1ms, were excluded from data analysis. From 300ms 
onwards the point at which 10% of P0 occurred was calculated, from which point a 
straight line was extrapolated along the slope of the force trace. The reason for 
extrapolating backwards from 10% of the P0 signal along the slope of a given force trace, 
was to account for the steepness of the force trace, which differed between different 
contracting skinned fibres. The point at which the line intersected the x-axis coordinate 
of the start of the contraction was considered to be the baseline force signal (Figure 3.2B) 
However, since the baseline force signal had been calculated, the point at which 10% P0 
occurred was subsequently altered. Therefore, 10% P0 was re-calculated and the line to 
the start point of a fibre contraction was re-plotted repeatedly, until there was an almost 
0% difference between the calculated start points. Once the zero point had been identified, 
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the Matlab programme calculated the P0 and t50 for each contraction of an individual 
skinned fibre (Figure 3.2C) 
The impact of removing the 300ms signal artefact from calculations of skinned 
fibre P0 can be determined using the force trace illustrated in Figure 3.2. Here, the P0 
calculated using the Matlab programme, after removal of the 300ms artefact and 
calculation of the baseline force signal, was 0.56mN. The corresponding skinned fibre 
CSA, without correction for swelling, was 4727µm2. The P0 normalised to CSA gives a 
specific force value of 118kPa. However, if the extra 0.09mN of force signal which was 
excluded as signal artefact had been included in the P0 calculation, the subsequent specific 
force for the same fibre would have been 16% higher, at 138kPa. Furthermore, the 
0.09mN difference in P0, due to the excluded signal artefact, would have an even greater 
effect on specific force calculations from fibres of smaller CSA. Therefore, the removal 
of the signal artefact, which was consistently found to be 300ms in duration, was used to 
eliminate the effect of signal artefact on the measurement of force.  
3.11 Identification of muscle fibre types 
 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) was 
used to identify the fibre type of individual skinned fibres based on their myosin heavy 
chain isoform expression. The SDS PAGE protocol (section 8.2) needed to be optimised, 
as differentiation between MHC I and MHC II fibres was possible, but not initially 
between MHC IIA and IIX fibres. Therefore, a process of optimisation was undertaken 
to be able to differentiate between MHC I, IIA and IIX human skeletal muscle fibres in 
the current laboratory.  In order to identify the three MHC isoforms expressed in human 
skeletal muscle, a sample containing all three isoforms was required. Several potential 






Figure 3.2. An example of the determination of the skinned fibre baseline force 
signal, from which P0 could be calculated.  
A: the point at which the fibre was transferred into a new experimental solution was 
regarded as the start point of a contraction, indicated by a red diamond.  
B: A zoomed in image of the circled section in A. A red line was from the point of 10% 
peak force signal and extrapolated backwards along the slope of the force trace. The point 
at which the extrapolated line reaches the x-axis of the contraction start point (pictured in 
A) is regarded to be the baseline force signal. The signal artefact, lasting ~300ms, which 
was excluded is outlined in a black box.  
C: Once the baseline has been established the signal was smoothed in Matlab and the P0 
(indicated by the horizontal red line) and the t50 (indicated by the vertical red line) are 























tissue containing numerous fibres in standard Laemmli sample buffer (LSB) (Laemmli, 
1970) using a gentleMACS dissociator (Miltenyi Biotec, Surrey, United Kingdom). 
Samples were heated at 100°C for 3-5 minutes. In order to obtain separation between 
MHC IIA and IIX, numerous experimental trials were undertaken. Several 
polyacrylamide gels of different acrylamide:bisacrylamide ratios were tested, as well as 
running buffers of different chemical compositions and protocols of either constant 
voltage or constant current were applied for different lengths of time.  
The protocol which revealed the three MHC isoforms present in human skeletal 
muscle was carried out using a ‘Biorad mini-protean 3 cell’ apparatus. A 0.75mm thick, 
4% stacking gel with an 8% resolving gel both containing 30% glycerol were used 
(Talmadge and Roy, 1993). Running buffer from the protocol of Blough et al. (1996) was 
used, which utilised β-mercaptoethanol in the upper running buffer. Over a 26-hour 
period, a constant current of 4mA was set until the bromophenyl blue marker had 
migrated into the separating gel, at which point the current was increased to 8mA. Gels 
were subsequently stained using a commercially available Coomasie blue stain (Novex 
SimplyBlue safe stain, LC6060) to reveal the MHC bands. Details of the gel (Table 8.1 
and Table 8.2) and running buffer constituents (Table 8.3 and Table 8.4) are provided in 
in the Appendices. 
Three clearly separated bands were found in one of the human control samples 
tested (Figure 3.3A), which were within the region of the known molecular weight of 
myosin (~220 kDa). Subsequent western blotting analysis was carried out to confirm the 
identity of the MHC isoforms (Figure 3.3B). 
Briefly, proteins were transferred electrophoretically from the gel to the 
nitrocellulose membrane using a constant voltage of 10V for 45 minutes. The 
nitrocellulose membrane was incubated in blocking solution (PBS-Tween containing 
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0.1% tween with 5% w/v milk powder) for three hours at room temperature. Following 
blocking, the primary antibody was applied for 1.5 hours at room temperature, after which 
the membrane was washed in four to five changes of PBS-Tween containing 0.1% Tween 
for 45 minutes. The membrane was then incubated in the secondary antibody for one hour 
with gentle agitation, following which PBS-tween was used to wash the membrane using 
several washes over a 10 minute period. The stain was developed in ECL solution. 
The Western blotting analysis was carried out by Ms. Katie O’Brien, from the 
Centre of Human and Aerospace Physiological Sciences at King’s College London. The 
results confirmed the presence of the MHC I and IIA isoforms in the human control 
sample tested using the mammalian primary monoclonal antibodies BA-F8 
(Immunoglobulin G, IgG) and Sc-71 (IgG) respectively (Figure 3.3B). Confirmation that 
the third band was type IIX myosin could not be achieved using the mammalian primary 
monoclonal antibody 6H1 (IgM). However, Bamman et al. (1999) used western blotting 
analysis on a polyacrylamide gel of exactly the same composition as that utilised in the 
present thesis, to show that the third band was human IIX myosin. Based on this 
information, the third band from the human control muscle sample was assumed to be 
IIX myosin. 
In order to identify the myosin heavy chain composition of single skinned fibres, 
fibre segments were placed into standard Laemmli sample buffer (Laemmli, 1970) 
immediately following force measurements. Ten microliters of sample buffer were used 
per 1mm of skinned fibre length. The skinned fibre samples were then heated at 100°C 
for 3-5 minutes before being loaded onto a 0.75mm thick gel. Results were scanned using 












Figure 3.3. The SDS PAGE protocol used to distinguish between type I, IIA and IIX 
myosin heavy chain isoforms in human skeletal muscle.  
A: A new protocol was developed which yielded separation of three clear bands in a 
sample of human skeletal muscle, in the lane outlined in a black box on the right hand 
side of the gel. These bands were in the range of the molecular weight of myosin, as 
indicated by the molecular weight marker pictured in the first lane to the left of the gel, 
in which the lower and upper bands correspond to molecular weights of 150 and 250 kDa 
respectively. The other bands pictured on the gel are from human, single muscle fibres 
and correspond to MHC I, MHC II or MHC IIA-IIX myosin heavy chain, as is indicated 
by above each band. 
B: Western blotting analysis identified MHC I and IIA myosin heavy chain isoforms in 
the human control sample using BAF-8 and Sc-71 antibodies respectively. The MHC 
isoform of the third, upper band, could not be confirmed using the antibody 6H1, but was 
assumed to be human IIX myosin based on Wester blotting results from previous work 
studying human skeletal muscle which used a gel of exactly the same composition 
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3.12 Quantification of skinned fibre myosin content 
 
One aim of the present thesis was to assess the mechanism of any observed age-
related specific force loss by quantifying the myosin content of individual skinned fibres 
and correlating myosin content with skinned fibre specific force. The myosin content of 
an individual skinned fibre was calculated by quantifying the optical density, termed the 
brightness area product (BAP), of MHC bands from single fibres on SDS PAGE gels 
using image analysis software (ImageJ). Once the BAP of a given MHC band had been 
quantified, the total myosin content of a given skinned fibre was calculated assuming that 
the myosin content was uniformly distributed throughout the whole sample, only part of 
which had been loaded onto the gel. The total skinned fibre myosin content was then 
normalised to skinned fibre volume, which in turn was calculated from length and depth 
measurements (section 3.8), thus giving a measurement of skinned fibre myosin content 
per unit of fibre volume. The length of the skinned fibres suspended between two t-clips 
had been measured, so the segment of the fibre between the t-clips was carefully cut using 
fine dissection scissors and processed for analysis in LSB. 
In order to quantify the myosin content of a given MHC band, the linear range of the 
myosin sample needed to be identified. This was to ensure than any differences in the 
BAP of individual bands were due to differences in myosin content. Three samples of a 
commercially available myosin standard (Sigma M7659) containing either 1µg, 3µg or 
5µg of rabbit skeletal muscle myosin, were loaded onto the same gel as human, single 
fibre samples (Figure 3.4A). The linear range of the myosin standard was successfully 
identified as being in the range of 1µg-5µg of myosin (Figure 3.4B), indicating that the 
BAP was proportional to myosin content between 1µg-5µg. Therefore, the BAP of 
samples of human single fibres which have corresponding MHC bands within the 1µg-
5µg range (Figure 3.4B) will be proportional to the sample’s myosin content, within a 
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Figure 3.4. Optimisation of the myosin quantification method.  
A: Myosin standard samples of 1µg, 3µg, 5µg or 7µg (clear circles) were loaded onto a 
gel containing human skinned single fibres, from the left, in lanes two, four, six and eight.  
B: The linear range, where the optical density of a given myosin standard band increases 
proportionately with the sample’s myosin content, was observed to be between 1µg-5µg. 
Therefore, the brightness area product of MHC bands from human skinned fibre samples 
(clear triangles) which were within the linear range of the myosin standard (lanes two, 
four, six and eight) could be quantified knowing that the optical density was proportional 
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4 The impact of commonly used activating solutions on 
skinned fibre specific force. 
 
4.1 Extended introduction: features of activating solutions used to 
study skinned skeletal muscle fibres. 
 
The different methodological practices utilised by different research groups 
assessed in Chapter 2 were found to account for ~30% of the variability in published 
specific force measurements from skinned fibres. One methodological difference which 
it was not possible to correct for was the effect of different activating solutions used in 
different publications on the reported skinned skeletal muscle fibre specific force.  
Being able to carefully control the solutions surrounding skinned muscle fibres, 
is considered a major advantage of the skinned fibre technique and has been important in 
elucidating and linking biochemical processes with mechanical events (Stienen, 2000). 
The vast majority of research carried out to develop activating solutions which could 
effectively elicit a peak isometric force response from skinned fibres, occurred in the 
1970s and 1980s. From the 1990s onwards the skinned fibre technique has been 
predominantly used to investigate the impact of a given intervention or physiological 
condition on muscle contraction at the level of the myofilaments. In developing activating 
solutions, the primary considerations made were the physiological requirements for a 
muscle contraction, in parallel with practical issues associated with the skinned fibre 
preparation, such as ensuring the uniform diffusion of a given chemical substrate across 
a fibre. 
The primary features of a given activating solution include the precise regulation 
of pH, the incorporation of ATP and associated regenerating system based around CP, 
and a pCa which will maximally saturate a fibre with Ca2+ for which EGTA is used as a 
Ca2+ chelator. These chemical features must also be incorporated in such a way as to 
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ensure that the activating solution has an appropriate ionic strength. In this extended 
introduction, the rationale underpinning the aforementioned chemical features of 
activating solutions used to study skinned fibres will be outlined, with specific emphasis 
on the selection of an appropriate pH buffer to regulate the solution’s pH. 
 
4.1.1 Importance of pH regulation in skinned fibre experiments. 
 
The study of biological reactions is complicated by the fact that a given reaction can 
produce thousands of times the amount of hydrogen required for maintenance of a given 
pH (Good and Izawa, 1972). Indeed, when the movements of cations and anions across 
membranes are not equal in experimental preparations such as skinned fibres, local pH 
changes can occur. In their highly cited work, Good et al. (1966) emphasise the 
importance of using efficient pH buffers by stating that “It is impossible even to guess 
how many exploratory experiments have failed, reactions rates have been depressed or 
how many processes have been distorted because of the imperfections of the buffers 
employed.” 
Controlling pH in the skinned fibre preparation can be problematic due to processes 
such as the hydrolysis of ATP during the attachment and/or detachment of myosin to and 
from actin, during skinned fibre contraction, which produces hydrogen ions. The 
maintenance of a neutral pH in an activating solution used, in order to regulate the internal 
skinned fibre pH, is important for several reasons. The regulation of Ca2+ in solution, 
necessary to elicit peak isometric force from skinned fibres, is accomplished using the 
metal chelator EGTA, which in turn requires stringent pH control (Murphy and Koss, 
1968). Furthermore, the force-pCa relationship in both skinned crustacean (Ashley and 
Moisescu, 1977) and frog (Fabiato and Fabiato, 1978) skeletal muscle fibres was 
observed to be less sensitive at acidic compared to neutral pH ranges. The peak isometric 
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force measured from frog skinned fibres in an acidic (pH 6.2) activating solution was 
depressed compared to when measured in an activating solution of neutral (pH 7) pH 
(Fabiato and Fabiato, 1978). Finally, the distances between myofilaments of skinned 
crayfish fibres were irreversibly decreased at low pH (pH 4.4), suggesting that there may 
be a denaturing effect of acidic pH on myofibrillar proteins (April et al., 1972). The 
aforementioned findings support that selecting an appropriate pH buffer to regulate the 
pH of a given activating solution is important in the skinned fibre preparation.  
 
4.1.2 Selecting an appropriate pH buffer: traits of good pH buffers 
 
 Good and Izawa (1972) specified that a desirable pH buffer has maximum 
solubility in water but not in other solvents, contributes as few ions as possible to a 
solution and has an acid dissociation constant (expressed as pKa) which is not 
significantly affected by a solution’s temperature or ionic composition.  Furthermore, 
having a pH buffer with a pKa close to the desired pH of a given experimental solution is 
beneficial because consequently a lower buffer concentration is required for a given 
amount of pH regulation (Good and Izawa, 1972). Finally, among other properties, good 
pH buffers should not react with other components in the solution. 
Consistent with the criteria of a desirable pH buffer outlined above, Good et al. 
(1966) systematically investigated different buffers to assess their chemical properties 
and utility in biological research. Among the compounds which met the criteria for an 
efficient pH buffer, 2-[(2-Hydroxy-1,1-bis(hydroxymethyl)ethyl)amino]ethanesulfonic 
acid (TES) was highly recommended for use in biological research, based on its solubility 
in water, pKa values at different temperatures and negligible metal-buffer binding 
constants, among other properties. Furthermore, Good et al. (1966) explicitly state that 
Imidazole is not a satisfactory pH buffer, and that apart from the buffering range of 
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Imidazole there were few other positive characteristics reported (Good and Izawa, 1972). 
The identification of Imidazole as a poor pH buffer is highly relevant because the majority 
of studies which have measured specific force from human skinned fibres have utilised 
Imidazole as a pH buffer in their activating solutions. Given the clear published 
recommendations to not use Imidazole, the inclusion of Imidazole as a pH buffer in 
experimental solutions used to study skinned skeletal muscle fibres is surprising. The 
implications of the use of either TES or Imidazole as a pH buffer in activating solutions 
used to elicit peak isometric force from chemically skinned, human skeletal muscle fibres 
is discussed extensively in section 4.4. 
 
4.1.3 The MgATP complex in activating solutions used to study skinned skeletal 
muscle fibres 
 
Cross-bridge cycling during skinned skeletal muscle fibre contraction requires the 
hydrolysis of MgATP, which in turn requires myofibrillar ATPase activity. In the skinned 
fibre preparation ATP is supplied to the skinned fibre via the activating solution. Mühlrad 
et al. (1965) demonstrated that at different concentrations of ATP the maximal ATPase 
activity of myofibrils required Mg2+. Furthermore, when several bivalent cations were 
tested, ATPase activity was found to be optimal in the presence of Mg2+. The MgATP 
complex was also implicated in the relaxation of skeletal muscle as high ATP 
concentrations alone did not dissociate the actomyosin complex of myofibrils unless 
sufficiently high Mg2+ was present. The opposite was also observed, i.e. in the presence 
of Mg2+, relaxation did not occur if the ATP concentration was sufficiently low (Mühlrad 
et al., 1965).  
The requirement of MgATP for skinned fibre force generation was observed in 
skinned, single crayfish fibres, which only produced 50% of maximum force in the 
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absence of Mg2+ and ATP. Indeed, maximum skinned fibre force was only obtained in 
the presence of both substrates. Godt (1974) observed that the MgATP concentration 
utilised in a given activating solution affected the force-pCa relationship in skinned frog 
fibres. As MgATP was decreased, a higher pCa was required to elicit maximum tension 
and if too little MgATP was present rigor complexes would form, preventing tension 
generation from being controlled by Ca2+ concentration. These findings support that the 
MgATP complex is necessary for an optimal skinned fibre contraction.  
 
4.1.4 The ATP regenerating system in activating solutions used to study skinned 
skeletal muscle fibres 
 
Given the importance of MgATP to skinned fibre force generation, the diffusion of 
MgATP from the activating solution into the skinned fibre interior must be uniform. 
However, the hydrolysis of ATP by the myofilaments prevents the concentration of 
MgATP in the interior of skinned fibres from being the same as that present in the 
experimental solution surrounding the fibre. Godt (1974) presents calculations indicating 
that for a fibre 100µm in diameter, bathed in a solution containing 2mM of ATP outside 
the fibre, ATP will only be present in 41% of the fibre volume when the fibre is maximally 
activated with Ca2+. This causes a gradient of differing ATP concentrations across the 
fibre diameter, meaning that ATP diffusion is not uniform across the fibre. Therefore, an 
ATP regenerating system of Creatine Phosphate (CP) and/or Creatine Phosphokinase 
(CPK), is typically used to regenerate ATP from ADP, to minimise issues relating to 
diffusion  which can be caused by the intrinsic ATPase activity of skinned fibres (Ashley 
and Moisescu, 1977). Furthermore, the inclusion of CP and CPK was suggested to create 
a better representation of the normal myofibrillar environment, since both serve to 
maintain ATP concentration in intact muscle fibres (Godt, 1974).  
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The concentration of CP to be used in a given activating solution was determined 
experimentally in skinned frog fibres by assessing the effect of different concentrations 
of CP on the force-pCa relationship. Peak isometric force was not affected by different 
concentrations of CP, although submaximal force was reduced at CP concentrations lower 
than 14.5mM, indicating that below 14.5mM of CP the skinned fibre Ca2+ sensitivity was 
diminished. Therefore, 14.5mM of CP was selected as an appropriate concentration, 
which has also been widely employed in activating solutions used to measure specific 
force from human skinned fibres. Indeed, approximately 60% of the human skinned fibre 
specific force data sets reviewed in Chapter 2 were measured using activating solutions 
containing 14.5mM of CP.  
 
4.1.5 The relationship between Calcium concentration and force in skinned fibres 
 
The importance of Ca2+ in the development of force during a skinned and intact 
fibre muscle contraction was initially observed in the 1960s. Bianchi and Shanes (1959) 
tracked the Ca45 radioisotope during contraction of intact frog Sartorius muscle and 
observed that there was a direct relationship and strong agreement between the strength 
of the contraction twitch and the amount of Ca2+ entering the muscle. This evidenced a 
simple, direct relationship between Ca2+ influx and twitch height. In glycerinated rabbit 
psoas fibres Seidel and Gergely (1963) observed a lack of tension when fibres were in a 
solution containing purified ATP which was free from contaminating Ca2+, which was in 
contrast to un-purified ATP. This pointed to a role of Ca2+ in the contraction of skinned 
skeletal muscle fibres. Indeed, adding CaCl2 to solution caused an increase in tension by 
increasing the Ca2+ concentration in the experimental activating solution.  
The role of Ca2+ in skinned fibre force production was also implicated indirectly 
through observations made using EGTA, a chelating agent used in skinned fibre solutions 
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due to its selective affinity for Ca2+ ions compared to other metal ions such as Mg2+. 
Ebashi and Ebashi (1962) showed that the relaxing ability of different metal chelators 
was linearly proportional to their Ca2+ binding capacity, implicating a role of Ca2+ in force 
development. Indeed adding EGTA was found to inhibit Ca2+ elicited contractions in 
glycerinated psoas fibres (Filo et al., 1965).  
Since Ca2+ had been identified as having a critical role in eliciting skinned fibre 
force production, several publications in the mid-1970s to early 1980s assessed the impact 
of different Ca2+ concentrations in activating solutions, on force production. The force-
pCa relationship was studied in parallel with varying concentrations of another substrate 
in solution, such as CP (Godt, 1974), Mg2+ (Donaldson and Kerrick, 1975, Stephenson 
and Podolsky, 1977), or K+ and ionic strength (Ashley and Moisescu, 1977). The impact 
of chemical skinning on the force-pCa relationship (Orentlicher et al., 1974), and Ca2+ 
kinetics in the process of tension development were also studied (Moisescu, 1976). These 
studies all observed that peak skinned fibre force was generated in the presence of high 
concentrations (pCa 4.5-5) of Ca2+. Fuchs and Fox (1982) determined the relationship 
between skinned rabbit psoas fibre  Ca2+ saturation and force, reporting that peak force 
was elicited when skinned fibres were fully saturated with Ca2+, which in turn occurred 
in solutions at pCa 5. Therefore, investigations studying the peak isometric force response 
of skinned skeletal muscle fibres use activating solutions at pCa 4.5 in order to provide 
an excess of Ca2+, to ensure peak force is achieved, which corresponds to a total Ca2+ 
concentration of 30mM (Ferenczi et al., 1984). Indeed, all the studies assessed in the 
systematic review presented in Chapter 2 measured specific force from human skinned 
skeletal muscle fibres using activating solutions at pCa 4.5.  
Maintaining a constant Ca2+ concentration throughout a given skinned fibre can 
be complicated by the generation of H+ from the hydrolysis of ATP during contraction. 
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The movement of protons across a skinned fibre can cause local pH changes which affect 
the apparent binding constant of Ca2+ to the Ca2+ buffer (EGTA) utilised. Therefore, 
Moisescu and Thieleczek (1978) developed a method to rapidly equilibrate the Ca2+ 
concentration between  the activating solution used and the skinned fibre interior. This 
involved incubating a fibre in a pre-activating solution with a low EGTA concentration, 
followed by rapid immersion into an activating solution containing a high Ca2+ buffering 
capacity, causing the desired ratio between CaEGTA and EGTA to be attained more 
quickly. Indeed, based on the light intensity of aequorin, the Ca2+ sensitive photoprotein, 
the time course for the Ca2+ concentration of the whole skinned fibre to reach 90-95% of 
that in the activating solution was 100-150ms. The technique of utilising a pre-activating 
solution is now common practice.  
 
4.1.6 The impact of the experimental solution ionic strength on skinned fibre force. 
 
The ionic strength of a given activating solution used to study skinned skeletal muscle fibre 
contraction is important, since at sub-physiological temperatures high ionic strengths have been 
shown to reduce P0. In experiments conducted at room temperature (20-22°C), a reduction in Ca2+ 
induced force from skinned frog fibres transferred from solution of 170mM to 330mM ionic 
strength was observed. Furthermore, force was irreversibly lowered when fibres were immersed 
in solutions of 400-500mM ionic strength. The force response of skinned frog fibres was in high 
agreement with that observed in intact frog fibres, indicating that the decline in force was likely 
due to an elevated internal ionic strength, causing the force generation of myofibrillar proteins to 
be compromised (Gordon et al., 1973). In mechanically skinned soleus and extensor digitorum 
longus (EDL) rat fibres and Iliofibularis toad fibres, Ca2+ sensitivity was reduced as the ionic 
strength of the activating solution increased. Furthermore, P0 decreased with increasing ionic 
strength in all fibres studied (Fink et al., 1986). The mechanism of these observations is discussed 
further in section 4.4.5.5. Due to the negative effect of high ionic strength on skinned fibre force, 





Substantial literature exists which has investigated how different chemical 
substrates in solution affect the skinned fibre contractile response. Even so, a consensus 
does not exist as to the chemical composition of an activating solution which elicits the 
optimal skinned fibre contractile response with regard to force generation. This has 
resulted in different research groups using different activating solutions to study the 
contractile properties of skinned fibres. Therefore, in order to assess whether the different 
activating solutions used by different research groups contributes to the variability in 
reported specific force results, the aims of the present study were to: 
1. Quantify the effect that two different and commonly used activating solutions 
have on the contractile response of chemically skinned, human skeletal muscle 
fibres. Each activating solution tested is used by a different research group 
that routinely takes mechanical measurements from skinned skeletal muscle 
fibres (Larsson and Moss, 1993, West et al., 2013). 
2. To systematically identify the cause of any observed differences in skinned 
fibre contractile response elicited by the two different activating solutions, by 







One young, healthy, male participant (24 years old) provided informed consent to 
volunteer for the study, which was approved by the King’s College London ethics 
committee and ran in accordance with the declaration of Helsinki (1964).  
4.2.2 Biopsy and preparation of muscle samples for mechanical experiments 
 
A muscle biopsy was taken from the Vastus Lateralis using a Bergstrom biopsy 
needle with suction (Bergstrom, 1962) (section 3.3), and bundles of approximately fifty 
to one hundred fibres were chemically skinned (section 3.4). All bundles were processed 
for long-term storage (section 3.5) and subsequently de-sucrosed before being prepared 
for experimentation (section 3.6), to ensure that all skeletal muscle fibres had undergone 
the same treatment prior to force measurements being taken. Individual fibres were 
dissected from a bundle, t-clipped and mounted to the experimental set up (section 3.8), 
sarcomere length was set to an optimal length of 2.75µm and the dimensions of a given 
skinned fibre were measured. Skinned fibre CSA was calculated assuming a cylindrical 
cross-section, without correcting for the swelling which occurs upon skinning (section 
3.8).  
4.2.3 Force measurements from chemically skinned skeletal muscle fibres 
 
Skinned fibres were transferred from a relaxing (pCa 9.0) to a pre-activating 
solution, followed by an activating solution (pCa 4.5) (section 3.9) where the fibres 
contracted until a plateau in force signal was reached, before being transferred back into 
relaxing solution. Peak isometric force (P0) was classified as the calculated baseline force 
signal of the fibre in the activating solution subtracted from the maximum force signal 




4.2.4 Identifying the fibre type of individual fibres using SDS-PAGE 
 
SDS PAGE was used to identify the MHC isoform composition of individual 
skinned fibres based on their myosin heavy chain isoform expression, as described in 
section 3.11. A sub-set of the skinned fibres tested in the present study were stored at -
20°C for up to fourteen months. Unfortunately, when fibre typed these samples yielded 
no bands, which was attributed to protein degradation over time. The data from these 
fibres has been grouped together and they are referred to as fibres of ‘unclassified fibre 
type.’ Subsequently all fibres tested following this were stored at -80°C and were 
analysed within two months. The fibres yielded clear bands, enabling the differentiation 
of different fibre types (section 3.11). 
 
4.2.5 Comparing the effect of solutions A and B on specific force elicited from the 
same fibre. 
 
As the same skinned Vastus Lateralis fibres were being compared in two different 
activating solutions, a protocol was developed in order to ensure that any observed results 
were due to the contractile properties of the skinned fibres tested, and not the order in 
which the activating solutions were used. Furthermore, repeated contractions are known 
to potentially cause damage to skinned fibres. Therefore, a means of verifying that the 
structural integrity of the skinned fibres tested remained intact was necessary. A protocol 
in which five maximal isometric contractions were elicited from each fibre tested was 
used to differentiate between the effects of the two different activating solutions used, 
referred to as ‘solution A’ and ‘solution B.’ The chemical constituents of solutions A and 
B are detailed in Table 3.2, while the constituents of all other solutions used in this study 
are in Table 4.1. 
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P0 was measured from each fibre five times: two successive contractions were 
measured in each activating solution, followed by a final contraction in the initial solution. 
The order in which the activating solutions were used was allocated randomly. Measuring 
fibre force in each activating solution twice ensured consistency in the data, while the 
final contraction served as a control value. If the force of the final contraction was not 
sufficiently consistent with that of the second contraction, the inference made was that 
the force produced was due to the fibre condition and not the effect of a given activating 
solution. 
Skinned fibres were tested if they did not exhibit any damage upon visual 
inspection, such as tears or nicks along the fibre length or diameter. Data were included 
for analysis if there was a coefficient of variation of < 28% in specific force within a pair 
of contractions measured in the same activating solution. 28% was selected because it 
was the value which allowed the inclusion of as many data points as possible without 
affecting the correlation (R2) between the mean specific force of a pair of contractions 
from a skinned fibre in solution A vs solution B. It was observed that the force produced 
by a fibre during its second contraction was typically greater than the first. Therefore the 
force produced during the first contraction was discounted from data analysis. 
 
4.2.6 Examining the cause of the different contractile responses elicited by the two 
solutions. 
 
Solutions A and B had three obvious differences in chemical composition which 
warranted further testing to isolate the effects of each chemical.  The differences were 1) 
the use of Imidazole in solution A or TES in solution B as a pH buffer, 2) the use of 
Glutathione (GL) in solution B which was not used in solution A and 3) the use of 
Potassium Chloride (KCl) or Potassium Propionate (K-prop) to adjust the ionic strength 
of solutions A and B respectively (Table 3.2). The chemical compositions of solutions A 
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and B were manipulated in order to isolate the effect of specific compounds which were 
different between the two solutions. Hence, the effect any of the aforementioned 
compounds had on the contractile response of skinned fibres could be identified. 
A purpose written computer programme designed in Matlab by Professor Roger 
Woledge (section 3.10) was used to manipulate the chemical composition of solution B 
in order to make modified versions of both solutions A and B. Two modified versions of 
solution B were made, and one modified version of solution A was made, keeping the 
concentrations of all chemical constituents essentially the same:  
i) In the first modified activating solution an optimal concentration of 
Imidazole (20mM) was substituted for TES (solution B1). This was to 
assess the effect of using TES or Imidazole in a given activating solution 
on the skinned fibre contractile response. The investigator was blinded for 
the comparison of specific force elicited by activating solution B 
compared to B1. 
ii) In the second modified activating solution tested, GL was excluded 
entirely from solution B, to assess the effect of GL on the contractile 
response of skinned skeletal muscle fibres. This solution is referred to as 
solution B2.  
iii) The third modified activating solution made was a variation of solution A, 
named solution A1, which was made using K-prop instead of KCl to adjust 
the ionic strength. Therefore, the impact of K-prop (in solution B) or KCL 
(in solution A) on the contraction of skinned skeletal muscle fibres could 
be assessed.  
The two activating solutions, A and B, and the modified activating solutions, B1, 
B2 and A1, were tested using the previously described 5 contraction protocol. The 
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optimum concentration of Imidazole for skinned fibre specific force production, which 
was used in solution B1, had been previously determined experimentally using a dose-
response curve. These findings are illustrated in Figure 4.6 and discussed in section 4.4.5. 
The optimum concentration of TES for skinned fibre specific force production was also 
determined using a dose-response curve, described below. 
The effect of TES and Imidazole on the contractile response of skinned fibres was 
examined more closely by plotting a dose-response curve for each compound. New 
versions of solution B were made each containing either 20, 40, 60, 80 or 100mM of TES. 
A pair of contractions was elicited from a skinned fibre in each of the five activating 
solutions which were used in a random order. The data was accepted if a high consistency 
in force production was observed in each solution. A comparison using the previously 
described five contraction protocol was also made between solution B and another version 
of solution B from which all TES was removed, which was plotted on the dose-response 
curve Figure 4.6.  
To plot the Imidazole dose response curve solution B was made containing 0, 5, 
10, 15, 20, 40, 60, 80 or 100mM of Imidazole. Two dose response curves were plotted 
between Imidazole concentrations of 0mM to 20mM and 20mM to 100mM. Both dose-
response curves are plotted on the same figure as the TES dose response curve for 
comparative purposes. The concentrations of the other chemical constituents in the new 
versions of solution B remained the same apart from minor differences in K-prop so as to 
adjust the ionic strength to 200mM. In two solutions, containing 80 or 100mM of 
Imidazole, the ionic strength had to be adjusted to 210mM and 220mM respectively to 
accommodate the increased Imidazole concentration. Details of the constituents of all 
solutions are given in Table 1. A twelve contraction protocol was employed for the dose-
response curve of Imidazole. A pair of contractions was elicited from a skinned fibre in 
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each of 5 activating solutions used in a random order, followed by a final pair of 
contractions in the initial activating solution which served as an internal control. 
 
4.2.7 Proton nuclear magnetic resonance spectroscopy (1H NMR) 
 
In order to identify whether the inclusion of Imidazole or TES in solutions B and 
B1 respectively, caused the formation of any compounds affecting the skinned fibre 
contractile response, a spectrum of the compounds containing H+ nuclei was recorded 
using proton nuclear magnetic resonance spectroscopy (1HNMR). Samples of 475µl of 
each solution were mixed with 25µl of deuterium oxide (D2O) in ependorph tubes before 
being transferred to 5mm diameter NMR tubes (Willmad-LabGlass). A ‘blank’ sample 
containing only the distilled water (H2O) used to make the experimental solutions in the 
present thesis, and no other chemicals apart from 25µl of D2O, was also tested to assess 
the purity of the distilled H2O. 
 1D 1H NMR spectra were recorded at 298K and 700 MHz (representing the 1H 
frequency at that magnetic strength) on a Bruker Avance III 700 NMR spectrometer. 
The signal from the distilled water used to make up solutions B and B1 was suppressed 
using a 1D NOESY pulse sequence (noesygppr1d). Samples were scanned thirty-two 
times with a relaxation delay of four seconds between each scan. Spectral width was set 
to 20.5ppm.  
Data was processed and analysed in the manufacturer’s software (Topspin 
v.3.2). The raw spectra obtained were treated with an exponential multiplication 
window function (line broadening of 0.3 Hz), prior to being processed using a Fourier 
transformation. Spectra were calibrated to an external reference (4,4-dimethyl-4-





The mean specific force elicited from each contraction of the five contraction protocol 
was compared within the specific force data collected in solution A or solution B using a 
one-way ANOVA. The mean specific force data collected from a given fibre in the 
activating solutions used for the dose-response curves for TES or Imidazole were also 
analysed using a one-way ANOVA. 
  Mean specific force measurements from pairs of contractions of the same fibres in 
two given, different activating solutions tested using the previously described five 
contraction protocol, were analysed using a paired t-test. The corresponding mean t50 
values were also analysed using a paired t-test. The experiments for which the data were 
analysed using a paired t-test were: solution A vs B; B vs B1; B vs B2; A vs A1 and 
solution B vs solution B containing no TES. Mean specific force measurements from 
pairs of contractions of two different sets of fibres tested in either solution B containing 
no TES or solution B containing no Imidazole, were analysed using an independent t-test. 
Correlations between t50 and skinned fibre CSA and between specific forces elicited 





























4.65 14.50 7.00  5.46 17.70 
(µM) 
 20.00  77.63  200 
Pre-activating 5.20 19.60 0.50  5.42 16.00 
(µM) 
 20.00  79.25  200 
Activating 
(A1) 
4.76 14.50  14.00 5.27 15.00 
(µM) 
 20.00 81.70   200 
Activating 
(B1) 
4.65 20.00 0.17 24.83 7.7  60.00  26.10   200 
Activating 
(B2) 
4.65 20.00 0.17 24.83 7.7   60.00 1.70  10.00 200 
TES dose 
response 
4.65 20.00 0.17 24.83 7.7  20.00  23.70  10.00 200 
TES dose 
response 
For TES concentrations of 40, 60, 80 and 100mM there were corresponding K-prop concentrations of 19.90, 16.00, 12.20 and 8.40mM. The 
concentrations of all other constituents remained the same. 
Imidazole 
dose response 
0.47 20.00 0.17 24.83 7.70   20.00 18.90   200 
Imidazole 
dose response 
For Imidazole concentrations of 0, 5, 10, 15, 40, 60, 80 and 100mM there were corresponding K-prop concentrations of 27.60, 25.40, 23.20, 21.10, 
10.30, 1.70, 3.00 and 4.30mM. At Imidazole concentrations of 80 and 100mM the ionic strength had to be increased to 210mM and 220mM 
respectively. The final difference between solutions of different Imidazole concentrations was that solutions containing 0, 80 and 100mM had 
corresponding ATP concentrations of 4.64, 4.68 and 4.70mM. 
Table 4.1. The concentrations of the chemical constituents in the relaxing and pre-activating solutions used, as well as all modified 






4.3.1 Specific force elicited by solutions A and B 
 
Specific force was similar between contractions in solution A or solution B (p > 
0.05) but was found to be consistently higher in solution B for all fibre types examined 
(Figure 4.2). Therefore, the specific force produced by a skinned fibre was dependent on 
the specific activating solution used and was not affected by the order in which solutions 
A and B were utilised. 
The mean specific force measured from a pair of contractions of the same fibre 
was significantly (p < 0.05) greater for MHC I fibres (n = 10) activated in solution B (162 
± 68 kPa) compared with solution A (97 ± 43 kPa). The same significant trend (p < 0.05) 
was observed for fibres of unclassified MHC isoform (n = 33) in solution B (105 ± 43 
kPa) compared with solution A (66 ± 32 kPa). However, while there was a trend for MHC 
IIA (n = 10) fibres to produce a higher specific force in solution B (135 ± 34 kPa) 
compared with solution A (122 ± 41 kPa) the effect was not statistically significant (p > 
0.05) (Figure 4.3).  
 
4.3.2 Time to half peak tension (t50) in fibres contracting in solutions A and B 
 
A major difference in the contractile response of skinned fibres activated in 
solutions A & B was the t50 (Figure 4.4). Skinned fibre t50 was significantly (p < 0.05) 
longer in solution A compared with the same fibres activated in solution B, requiring 9.5 
± 5.2 seconds and 1.7 ± 0.8 seconds respectively in fibres of unclassified MHC isoform. 
t50 was significantly shorter (p < 0.05) in MHC I fibres contracting in solution B (2.27 ± 
1.4 seconds) compared with solution A (7.7 ± 5.6 seconds), as well as in MHC IIA fibres 
contracting in solution B (1.12 ± 0.6 seconds) compared with solution A (4.34 ± 3.7 




    
 
Figure 4.1. A visual representation of a force trace obtained from the same skinned fibre contracting in solution A (A) and solution B (B).  
The vertical axis represents force measured in mN and the horizontal axis represents time measured in seconds. The time required to reach P0 was 














Figure 4.2. Activation protocol used in the present study.  
The solution used to elicit the first contraction was selected randomly. The final 
contraction was measured in the same solution as the first contraction and served as an 
internal control measurement. Fibres (n = 55) were caused to contract in both solution A 
or B for two successive force measurements to ensure consistency of skinned fibre 
contractile performance in each solution. There was no significant (p > 0.05) difference 
between any of the specific forces measured in the same activating solution, irrespective 














































Figure 4.3. Specific force measured from the same individual fibres activated in 
solution B (y-axis) vs solution A (x-axis).  
Each data point represents the mean value of a pair of specific force measurements taken 
in each activating solution. The solid black line represents the line of identity. Paired t-
tests indicated that specific force was significantly higher (p < 0.05) in solution B 
compared with solution A, for MHC I fibres and fibres of unclassified fibre type, but not 









































shorter than the t50 of MHC I fibres, whereas in solution A the same trend was statistically 
insignificant (p > 0.05). 
In order to assess whether diffusion of solution A or B into the skinned fibre 
interior may have caused the observed trends in t50, the t50 was correlated against the fibre 
CSA. An R2 of 0.36 and 0.31 was observed for MHC IIA fibres in solutions A and B 
respectively. However, these R2 values were skewed by a single outlying data point, 
which when removed reduced the R2 values to 0.0046 and 0.025 in solutions A and B 
respectively. Therefore, it was concluded that there was no correlation observed between 
the t50 in solutions A (Figure 4.5i) or B (Figure 4.5ii) and skinned fibre CSA for all fibre 
types, as evidenced by the weak R2 values. 
 
4.3.3 Chemical differences between solutions A and B and their effect on skinned 
fibre contractile properties 
 
1) TES vs Imidazole dose response curves 
A dose-response curve for TES was constructed using five activating solutions, 
all of which were modified versions of solution B (already containing 60mM of TES), 
with TES concentrations of 20, 40, 80 and 100mM, and their effect on skinned fibre 
specific force was compared. An optimum specific force was obtained using a solution 
containing 60mM of TES (Figure 4.6), but there was no significant difference (p > 0.05) 
in specific force observed at the other TES concentrations tested between 20-100mM. 
Specific force was significantly lower (p < 0.05) in a solution containing no TES 
compared with solution B, which contains 60mM of TES. The specific force data from 
the TES dose response curve are expressed relative to the peak specific force measured 
in an activating solution containing 60mM of TES, i.e. as a proportion of the maximum 








Figure 4.4. The mean time to half peak tension (t50) measured from the same 
individual fibres activated in solution A vs solution B. 
 Data are displayed as means ± SEM. t50 was significantly (p < 0.05) longer in solution A 
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Figure 4.5. t50 vs CSA of skinned fibres. 
i): in solution A. ii): in solution B. Blue circles represent fibres of unclassified fibre type, 























Sol A - unclassified fibre type
Sol A - type I
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Nine modified versions of solution B, containing either 0, 5, 10, 15, 20, 40, 60, 80 
or 100mM of Imidazole were used to obtain a dose-response curve of the sensitivity of 
skinned fibre specific force to Imidazole.  No significant differences in specific force 
elicited from skinned fibres using activating solutions containing 0, 10, 15 or 20mM of 
Imidazole were observed, although peak specific force was recorded in the activating 
solution containing 10mM of Imidazole. Specific force was significantly lower in an 
activating solution containing 5mM of Imidazole compared to 0, 10, 15 and 20mM of 
Imidazole. Specific force elicited in activating solutions containing greater than 20mM 
of Imidazole was reduced, exhibiting a negative linear relationship between increasing 
Imidazole concentration and specific force (Figure 4.6). Specific force was significantly 
lower (p < 0.01) in activating solutions containing 80mM and 100mM of Imidazole 
compared with 20mM. The specific force data from the Imidazole dose-response curve 
are expressed relative to the specific force measured in the activating solution containing 
20mM of Imidazole, which is the concentration most frequently used in the skinned fibre 
literature. 
 
4.3.4 The impact of TES and Imidazole on specific force at their optimal 
concentrations. 
 
Having identified the concentrations of TES (60mM) and Imidazole (20mM) 
which elicit the greatest specific force from skinned fibres, it was of interest to compare 
the effect that each compound had on specific force at their optimal concentrations in 
solution. Given that there was no significant difference between specific force elicited in 
solutions containing 10mM and 20mM of Imidazole, and the fact that the latter 
concentration is used by the majority of the skinned fibre literature in human skeletal 
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muscle, Solution B (containing 60mM of TES) was compared against solution B1, 
containing 20mM of Imidazole. 
The mean specific force measured in activating solution containing 20mM of 
Imidazole was significantly lower (p < 0.05) than in solution B containing 60mM of TES, 
for fibres of unclassified MHC isoform, MHC IIA and MHC IIA-X fibres. SDS-PAGE 
revealed that only two fibres tested in this experiment were MHC I fibres and although 
specific force was lower in solution B1 containing 20mM of Imidazole, this effect was 
not statistically significant (p > 0.05) (Figure 4.7A). The t50 of fibres contracting in 
solution B compared to solution B1 were not significantly different for all fibre types 
studied (Figure 4.7B). 
Furthermore, a scatter diagram of the specific force data from each fibre activated 
in solutions B and B1 yielded high correlations for fibres of unclassified fibre type (R2 = 
0.93), MHC IIA fibres (R2 = 0.99) and MHC IIA-X fibres (R2 = 0.84) (Figure 4.8).  This 
indicates that the depressive effect on specific force of Imidazole, in activating solution 
B1, was consistent across different fibre types. However, a correlation was not calculated 
for MHC I fibres since there were too few samples.  
1H NMR spectra of solutions B and B1 corresponded to the compounds expected 
based on their known chemical compositions. There was no indication of reaction 
products as a result of the use of either TES or Imidazole. The distilled water sample did 







Figure 4.6. Specific force dose response curves for both TES (red circles) and 
Imidazole (blue circles) pH buffers.  
Skinned fibres were activated in solutions containing different pH buffer concentrations 
in a random order, but data are presented in order of increasing buffer concentration on 
the x-axis. Data are mean values normalised to the peak specific force observed ± SEM. 
No significant difference (p > 0.05) in specific force was observed when fibres contracted 
in solutions containing different concentrations of TES (n = 9). In a separate experiment 
specific force was significantly (p < 0.05) lower in a solution containing 0mM TES 
compared with a solution containing an optimal amount of TES (60mM) (n = 8), 
displayed on the current figure. The Imidazole dose response curve was carried out in two 
separate experiments, the first between 20-100mM (n = 9) and the second between 0-
20mM of Imidazole (n = 12). Specific force was plotted relative to force at 20mM of 
Imidazole, the concentration most widely used in the literature. 5mM, 80mM and 100mM 
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Figure 4.7. Specific force and t50 of skinned fibres activated in solutions B and B1.  
A: The mean specific force of the same individual fibres activated in solution B vs 
solution B1. Solution B contained an optimal (60mM) concentration of TES, while 
solution B2 contained an optimal concentration (20mM) of Imidazole as a pH buffer. 
Specific force was significantly (p < 0.05) lower in the same fibres contracting in solution 
B1 compared with solution B in all fibre types examined except for MHC I fibres (p > 
0.05), as indicated by the asterisks. B: The mean t50 from the same individual fibres 
activated in solution B vs B1. No significant differences were observed. All data are 
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Figure 4.8. The correlation between specific force produced by the same fibres in 
solution B (containing 60mM TES) and solution B1 (containing 20mM Imidazole).  
Blue circles represent fibres of unclassified type, green circles represent type IIA fibres 
and purple circles represent MHC IIA-X fibres. High R2 values of 0.84, 0.92 and 0.99 





















































Figure 4.9. A sample portion of two 1HNMR spectra. 
A: The spectra corresponding to the ‘blank’ sample of distilled water tested. No 
compounds were observed other than H2O. 
B: the portion of the spectra illustrating the compounds detected in solutions B and B1. 
The only compounds which were found to differ were those which were already known 
to be different, e.g. the two large peaks corresponding to Imidazole (pictured) which were 






4.3.5 Use of Glutathione (GL) 
 
GL is a reducing agent that is a constituent part of solution B, but was absent in 
solution A. To assess the effect of GL on specific force a new solution with the same 
constituents as solution B but which excluded GL was made, called solution B2. The 
mean specific force measured from skinned fibres activated twice in both solutions B and 
B2 were not significantly different (p > 0.05) in all fibre types examined (Figure 4.10A). 
However, a significant effect of GL on the t50 was observed. Fibres of unclassified type 
and MHC I fibres activated in solution B had a significantly (p < 0.05) faster t50 than the 
same fibres activated in solution B2. While the same trend was observed for MHC IIA 
fibres, the difference was not statistically significant (Figure 4.10B). 
4.3.6 KCl vs K-prop 
 
To adjust the ionic strength, KCl was used in solution A, whereas K-prop was 
used in solution B. Solution A1 was made to be essentially the same as solution A except 
that the ionic strength was adjusted using K-prop instead of KCl, which reduced the 
concentration of free Cl- ions in solution.  
The specific force elicited by activating solutions A and A1 from fibres of 
unclassified MHC isoform and MHC I fibres, was not significantly different (p > 0.05). 
However, MHC IIA specific force was significantly lower (p < 0.05) in fibres contracting 
in solution A1, containing K-prop, compared with solution A which contained KCl 
(Figure 4.11A). The t50 of skinned fibres which contracted in solutions A and A1 was 






Figure 4.10. The specific force and t50 of skinned fibres in solution B vs solution B2.  
A: The mean specific force of the same individual fibres activated in solution B vs 
solution B2. Glutathione was excluded from solution B2. Specific force was not 
significantly different (p > 0.05) for all fibre types examined. B: The mean t50 from the 
same individual fibres activated in solution B vs B2. t50 was significantly (p < 0.05) 
quicker in fibres of unclassified type and in MHC I fibres which contracted in solution B, 
compared with solution B2 (indicated by the asterisk). Despite a trend for t50 to be quicker 
in type IIA fibres contracting in Solution B compared with solution B2, the difference 
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Figure 4.11. The specific force and t50 of skinned fibres in solution A vs solution A1.  
A: The mean specific force of the same individual fibres activated in solution A vs 
solution A1. K-prop was used instead of KCl to adjust the ionic strength of solution A1. 
MHC IIA fibre specific force was significantly (p < 0.05) lower in solution A1 compared 
with solution A. No other significant interactions were observed. B: The mean t50 from 
the same individual fibres activated in solution A vs A1. t50 was significantly (p < 0.05) 
quicker in all fibre types examined which contracted in solution A1, compared with 
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The present study sought to investigate whether the contractile responses elicited 
from skinned skeletal muscle fibres were different when using different activating 
solutions. Each activating solution tested is used by a research group that routinely 
measures specific force from skinned fibres. Solution A (Larsson and Moss, 1993) is used 
by a large proportion of the publications studying skinned fibres from humans. 
Approximately 45% of publications included in the systematic review in Chapter 2 used 
Solution A. Solution B is used by a group which typically studies mammalian, but not 
human, skinned fibres (West et al., 2013). The main findings were that skinned fibres 
exhibited different contractile responses in each of the two activating solutions, both with 
regard to specific force produced and t50. Furthermore, the cause of the difference in 
specific force elicited was identified to be the use of Imidazole in solution A, which has 
a depressive effect on force, and a faster t50 was associated with a lower free Cl
- 
concentration and use of Glutathione (GL), in solution B. 
4.4.1 Activation protocol used 
 
In order to differentiate between the effect of each individual solution on the 
contractile response from a skinned fibre the protocol employed needed to ensure that 
specific force measured was not affected by the order in which solutions A or B were 
used. Furthermore, skinned fibres can become damaged due to repeated activations, so a 
protocol was necessary which could indicate that a give skinned fibre remained 
structurally intact throughout an experiment. There was no significant difference in the 
specific force measured from multiple contractions of a fibre in the same solution, but 
there were significant differences in specific force measurements elicited between the two 
different solutions. This indicates that the order in which the solutions were used did not 
affect the results obtained and demonstrates that skinned fibre force is sensitive to the 
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experimental solutions used. Furthermore, these results verify that the structural integrity 
of a given fibre was maintained throughout an experiment, indicating that results were 
not influenced by damage to the skinned fibre. Therefore, the protocol utilised in the 
present investigation was appropriate for studying the effects of two different solutions 
on the contractile responses of skinned fibres. 
 
4.4.2 Differences in specific force and time to half peak tension (t50) in solutions A 
and B 
 
Several differences in the contractile response of skinned fibres in solution A 
compared to solution B were identified and quantified. The specific force recorded from 
type I fibres in solution B was significantly higher (p < 0.05) than from the same fibres 
contracting in solution A. While the same trend was observed for type IIA fibres, the 
higher specific force recorded in solution B compared with solution A was not statistically 
significant. This could imply that MHC I fibre specific force was preferentially increased 
in solution B, compared to type IIA fibre specific force.  
The t50 of fibres contracting in solution B was significantly faster (p < 0.05) 
compared to when they contracted in solution A, for all fibre types studied. These findings 
indicate that the use of different experimental solutions by different research groups is 
likely to be a significant contributor to the variation observed in published specific force 
values measured from human skinned fibres, discussed extensively in Chapter 2. 
4.4.3 Implications for the inclusion of data in a given study 
 
The present study’s results indicate that an investigator’s interpretation of a 
skinned fibre’s specific force is influenced by the methodological treatment of the fibres 
by using a given activating solution. The activating solution used to measure specific 
force from skinned fibres may also affect the interpretation of a given data set and 
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subsequent conclusions drawn by affecting which data are included in data analysis. 
Given that skinned fibre specific force is greater in solution B than in solution A, some 
fibres activated in solution A may be excluded from data analysis on the basis that they 
are ‘weak’ when actually they have been contracting sub-optimally. For example, if a 
fibre’s specific force data were only included if the specific force was greater than 
100kPa, of the same fifty five fibres which were compared in solution A vs B, sixteen 
tested in solution A would be included, compared with thirty six fibres tested in solution 
B. This large difference in the amount of data included in subsequent analysis suggests 
that the same statistical analysis could lead to the formulation of different conclusions 
due to the amount of data studied. Furthermore, the difference in the number of fibres 
included in data analysis based on their specific force suggests that this would be an 
inappropriate inclusion criterion. Rather, the consistency of force production used in the 
present study is a more appropriate criterion for the inclusion of force data as ‘weak’ 
fibres, which may also occur physiologically, are not excluded from analysis. 
 
4.4.4 Physiological significance of the difference in specific force response  
 
Specific force was measured from the same skinned fibres in solutions A and B. 
Therefore, there was no difference in the force generating potential with regard to 
myofibrillar protein content or number of available cross-bridges in the fibres contracting 
in a given solution. This indicates that the higher specific force observed in solution B is 
due to a difference in cross-bridge behaviour of the skinned fibres. Furthermore, this 
finding highlights the potential for different activating solutions to be used as a means of 
studying cross-bridge behaviour in skinned fibres from different cohorts, such as young 
and elderly groups, discussed further in Chapter 5.  
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Solutions A (Larsson and Moss, 1993) and B (West et al., 2013) are each used by 
different research groups which routinely measure force from skinned single muscle fibre 
segments. The fact that different research groups use different activating solutions shows 
that standardised, optimal experimental solutions for skinned fibre experiments have not 
yet been developed. The higher specific force observed in solution B indicates that 
solution B is more efficient than solution A for recording specific force, but further 
experiments would be required to verify that solution B is ‘optimal.’  
 
4.4.5 The effect of chemical differences between solutions A and B on the skinned 
fibre contractile response. 
 
4.4.5.1 Effect of TES on skinned fibre specific force 
 
Solutions A and B used Imidazole or TES respectively as a pH buffer. The effect of 
containing different pH buffers was first tested by measuring the specific force response 
to different concentrations of either TES or Imidazole, illustrated in the dose-response 
curve in Figure 4.6. There was no significant difference in specific force measured from 
the same fibres tested in solutions containing TES in concentrations ranging from 20mM 
to 100mM, although an optimal specific force was measured at 60mM of TES. In contrast, 
a separate experiment demonstrated that specific force was significantly (p < 0.05) lower 
in a solution containing 0mM TES compared to solution B, which contained an optimal 
TES concentration (60mM). TES was developed by Good et al. (1966) as a structural 
analogue to Trizma buffer, to meet the previously outlined criteria of a good pH buffer 
for use in biological research. The beneficial effect of TES on specific force measured in 





4.4.5.2 Effect of Imidazole on skinned fibre specific force 
 
In contrast to the positive effect of using TES as a pH buffer, Imidazole in 
concentrations greater than 20mM had a negative effect on specific force. Specific force 
decreased in a linear fashion in solutions containing between 20-100mM of Imidazole 
(Figure 4.6), suggesting that the reduction in specific force was proportional to the 
Imidazole concentration in solution. No significant difference (p > 0.05) in specific force 
was observed in solution containing no Imidazole (0mM) compared to 10, 15 and 20mM 
of Imidazole. Therefore, there appears to be no benefit to including Imidazole as a pH 
buffer for skinned fibre specific force generation, in contrast to the inclusion of TES as a 
pH buffer, which increased specific force generation.  
The Imidazole dose response curve (Figure 4.6) demonstrated that specific force was 
significantly lower (p < 0.05) in solutions containing 80mM and 100mM of Imidazole, 
compared to 20mM of Imidazole. This reduction in specific force could be related to the 
fact that the ionic strengths of the solutions containing 80mM and 100mM of Imidazole 
were higher, at 210 and 220mM respectively. Previous work has shown reductions in 
skinned fibre force in solutions of high ionic strengths of approximately 300-500mM 
relative to solutions of lower ionic strengths of 150-200mM (Gordon et al., 1973). This 
range is considerably higher than in the present study, where an increase in ionic strength 
of 10-20mM is unlikely to have a significant effect on skinned fibre specific force 
production. Indeed, Ashley and Moisescu (1977) observed that a difference in ionic 
strength of approximately 25mM did not affect the force-pCa relationship in barnacle 
muscle fibres. This implies that the reduction of specific force in solutions of higher 
Imidazole concentrations is primarily due to the presence of Imidazole, as opposed to the 
slightly higher ionic strength. 
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Skinned fibre specific force was significantly lower (p < 0.05) in a solution containing 
5mM of Imidazole, reaching a similar mean value to that recorded in a solution containing 
60mM of Imidazole. This is difficult to explain but based on this similarity one possibility 
is that an error in solution making occurred and that the concentration of Imidazole in 
solution was in fact approximately 50mM, not 5mM. This is supported by the fact that 
specific force was not significantly different (p > 0.05) in solutions containing between 
0, 10, 15 and 20mM of Imidazole. 
  
4.4.5.3 Concentrations of TES and Imidazole used 
 
Interestingly, solution B contains 60mM of TES, which in the present study was found 
to be the optimal concentration for skinned fibre specific force generation. Also, the 
majority of studies in the human skinned skeletal muscle fibre literature use an activating 
solution containing 20mM of Imidazole, which the present study identified as being in 
the optimal range for specific force production, in solutions using Imidazole as a pH 
buffer (Figure 4.6). These two observations suggest that at some point research was 
conducted to determine the appropriate concentrations of compounds in experimental 
solutions used to study the contractile response of skinned fibres, the knowledge from 
which has been utilised by research groups studying muscle physiology. However, based 
on extensive literature searching and communication with experts in muscle physiology 
(Emeritus Professor George Stephenson, Professor Jon Kentish), it appears that the 
research which may have identified optimal concentrations of TES, Imidazole and other 
compounds investigated in the present study, has not been published. One possible reason 
for the use of 20mM of Imidazole in the activating solutions used, is that Ogawa (1968) 
reported that the Ca-EGTA binding constant increased as Imidazole decreased below 
20mM, which could have implications for the force-pCa relation in skinned fibres. 
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4.4.5.4 TES vs Imidazole 
 
In order to determine whether TES or Imidazole was more effective at eliciting 
specific force from skinned fibres at their respective optimal concentrations, the two 
compounds were directly compared against each other. Specific force was measured from 
skinned fibres contracting in solution B (containing 60mM of TES) and solution B1 
(containing 20mM of Imidazole) which were almost identical in chemical composition 
but for the use of the different pH buffers. A concentration of 20mM of Imidazole was 
selected for solution B1 as the present study found this to be in the optimal range for 
specific force production, which would also enable a comparison with the majority of the 
human skinned fibre literature, which uses the same concentration. Specific force was 
consistently (Figure 4.8) and significantly greater (p < 0.05) (Figure 4.7) in solution B 
compared with solution B1, for MHC IIA, IIA-X fibres and fibres of unclassified fibre 
type. MHC I fibres exhibited the same trend but only two MHC I fibres were identified, 
so a statistical comparison was not possible. 
The consistency of the difference in specific force elicited by the two solutions 
suggests that the present investigation succeeded in isolating the effect of a single 
chemical compound, in this case Imidazole, on the skinned fibre contractile response. 
Therefore, the lower specific force observed in solution A in the present study is at least 
in part due to the use of Imidazole as a pH buffer. Furthermore, this finding clearly 
suggests that the majority of publications are taking sub-optimal force measurements 
from human skinned fibres by using Imidazole as a pH buffer instead of TES. Sub-
optimally activating skinned fibres may affect the conclusions drawn from a given study 
either by affecting the relationship between type I and type IIA fibres, or by affecting 
which data are included for statistical analysis, as has been previously discussed. 
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4.4.5.5 Potential mechanism of action of Imidazole 
 
A potential mechanism of the depressive effect of Imidazole on skinned fibre force 
appears to be how Imidazole influences ionic strength. The ionic strength of the solutions 
used to directly compare the effect of either TES or Imidazole on force was the same 
(200mM), but the amount of K-prop required to maintain the ionic strength in either 
solution differed. Indeed, in order to accommodate Imidazole concentrations of 80mM 
and 100mM the ionic strength had to be raised to 210mM and 220mM respectively. In 
contrast, 80 and 100mM of TES were easily accommodated in solution without 
alterations in ionic strength. This suggests that Imidazole exerts a different effect on the 
ionic strength of a solution compared with TES.  The impact of Imidazole and TES on 
the ionic strength of solutions B and B1 could not be assessed using the 1HNMR 
experiments employed in the present study. Also, the ionic strength of the solutions was 
calculated, not measured, in the present study, which could introduce some error into the 
actual ionic strengths of each activating solution. 
Given that the ionic strength is a measure of the concentration of free ions in solution, 
the effect of Imidazole may simply be to increase the availability of ions such as Mg2+ 
which may suppress force generation. Increases in the millimolar range of Mg2+ had a 
significant inverse effect on sub-maximum Ca2+ activated force production in frog 
muscle. This was associated with decreased binding of Ca2+ to myofibrils at a given Ca2+ 
concentration,  and was attributed to Mg2+ competing with Ca2+ for binding sites on the 
myofilaments (Donaldson & Kerrick, 1975).  Indeed, Ashley & Moisescu (1977) showed 
that increasing [Mg2+] caused a shift in the tension-pCa curve such that a higher [Ca2+] 
was required for a given amount of force. This was also attributed to competitive 
inhibition between Mg2+ and Ca2+ for the functional unit.  The 1H NMR experiments 
employed in the present study did not detect any compounds in solutions B and B1 which 
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were not already known to be there based on the chemical composition of the two 
solutions. However, metal ions such as Mg2+ or Ca2+ could not be visualised using 
1HNMR as they do not contain H+ atoms, so the competing action of these two ions cannot 
be ruled out based on the 1HNMR data. 
The ionic strength of solutions B (containing 60mM of TES) and B1 (containing 
20mM of Imidazole) were the same. Therefore, the negative effects of increased ionic 
strength on skinned fibre force would not have caused the observations made in the 
present study, but may provide some indication as to the effect of Imidazole on cross-
bridge behaviour, if Imidazole does indeed affect ionic strength. P0 of rabbit psoas fibres 
measured at 3-5°C was reduced by increasing the ionic strength of the activating solution 
between 120-520mM. The decline in P0 was associated with a reduced skinned fibre 
stiffness. Interestingly, stiffness increased relative to force at high ionic strengths, 
suggesting that fewer cross-bridges are formed and force produced by each cross-bridge 
is lower at high ionic strengths (Iwamoto, 2000). Consistent with these findings, rabbit 
psoas fibre P0 measured at 20°C was reduced when the activating solution ionic strength 
was increased between 150-300mM, which was also associated with reduced stiffness 
(Kawai et al., 1990). Furthermore, lowering ionic strength increased P0 in rabbit psoas 
fibres, which was associated with increased fibre stiffness (Sugi et al., 2013). Therefore, 
assuming Imidazole exerts a different effect on ionic strength compared to TES, a 
potential explanation of Imidazole’s negative effect on specific force is reduced fibre 
stiffness.  
In contrast to the aforementioned findings from studies conducted at sub-
physiological temperatures, West et al. (2005) studied the effect of ionic strength on P0 
in dog fish fibres contracting at temperatures (12°C) which are physiological for that 
species. Increased ionic strength did not negatively affect P0 in dog fish fibres contracting 
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at physiological temperatures, although the rate of force development was reduced. 
Therefore, changes in ionic strength may not affect P0 in vivo, since a given muscle would 
be contracting at a physiological temperature. However, the experiments in the present 
thesis and in the majority of the human skinned fibre literature are conducted at sub-
physiological temperatures (12-15°C), indicating that maintaining an appropriate ionic 
strength is relevant for P0 measurements. 
Given that Imidazole is a pH buffer, a simple explanation for the negative effect of 
Imidazole on skinned fibre specific force, is that Imidazole does not adequately maintain 
activating solution pH. Indeed low pH has been associated with reduced skeletal muscle 
fibre force production. Low intracellular pH (pH 5.97) caused a reduction in P0 from 
intact frog fibres compared to neutral (pH 7.24) values (Curtin et al., 1988). In skinned 
rat fibres from superficial portion of the Vastus Lateralis, lower pH (pH 6.2) reduced P0, 
which was attributed to a reduction in fibre stiffness (Metzger and Moss, 1989). The 
negative effect of lowered pH on force production from intact mouse flexor brevis fibres 
was shown to be reduced at higher experimental temperatures (32°C compared to 12°C 
and 22°C), although the effect was still significant (Westerblad et al., 1997). 
The pH of the activating solutions in the present study was carefully adjusted to pH 
7.1 when the solutions were made. However, pH could not be measured during an 
experiment due to the small volume (approximately 60µl) of activating solution used for 
each skinned fibre contraction. The activating solution temperature was controlled and 
monitored throughout a given experiment, indicating that any potential changes in pH 
would not be due to changes in the temperature of the solution. Furthermore, as previously 
mentioned, skinned fibre specific force data were included based on the consistency force 
production, so any inconsistencies in specific force due to changes in activating solution 
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pH would have been excluded. Therefore, that the effect of Imidazole is due to a change 
in the activating solution pH in the present study in unlikely. 
 
4.4.6 The rationale for using Imidazole as a pH buffer in activating solutions 
 
Some evidence exists, which although limited, may have been used as the 
rationale for utilising Imidazole as a standard pH buffer in activating solutions used to 
study skinned skeletal muscle fibres, prior to the technique becoming widely used in 
human research from the 1990s onwards. The following section assesses some of the 
reasons why Imidazole has been used in activating solutions, despite the observations 
made in the present study that Imidazole inhibits skinned fibre specific force. 
 
4.4.6.1 pH buffering in vivo: Imidazole containing dipeptides 
 
Smith (1938) studied skeletal muscle in rigor, as this model provided a simpler 
buffering system to analyse than that present in living muscle, and observed that the 
Imidazole containing dipeptides Carnosine and Anserine, accounted for approximately 
35% of the buffering of mammalian skeletal muscle, at least in rigor. Smith (1938) noted 
that Carnosine and Anserine were suitable for buffering between pH 6.5-7.5 due to their 
pK characteristics. Davey (1960) commented that the buffering actions of Carnosine and 
Anserine would prevent dangerous falls in pH due to H+ ion production as a result of 
anaerobic glycolysis during and following strenuous activity. Indeed, in humans a higher 
Carnosine content has been quantified in MHC II fibres compared to MHC I fibres, 
evidencing that Imidazole containing dipeptides are likely to contribute to H+ buffering 
in human skeletal muscle (C. Harris et al., 1998). Furthermore, increases in muscle 
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Carnosine content due to β-alanine supplementation were shown to attenuate fatigue 
during repeated dynamic contractions of the quadriceps muscle (Derave et al., 2007). 
The aforementioned findings support that Imidazole containing dipeptides such 
as Carnosine have a role in H+ buffering in human skeletal muscle. However, an important 
point is that Carnosine is not used as a pH buffer in activating solutions, rather, the 
Imidazole ring of the Carnosine molecule is used (Figure 4.12). Therefore, while 
Imidazole may be utilised as a structural analogue to dipeptides which contribute to H+ 
buffering in vivo, either the effect of the Imidzole ring alone does not provide as efficient 
a H+ buffering capacity, or the Imidazole ring may simply be inappropriate for the skinned 
fibre preparation.  
 
4.4.6.2 Experimental evidence which may have supported the use of Imidazole in activating 
solutions used to study skinned fibres 
 
Bowen (1965) demonstrated that shortening of glycerinated bundles of rabbit 
psoas fibres was facilitated by the inclusion of the Imidazole containing dipeptides, 
Histidine and Carnosine, in solution. Murphy and Koss (1968) later identified both 
Imidazole and TES as appropriate pH buffers for maintaining pH between 6-7, where 
ATPase activity was optimal. Furthermore, Imidazole was described as an economical 
pH buffer, indicating that perhaps the initial and continued use of Imidazole was due to 
financial reasons. This study was conducted on homogenised rabbit muscle, so the impact 
of pH buffers on skeletal muscle mechanical properties could not be examined.  
Apart from regulating pH in the desirable, neutral range for skinned fibre 
experiments, Imidazole was found to not affect the ATPase activity of contractile proteins 
(Kerrick & Donaldson, 1972). Furthermore, Donaldson & Kerrick (1975) state that 











Figure 4.12. The commercially available Imidazole ring, and an example of that 
which is present in vivo.  
A: The Imidazole ring is widely utilised as a pH buffer in activating solutions used to 
study skinned, skeletal muscle fibres. B: Carnosine, the Imidazole containing dipeptide 
observed in vivo in human skeletal muscle. While the Imidazole ring may provide a 
structural analogue to Carnosine in a given activating solution, the effect on skinned fibre 







muscle fibres. However, data to support this statement are not displayed and the effect of 
Imidazole on absolute force produced was not examined. 
Studying skinned frog semitendinosus fibres Fabiato and Fabiato (1978) used 
Imidazole as a pH buffer to examine the effect of pH 7.4, 7.0. 6.6 and 6.2 on force 
generation. Interestingly, they also did experiments at pH 7.4 using Tris and or Bis-(2-
hydroxyethyl)amino)-tris(hydroxymethyl)methane and observed that the change of pH 
buffer did not affect force at a given pH or pCa. This potentially provides a rationale for 
different research groups using Imidazole, under the incorrect assumption that compared 
with other buffers Imidazole does not negatively affect skinned fibre force production. 
As previously mentioned, Imidazole has an appropriate pKa (7.09 at 25°C) for 
maintaining the desirable pH in solutions used to study skinned fibres. However, this is 
nullified by the fact that highly recommended pH buffers such as TES have pKa values 
(7.4 at 25°C) in the same range (Murphy and Koss, 1968). Two different pH buffers may 
both have desirable buffering capacities but may not be equally effective in the same 
experimental preparation. Therefore, Good et al. (1966) recommend that extensive testing 
is carried out in order to select an appropriate pH buffer, as the side effects of a pH buffer 
are independent to their buffering capacity in a given pH range, as has been shown in the 
present study. 
Finally, several publications which were key (Ashley and Moisescu, 1977, 
Moisescu, 1976, Moisescu and Thieleczek, 1978) in the development of solutions used 
to study skinned skeletal muscle fibres use TES as a pH buffer. TES was preferred to 
Imidazole due to the latter having a pK sensitive to temperature, being unstable in solution 
in the presence of light and because the protonated form of Imidazole changes the 
sensitivity to Ca2+ of skinned fibres (personal correspondence with George Stephenson). 
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Therefore, the use of Imidazole in experimental solutions used to study skinned fibres is 
strange, since TES was preferred in the solutions used in some highly cited research. As 
this work (Ashley and Moisescu, 1977, Moisescu, 1976, Moisescu and Thieleczek, 1978) 
was conducted in animals, perhaps research groups working on human muscle followed 
a different practice, or perhaps because the main emphasis was not on the pH buffer this 
aspect of the experimental solutions was overlooked in future research. 
 
4.4.7 Time to half peak tension (t50) in solutions A and B 
 
The t50 was significantly longer in solution A compared with solution B (Figure 
4.4). A potential mechanism examined was the role of diffusion, by correlating the t50 
with skinned fibre CSA. If diffusion was a limiting factor then t50 should be greater in 
larger fibres. However, no correlation was observed in either solution A or B, indicating 
that diffusion does not limit the t50 in skinned fibres irrespective of fibre type. This is in 
agreement with previous work on skinned fibres from rat hindlimb (EDL and Soleus) 
muscle where force equilibrated faster at higher temperatures, showing that the physical 
process of Ca2+ diffusion is not rate limiting to force development (Stephenson & 
Williams, 1981). Furthermore, Ferenczi et al (1984) found no appreciable correlation 
between Vmax and CSA, indicating that diffusion of substrates and their subsequent 
concentration in the core of skinned fibres is not different between fibres of small or large 
diameter. 
 
4.4.7.1 Use of Glutathione 
 
Glutathione (GL) is a reducing agent and is not a common feature of activating 
solutions typically used to study human skinned fibres. The reason for including GL in 
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solution B is likely to be to preserve enzyme function or prevent reactive oxygen species 
induced damage during an experiment. Indeed, GL was found to attenuate a five-fold 
reduction in force produced by mechanically skinned, rat EDL fibres, caused by hydrogen 
peroxide (Murphy et al., 2008). The results from the present study indicate that GL is not 
necessary to maintain skinned fibre force production in the absence of reactive oxygen 
species, although no negative effect of GL was observed. 
Solution B contained GL, whereas solution A did not. Excluding GL in solution B2 
significantly increased the t50 compared with the contractile response elicited by solution 
B, irrespective of fibre type (Figure 4.10B). Assuming that t50 is an indirect measure of 
the rate of force development, this finding shows that the effect of GL is to increase the 
rate of force development in skinned fibres. Indeed, a similar observation was made by 
Posterino and Lamb (1996), who reported no effect of GL on mechanically skinned rat 
EDL fibre force, but the duration of the force response was reduced. This observation was 
attributed to a small, GL induced reduction in skinned fibre Ca2+ sensitivity. The 
difference in t50 between solutions B and B2 is not as great as between solutions A and 
B, suggesting that GL only partly accounts for the faster t50 observed in solution B. 
 
4.4.7.2 KCl vs K-prop 
 
Solution A1 was essentially the same as solution A but for the use of K-prop 
instead of KCl to adjust the ionic strength to 200mM. Since K-prop does not contain 
chloride, the use of K-prop instead of KCl was assumed to reduce the concentration of 
free Cl- ions in solution A1. Therefore, the significantly faster t50 (p < 0.05) observed in 
fibres of all fibre types in solution A1 compared with solution A (Figure 4.11B), can be 
attributed to the effect of a lower concentration of Cl- ions on the contractile response. 
The difference in t50 between solutions A1 and A was similar to that between solutions A 
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and B, suggesting that the primary mechanism causing the difference in t50 between 
solutions A and B is the greater [Cl-] in solution A compared with solution B.  
Stephenson and Podolsky (1977) observed that Cl- ions diffused uniformly into 
skinned frog muscle fibres, suggesting that the skinned fibres in the present study would 
have been permeated with Cl- ions, particularly in solution A which contained a higher 
Cl- concentration. Furthermore, intracellular concentrations of Cl- increase in proportion 
to the tonicity of a given solution, tonicity representing the solutes that cannot cross the 
sarcolemma, which exert osmotic pressure (Gordon and Godt, 1970). Given that the 
sarcolemma of skinned fibres has been permeabilised, the solution tonicity is unlikely to 
affect the Cl- ions entering a given fibre. Therefore, the intracellular Cl- concentration in 
the skinned fibre preparation is likely due to the Cl- concentration in the activating 
solution. The presence of increasing Cl- ion concentrations was found to affect the rate at 
which actin and myosin dissociate (GEEVES and GOLDMANN, 1990). However, this 
was observed using fluorometric titration of pyrene-labelled actin, where actin and 
myosin are dissociated from the myofilaments, so whether Cl- ions affect the dissociation 
of actin and myosin during skinned fibre contraction is difficult to determine. 
The rate of force development in skinned fibres of rat EDL and Soleus muscle 
was shown to depend strongly upon the ionised Ca2+ concentration and experimental 
temperature. Given that the temperature of the experiments in the present investigation 
was maintained at 15⁰C, Cl- may act via a mechanism which affects the free ionised Ca2+ 
concentration available to bind to the myofilaments. As the fibres in the present study are 
skinned using glycerol, Cl- could potentially affect the Ca2+ released from the SR. 
Specific force was found to be similar in fibres of unclassified type and type I 
fibres tested in solutions A and A1, but type IIA fibre specific force was found to be 
significantly lower (p < 0.05) in solution A1 compared with solution A (Figure 4.11A). 
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That a reduction in Cl- ions should cause a reduction in type IIA fibre specific force is 
difficult to explain. The use of KCl to adjust ionic strength was shown to have a negative 
effect on force produced from skinned frog fibres, compared to the use of K-prop, even 
though the ionic strength of the two solutions used was the same (Gordon et al., 1973). 
Therefore, the anion used to adjust ionic strength can affect skinned fibre force 
generation. However, the effect observed was the opposite to that reported in the present 
study, i.e. Gordon et al. (1973) reported a decreased skinned fibre specific force due to 
the use of KCl, whereas an increase in type IIA fibre specific force was observed in the 
present study as a result of using KCl instead of K-prop to adjust ionic strength.  
A practical consideration to take into account is that solution A1 was made using 
a custom written Matlab programme which was designed to make solution B. Therefore, 
solution A1 was created to mimic solution A as closely as possible, but using the same 
chemicals constituting solution B was necessary due to the technical limitations of the 
solution composition computer programme. The implication of this technical limitation 
is that the sole difference between solutions A and A1 was not exclusively the 
concentration of Cl-. Therefore, the reduction in specific force observed in MHC IIA 
fibres contracting in solution A1 cannot be solely attributed to the impact of a reduction 
in Cl- concentration, although this is the primary difference between solutions A and A1.  
4.4.8 Summary and conclusions 
 
The main findings in the present chapter were that the contractile response of the 
same skinned fibres was markedly different depending on the activating solution used. 
This strongly suggests that the variance in skinned fibre specific force reported in the 
literature is contributed to by the lack of consistency in the chemical composition of the 
activating solutions used across different studies. Furthermore, Imidazole, a pH buffer, 
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was found to be the primary compound affecting force production and had a negative 
effect on skinned fibre specific force. A lower concentration of Cl- ions and the inclusion 
of Glutathione was found to be associated with a faster time to half peak tension, implying 
that the rate of force development could be affected by these two chemicals, although this 
would need to be verified with further experiments. The fact that the same fibres, which 
by definition have the same force generating potential, produce different amounts of force 
in solutions A and B, indicates that the use of two different activating solutions can be 
used as a tool to reveal differences in cross-bridge behaviour. While the present study has 
shown that solution B induces a stronger and faster contraction from skinned fibres, 




5 The impact of physical activity on the development of age-




Specific force loss at the whole muscle level in elderly humans was first observed 
by Men et al. (1985), who reported that quadriceps P0 was 39% weaker in elderly 
compared to young men, but quadriceps CSA measured using ultrasound was only 25% 
smaller. As discussed in section 0, a host of methodological factors need to be taken into 
account in order to obtain a reliable, whole muscle specific force measurement. Studies 
which have accounted for all, or at least the majority of these factors have confirmed that 
specific force loss can occur at the whole muscle level in healthy, elderly individuals 
(Klein et al., 2001, Macaluso et al., 2002, Morse et al., 2005).  
Measuring specific force in vivo cannot provide information as to whether the 
mechanism of age-related specific force loss is due to alterations or deterioration in the 
function of the force generating myofilaments in individual skeletal muscle fibres. 
Therefore, the skinned fibre preparation has been used to assess whether age-related 
specific force loss is due to changes in the contractile properties of the myofilaments, as 
a result of advancing age (D’Antona et al., 2007, Frontera et al., 2003, Frontera et al., 
2000a, Hvid et al., 2011, Hvid et al., 2013, Korhonen et al., 2006, Miller et al., 2014, 
Ochala et al., 2007, Power et al., 2016, Reid et al., 2012, Reid et al., 2014, Venturelli et 
al., 2015, Larsson et al., 1997, Yu et al., 2007, D'Antona et al., 2003, Grosicki et al., 2016, 
Callahan et al., 2014).  
As described in section 1.7.2, the observation that specific force loss occurs in 
skinned Vastus Lateralis fibres from sedentary elderly, compared to young people has 
been reported inconsistently. Nevertheless, trends in specific force between young and 
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elderly cohorts have been mirrored by differences, or lack thereof, in myofibrillar protein 
content (section 1.7.7.1). This indicates that the mechanism underpinning a given trend 
in reported skinned fibre specific force, with regard to myofibrillar protein content, is 
consistent. Indeed, D'Antona et al. (2003) demonstrated that skinned fibre specific force 
has a linear relationship with skinned fibre myosin content, and that lower specific force 
in elderly cohorts is associated with lower myosin content. These two measurements were 
taken from separate sets of fibres (Figure 1.8). Consistent in principle with these findings, 
elderly and young cohorts exhibited similar skinned fibre specific force, and analogously 
had a similar myofibrillar protein content, although this was measured in homogenate 
muscle samples  (Trappe et al., 2003). 
The equivocal results regarding age related specific force loss at the skinned fibre 
level have also been attributed to the varying daily physical activity levels of participants 
studied, and reports suggest that skinned fibre specific force loss is ameliorated by 
physical activity (D'Antona et al., 2007). Indeed, studying physically active elderly 
cohorts such as master athletes has been proposed as a model of biological ageing free 
from the negative effects on health of a sedentary lifestyle (Pollock et al., 2015, Lazarus 
and Harridge, 2010). 
In addition, methodological differences between studies such as the different 
activating solutions used to elicit maximal isometric contractions from skinned fibres are 
a likely source of the variability in published results. As discussed extensively in Chapter 
4, the same skinned fibres produced a markedly different contractile response, revealing 
differences in cross-bridge behaviour, depending on the activating solution used to elicit 
contractions. The use of different activating solutions may therefore provide a potential 
means to further investigate the mechanisms of age-related specific force loss. 
Furthermore, techniques which provide information as to the structure of the myofibrillar 
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proteins during contraction, such as low-angle X-ray diffraction, may also help reveal the 
cause of any observed age-related specific force loss.  
Therefore, the aims of the present chapter were to: 
1. Assess the impact of physical activity on the development of specific force loss 
at the skinned fibre level, using master cyclists as a model of biological ageing, 
compared to comparatively frail hip fracture patients and a young, healthy 
cohort. 
2. Evaluate whether the use of two different activating solutions (solutions A and 
B) would yield two different conclusions from the same skinned fibres, as to 
the occurrence of age-related specific force loss.  
3. Measure myosin content of the same skinned fibres from which specific force 
has been measured, to determine whether any specific force differences 
observed between groups could be attributed to differences in skinned fibre 
myosin content. 
4. Use low-angle X-ray diffraction to obtain preliminary data regarding 
myofibrillar structure during contraction in skinned fibres from young and 
elderly cohorts, to better understand the cause of any observed differences in 







Three mixed sex cohorts were recruited to participate in the present study 
(section 3.1). Five young participants (mean age: 25.8 ± 4.7 years), five master cyclists 
(mean age: 74.8 ± 3 years) and five patients who underwent dynamic hip screw 
insertion surgery (mean age: 74.6 ± 9 years) provided informed consent to participate in 
the present investigation. The study was approved by the King’s College London ethics 
committee and ran in accordance with the declaration of Helsinki (1964). The age and 
gender of the participants are provided in Table 5.1. 
Elderly patients undergoing dynamic hip screw insertion surgery aged 55 years 
or older were identified by Mr Onur Berber or Mr Marc George, who were members of 
their healthcare team. Patients underwent mental health screening to ensure that they 
were able to provide informed consent prior to surgery. The patients also completed a 
basic physical health questionnaire and were considered eligible if they did not suffer 
from any neuromuscular disease. The hip fracture patients were recruited on the basis 
that they were likely to be frail individuals, and due to their age they sometimes had 
underlying health problems, thereby making up a heterogeneous elderly group.  
Physically active elderly individuals who were amateur, non-elite cyclists aged 
between 55-79 years old were recruited for a cross-sectional study evaluating the 
relationship between physiological function and age (Pollock et al., 2015). Based on a 
health questionnaire, participants were excluded if they smoked or consumed alcohol 
excessively, had known hypertension or any known cardiovascular, musculoskeletal or 
neurological conditions, or if they were on any medication. Participants were considered 
healthy if they met the criteria outlined by Greig et al. (1994). Males and females were 
included if they were able to cycle 100km in under 6.5 hours or 60km in under 5.5 hours, 
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respectively. Participants had to have completed the aforementioned distance within the 
specified time on two occasions in the three weeks prior to testing, as shown by their 
training logs or official timing cards. Therefore, these participants formed a homogeneous 
group of physically active elderly individuals, hereby referred to as ‘master cyclists.’  
 
5.2.2 Biopsy and preparation of muscle samples for experiments 
 
A muscle biopsy was taken from the Vastus Lateralis using a Bergstrom biopsy 
needle with suction (Bergstrom, 1962), and fibres were prepared as previously described 
(section 3.3). The muscle sample was dissected into bundles of approximately fifty to one 
hundred fibres which were chemically skinned, as described in section 3.4. All bundles 
were processed for long-term storage (section 3.5) and subsequently de-sucrosed before 
being prepared for experimentation (section 3.6), to ensure that all bundles had undergone 
the same treatment prior to force measurements being taken. Once individual skinned 
fibres had been dissected from a bundle, t-clipped and mounted to the experimental set 
up (section 3.7) sarcomere length was set to an optimal length of 2.75µm and the 
dimensions of a given skinned fibre were measured (section 3.8). Skinned fibre CSA was 
calculated assuming a cylindrical fibre shape, without adjusting for fibre swelling. 
 
5.2.3 Force measurements from chemically skinned skeletal muscle fibres 
 
As described in section 3.9, skinned fibres were transferred from a relaxing (pCa 
9.0) to a pre-activating solution, followed by an activating solution (pCa 4.5). The fibres 
contracted until a plateau in force signal was reached, at which point they were transferred 
back into relaxing solution. Peak isometric force (P0) was classified as the baseline force 
signal of the fibre in the activating solution subtracted from the maximum force signal 
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recorded (section 3.9). Specific force was calculated as the skinned fibre P0 normalised 
to CSA. 
The two different activating solutions described extensively in Chapter 4 were 
used to measure force from the same skinned fibres obtained from each participant 
studied. The same batch of solution A and solution B were used for all skinned fibre 
specific force measurements in the present study. Therefore, the five contraction protocol 
which was described in section 4.2.5 was utilised in order to ensure that the force results 
obtained were not affected by any structural damage to skinned fibres, or the order in 
which the two different activating solutions were used. Fibres were visually inspected 
prior to a given experiment, and fibres which had small tears or nicks were excluded. The 
same inclusion criteria described in section 4.2.5 was used in the present study, i.e. data 
were included for analysis if there was a coefficient of variation of < 28% in specific force 
within a pair of contractions, measured in the same activating solution. 
 
5.2.4 Modification made to the skinned fibre test system 
 
A technical modification was made to the solution changing system described in 
section 3.7, in order to reduce the signal artefact caused by the upwards and downwards 
movement of the metal trough, previously described in section 3.10. A coverslip was 
placed over the top of the metal trough and the relevant experimental solutions were 
contained within a ring of hydrophobic ink. Thus, in order to move a skinned fibre from 
solution to solution only sideways movement was required. This technical alteration to 
the solution changing system reduced the signal artefact caused by the upwards and 
downwards movement of the metal trough (Figure 5.1) and also reduced the time required 
for the fibre to be transferred to a different solution.  
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Following the previously described technical modification to the solution 
changing system, the Matlab programme used to calculate the skinned fibre baseline 
force, described in section 3.10, also needed to be modified. The reduction in the signal 
artefact due to the technical modification enabled clear baseline and peak force signals to 
be observed, as can be visualised in (Figure 5.1). Therefore the Matlab code was 
simplified so that the baseline and peak force signals were both calculated independently 
as the average signal between two manually selected points. The baseline signal could 








   
 
Figure 5.1. Representative images of a skinned fibre force trace before (A & C) and 
after (B & D) the technical modification made to the solution changing system. 
A and C: A zoomed in image of the signal artefact which concealed the baseline signal 
(A), prior to the technical modification (described in section 5.2.4). The whole force trace 
is pictured in C and the zoomed in section of the signal is circled. 
B and D: A zoomed in image of the flat baseline signal which could be measured (B), 
following the technical modification (described in 5.2.4) to the solution changing system. 
The whole force trace is pictured in D and the zoomed in section of signal is circled. 


























SDS PAGE was carried out in order to identify the MHC isoform expression of 
individual skinned fibres (section 3.11). The myosin content of individual skinned fibres 
was determined by quantifying the optical density of their MHC bands on SDS PAGE 
gels in relation to bands corresponding to myosin standards of known myosin content 
(section 3.12). Myosin content and specific force from the same fibres were correlated 
and the relationship between these two variables was assessed in each experimental group 
studied. Myosin content data is available from fourteen of the fifteen participants studied.  
In order to ensure that the calculated amounts of myosin in each MHC band were 
reliable, the linear range of the myosin standard’s optical density was identified (section 
3.12). Furthermore, whether the sample buffer used to de-nature and extract myosin from 
skinned fibres had a homogeneous effect within the same sample, was tested. This was 
carried out using two skinned fibre samples from a young individual, by applying two 
different loads of each sample to the same gel. The brightness area products (BAPs) of 
the subsequent MHC bands were expressed per µl of sample loaded, in order to assess 
whether the same relative BAP was present in the two different loads of the same sample 
(Figure 5.7).  
A new batch of Laemmli sample buffer (LSB) was made half-way through the 
present study and used to prepare skinned fibre samples for SDS PAGE gels. Therefore, 
whether the new batch of LSB had the same effect on the myosin standard was tested by 
processing the myosin standard in the old and the new batch of LSB, and quantifying two 
myosin standard curves from the same gel (Figure 5.8A). Furthermore, whether each 
batch of LSB had a homogeneous effect across different samples was tested. Four skinned 
fibres were cut into halves of equal length which were t-clipped, mounted to the skinned 
fibre test set up, and their dimensions were measured. Each half of a given skinned fibre 
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was processed in the same LSB. The samples were prepared using either the old or the 
new batch of LSB, processed for SDS PAGE experiments and their MHC bands were 
analysed. The calculated myosin content normalised to fibre volume for each half is 
presented in Figure 5.8B.  
 
5.2.6 X-ray diffraction 
 
Low-angle X-ray diffraction experiments were carried out at the Spring-8 
synchrotron facility in Japan, to garner information as to the structure of the myosin 
filament heads bound to actin during a skinned fibre isometric contraction. These 
experiments were organised by Dr Julien Ochala, in collaboration with Dr Hiroyuki 
Iwamoto. Bundles of skinned fibres to be prepared for low-angle X-ray diffraction 
experiments were de-sucrosed (section 3.5) and single fibres were dissected in relaxing 
solution. Individual fibres were clamped between two halves of a 3mm wide gold mesh, 
typically used for electron microscopy, which had been attached to a precision-machined 
ceramic chip (Figure 5.2A). Each pair of gold meshes held approximately thirty fibres, 
termed a ‘set.’ The sets of fibres were designed to fit the specimen chamber (Figure 5.2B) 
at the BL45XU beam line, where the samples were studied. Sets were mounted with 
skinned fibres from all participants in the young and master cyclist groups. However, only 
one hip fracture patient muscle sample had been obtained at the time of the X-ray 
diffraction experiments, so fewer sets were mounted for the hip fracture patient group and 
subsequently the data collected are pilot data. 
Due to the nature of X-ray diffraction experiments, large numbers of skinned 
fibres are necessary as radiation damage during the experiment causes a substantial 
number of skinned fibres to break. Therefore, sets of fibres were prepared for each 
experimental group, as opposed for each participant studied, simply because preparing 
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the high number of samples required to obtain visible diffraction patterns for individual 
subjects would be practically impossible. 
The majority of the sets containing skinned fibre samples to be tested were 
prepared in Japan, however a sub-set of samples were prepared at the Centre of Human 
and Aerospace Physiological Sciences at King’s College London. The sets of fibres 
prepared in London were transported to the Spring-8 facility in Japan on dry ice, in a 
relaxing solution containing 75% glycerol. Upon arrival in Japan the samples were 
transferred to a relaxing solution containing 50% glycerol and stored at -20°C until the 
day of an experiment. Diffraction patterns obtained from sets of fibres which had been 
prepared in London were similar to those from sets of fibres which had been prepared in 
Japan, indicating that the transportation procedure did not affect the subsequent results.  
On the day of an experiment, sets of fibres were washed in pre-activating solution 
(Figure 4.2) to remove the glycerol which the fibres had been stored in and placed into 
the specimen chamber. The sarcomere length of the fibres in a given set was adjusted to 
an optimum length of 2.75µm by changing the length between the two halves of the gold 
meshes, which subsequently altered the length of the fibres in the specimen chamber. The 
sarcomere length was measured using He-Ne laser diffraction, by shining the laser 
through a given set of fibres which was encased in the specimen chamber, and monitoring 
the diffraction spacing (1103P-1367, Uniphase, Manteca, Ca, USA, power = 4mW). 
The specimen chamber was placed into the x-ray set up (Figure 5.2C) and 
immersed in pre-activating solution (Figure 4.2) with the addition of 5mM dithiothreitol, 
200U of Creatine Phosphkinase (Sigma C755-35KU) and 1000U of catalase (Sigma 
C40). These enzymes served to scavenge hydrogen peroxide generated by the radiation 
during the x-ray diffraction experiment. A given set of fibres being tested was immersed 
in activating solution using a remotely controlled pump, which pumped activating 
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solution, also containing the aforementioned enzymes, through the set until the pre-
activating solution had been removed. The activating solution used was solution A (Table 
3.2), as this had been used in previous experiments conducted at the Spring-8 facility (Li 
et al., 2015).  
X-ray diffraction patterns were recorded at 15°C. For each set of fibres, the 
diffraction patterns from the first ten exposures to the X-ray beam were used for analysis. 
The wavelength used was 0.1nm and the distances of the sets of fibres to the diffraction 
pattern camera detector (C4742, Hamamatsu Photonics; 1024 x 1024 pixels) was 
2267mm and an image intensifier (VP5445, Hamamatsu photonics, Hamamatsu, Japan) 
was also used. The exposure time of the sets of fibres to the x-ray beam was kept low 
(two seconds) for each diffraction image taken, in order to reduce radiation damage 
during the experiment. The specimen chamber was moved so that diffraction patterns 
could be obtained every 100µm along the length of the fibres mounted in each set (Figure 
5.2D). Furthermore, an aluminium attenuator 0.8mm thick was placed upstream of the 
specimen chamber. The beam flux was between 2.7 x1011 and 4 x1011 photons s-1 after 
attenuation, and the beam size at the sample position was 0.2mm (vertical) and 0.3mm 
(horizontal).  
The intensity of the myosin meridional first layer line (MM1) reflection was 
recorded to give an estimate of the order of the array of the myosin cross-bridges during 
contraction of skinned fibres from young compared to elderly cohorts. The diffraction 
patterns obtained were taken and analysed by Dr Hiroyuki Iwamoto using specialised 
software at the Spring-8 facility. The principle of the diffraction pattern analysis was to 
summate the reflection intensities of the recorded diffraction patterns, followed by 






The scewness and kurtosis values of the mean specific force data did not differ 
significantly from normality and the Shapiro-Wilk test of normality indicated that the null 
hypothesis that the data were normally distributed could be accepted. The mean specific 
force values obtained from skinned fibres from each group in both solution A and solution 
B were analysed using a one-way ANOVA. The ratios of mean specific force in solution 
B compared to solution A and the mean MHC I skinned fibre myosin content was also 
analysed using a one-way ANOVA. Data are presented as means ± SEM. Statistical 
analysis was not carried out on the x-ray diffraction data, since the MM1 reflection 







Figure 5.2. The different elements of the x-ray diffraction equipment at the BL45XU 
beamline, at the Spring-8 Synchrotron facility, Japan.  
A: A set containing approximately thirty skinned fibres. Individual skinned fibres were 
clamped between two halves of a 3mm wide gold mesh which was attached to a ceramic 
chip. Approximately thirty fibres were mounted to each set. 
 B: The specimen chamber. A set of fibres was placed into the specimen chamber, 
pictured, positioned parallel to the opening (indicated by the white arrow), through which 
a laser could be shone to measure sarcomere length. The sarcomere length was adjusted 
by altering the length of the specimen chamber. 
C: The position of the specimen chamber in the x-ray diffraction setup, indicated by the 
black arrow. 
D: A side view of the specimen chamber viewed using a video camera. The skinned fibres 
are in a vertical position and are indicated by the black arrow. The centre of the black 
cross in the image indicates where the x-ray beam will be focused through the skinned 
fibres.  
E: the column through which the scattered x-ray beam travels before the diffraction 









5.3.1 Fibre type distribution 
 
The number and proportion of fibres studied of each type in each experimental 
group is illustrated in Figure 5.3. A total of ninety-eight fibres were studied from the 
young group, and ninety-two and ninety-seven fibres were studied from the master 
cyclists and hip fracture patients respectively. There was a relatively even proportion of 
MHC I (42.8%) and MHC IIA (44.9%) fibres studied in the young group. In contrast, 
85.9% of fibres studied from master cyclists and 72.2% of fibres studied from hip fracture 
patients were MHC I fibres. Due to the small number of MHC IIA and hybrid fibres, but 
relatively large number and proportion of MHC I fibres in the master cyclist and hip 
fracture patient groups (Figure 5.3), statistical comparisons of skinned fibre specific force 
between groups have only been made using MHC I fibres. 
 
5.3.2 Variability of specific force measurements within individuals 
 
Considerable variability was observed in specific force measurements taken from 
MHC I fibres within the individual participants studied. The average range of skinned 
fibre specific force values was calculated by dividing the maximum specific force 
recorded for a given individual, by the minimum specific force, which yielded the range 
of specific force values as a fold-difference. In solution A, within individuals, specific 
force varied 5.9 ± 6.5-fold for the young group, 5.1 ± 2.2-fold for master cyclists and 6.5 
± 5.4-fold for hip fracture patients. In solution B the average fold differences were 4.6 ± 
4.3 in the young group, 6.3 ± 4 for master cyclists and 7.5 ± 5.9 for hip fracture patients. 
Therefore, the variability in specific force values was slightly lower when fibres 
contracted in solution B, compared to solution A in the young group, but slightly higher 
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in solution B compared to solution A in fibres from master cyclists and hip fracture 
patients. Nevertheless, considerable variability in skinned fibre specific force 
measurements was observed in skinned fibres from individuals of all experimental 
groups. 
 
5.3.3 The trends in mean specific force data between groups 
 
The mean MHC I skinned fibre specific force measured in solution B was 
significantly greater than that measured in solution A, for all groups studied. However, 
between groups, specific force measured in solution A was no different between young 
participants, master cyclists or hip fracture patients (Figure 5.5) (p > 0.05) and there was 
no discernible trend for specific force to be higher or lower in a given group. In contrast, 
there was a trend for specific force measured from the same MHC I fibres in solution B 
to be highest in young participants, followed by master cyclists, and lowest in hip fracture 
patients, although no statistically significant differences were observed (p > 0.05). 
Interestingly, the MHC I fibre specific force measured from the same fibres in 
solution A compared to solution B, exhibited a different degree of change in the different 
groups. Skinned fibre specific force from young individuals increased almost two-fold in 
solution B compared to solution A. The differences in specific force between solutions A 
and B were not as great in skinned fibres from the elderly cohorts, increasing 1.65-fold 
in master cyclists compared with just 1.38-fold in hip fracture patients (Figure 5.6). 
However, despite the trend observed, the differences in MHC I skinned fibre response 
between solutions A and B across the different experimental groups were not significantly 









 Young Master Cyclists Hip Fracture Patients 
Subject Gender Age Gender Age Gender Age History of major illness 
(other) 
1 Female 21 Female 79 Female 78 Breast cancer, lymphoma 
2 Female 32 Female 76 Female 59 None 
3 Male 22 Male 75 Female 77 COPD  
(multiple falls in the last 
year) 
4 Male 25 Male 73 Female 82 Hypertension, rheumatoid 
arthritis, type 2 diabetes 
5 Male 29 Male 71 Male 77 Rheumatoid arthritis 
Mean age  25.8  74.8  74.6  
 
Table 5.1. Gender and age of male and female participants studied, with the addition 









Figure 5.3. A: The number of fibres of a given MHC isoform within each 
experimental group.  
There was a relatively even distribution of MHC I (n = 42) and MHC IIA (n = 44) fibres 
in young participants. In both master cyclists and hip fracture patients there was a 
predominance of MHC I fibres, being 79 of 92 and 70 of 97 fibres in each group 
respectively. B: The relative proportion of the total number of each fibre type in each 
group. There was a relatively even proportion between MHC I (42.8%) and MHC IIA 
(44.9%) fibres from young participants, whereas master cyclists and hip fracture patients 





































































Figure 5.4. Specific force of MHC I fibres of individual participants from young 
(YO), master cyclist (MC) and hip fracture patient (HF) experimental groups in 
solution A and solution B.  
The variation in MHC I fibre specific force for each individual subject is displayed by the 
individual data points which correspond to specific force data from a single fibre. The 
average fold-difference in specific force for each group in solution A was, YO: 5.9 ± 6.5, 
MC: 5.1 ± 2.2, and HF: 6.5 ± 5.4 fold-differences. In solution B, the variation fold-
differences for each group was: YO: 4.6 ± 4.3, MC: 6.3 ± 4, and HF: 7.5 ± 5.9. Data are 


















































































































5.3.4 Skinned fibre myosin content 
 
That the BAP of MHC bands corresponding to a given skinned fibre sample tested using 
SDS PAGE, is proportional to the myosin content in the sample, was demonstrated in 
section 3.12. Whether the Laemmli Sample Buffer (LSB) had a homogeneous effect 
across the whole of a given skinned fibre sample and between different samples, with 
regard to myosin extraction, needed to be verified. Furthermore, the use of two batches 
of LSB meant that the effect of both batches on skinned fibre samples needed to be tested. 
Two different volumes of the same skinned fibre samples exhibited the same BAP 
per µl of sample loaded onto a gel, indicating that the effect of the first batch of LSB was 
homogeneous throughout a given skinned fibre sample (Figure 5.7). Comparing the two 
different batches of LSB, both batches demonstrated a consistent effect on the myosin 
standard sample, since the myosin standard curves obtained using each batch of LSB on 
the same gel were virtually identical (Figure 5.8A). Furthermore, myosin content per unit 
of fibre volume, quantified from two different halves of the same skinned fibre, both of 
which had been processed in either the new or old batch of LSB, were similar. This 
indicates that the effect of each batch of LSB was homogeneous across different samples 
of skinned fibres (Figure 5.8B).  
The absolute myosin content of the skinned fibres examined was normalised to 
fibre volume, to provide a measurement of myosin content per unit of fibre volume. 
Consistent with the previously mentioned specific force values, variability was also 
observed in MHC I skinned fibre myosin content within individuals from each 
experimental group. The mean range of variation in MHC I fibre myosin content was 3.25 
± 0.6-fold in young participants, 9.4 ± 4.8-fold in master cyclists and 5.8 ± 2.3-fold in hip 










Figure 5.5. Mean specific force of each experimental group, measured from the same 
fibres tested in both solution A and solution B.  
Young: n = 85; Master Cyclists: n = 85; Hip fracture patients: n = 99. Specific force was 
significantly higher in the same MHC I fibres studied in solution B compared to solution 
A in all groups, as indicated by the asterisk. A difference in trend was observed from the 
same fibres activated in each experimental solution. In solution A, specific force was 
similar between experimental groups, whereas in solution B, specific force was highest 
in young individuals and lowest in hip fracture patients. However, no statistically 
significant differences were observed in mean specific force between groups in either 










































Figure 5.6. The mean ratio of specific force in solution B:specific force in solution A, 
for each experimental group.  
Young: n = 85; Master Cyclists: n = 85; Hip fracture patients: n = 99. The value of the 
ratio indicates that in young individuals specific force was approximately double (1.97 
times greater) in solution B compared with the same fibres activated in solution A. The 
specific force increase from the fibres contracting in solution B, compared with the same 
fibres in solution A, was not as great in elderly individuals, being 1.65 and 1.38 times 





























were similar between all three experimental groups, with no statistically significant 
differences observed (Figure 5.10). 
The mean MHC I skinned fibre myosin content of each experimental group was 
plotted against the corresponding mean specific force measured from the same fibres, in 
order to assess the relationship between these two variables in each group. Due to the 
similar MHC I fibre myosin content and specific force across all groups studied, a 
clustering of mean data points was observed (Figure 5.11). The relation between myosin 
content and specific force from individual fibres is illustrated in section 8.3.  
Correlations were made between myosin content and specific force from the same 
skinned fibres. The mean correlations for each experimental group revealed that there was 
no relationship between myosin content and specific force measured in solution A (R2 = 
0.08) or solution B (R2 = 0.09) in fibres from master cyclists. The mean correlation 
between type I fibre specific force and myosin content demonstrated a weak relationship 
in both solution A (R2 = 0.16) and solution B (R2 = 0.18) in the hip fracture patient group. 
In contrast to the two elderly groups, the mean correlation between myosin content and 
MHC I fibre specific force was relatively high in the young group for specific force 












Figure 5.7. The BAP per µl of sample loaded onto an SDS PAGE gel, plotted for two 
different sample loads of the same skinned fibre.  
Two skinned fibres were used to assess this relationship. The BAP per µl of sample was 
in close agreement for both sample loads for each skinned fibre tested, within 6% for 






























Figure 5.8. Testing the effect of two different batches of Laemmli sample buffer 
(LSB) on the myosin standard sample (A), and two halves of the same skinned fibres 
(B). 
A: The myosin standard curve plotted when the myosin standard sample was processed 
in either the first (LSB-1) or second (LSB-2) batch of LSB. The two curves are almost 
identical and both exhibit a highly linear relationship between myosin content and the 
corresponding BAP within the range of 1µg-5µg of myosin. 
B: The myosin content in each half of the same skinned fibre, processed in either the first 
or second batch of LSB. There was high agreement in the myosin content values of two 
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Figure 5.9. Mean type I fibre myosin content of individual participants from each 
experimental group.  
Young: n = 24; Master cyclists: n = 68; Hip Fracture patients: n = 65. The variation in 
type I fibre myosin content for each individual subject is displayed by the individual data 
points which correspond to specific force data from a single fibre. The average variation 
(mean ± SEM) was 3.25 ± 0.6-fold for the young group, 9.4 ± 4.8 and 5.8 ± 2.3-fold for 







































































Figure 5.10. Mean skinned fibre myosin content of each experimental group.  
Young: n = 24; Master cyclists: n = 68; Hip Fracture patients: n = 65. No statistically 










































Figure 5.11. Mean MHC I fibre specific force vs mean MHC I fibre myosin content 
for each experimental group.  
The similar mean myosin and specific force values for each group cause the data points 
to be grouped together, indicating that the relationship between myosin and specific force 
was similar between young, master cyclist and hip fracture patient groups. The vertical 
error bars represent the SEM of specific force and the horizontal error bars represent the 
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Figure 5.12. The mean of the correlation between specific force and myosin content 
within individuals of a given experimental group.  
The relationship was strongest in the young group in both solution A (R2 = 0.50) and 
solution B (R2 = 0.46), whereas a weak relationship was observed in hip fracture patients 
in both solution A (R2 = 0.16) or solution B (R2 = 0.18) and no relationship was observed 
in master cyclists in either solution A (R2 = 0.08) or solution B (R2 = 0.09). Data are 
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5.3.5 X-ray diffraction: myosin meridional first order layer line 
 
Numerous sets of ~30 fibres were mounted for each experimental group. The X-
ray diffraction recordings from all sets used from each group were summed together. The 
mean value of the MM1 reflection intensity was quantified for each experimental group 
studied, yielding one value for all sets of fibres tested from each group in pre-activating 
solution compared to activating solution. The MM1 reflection intensities are expressed 
as the ratio of MM1 to the sixth actin layer line. Due to there being one value per group, 
statistical analysis was not conducted on the preliminary data obtained. The ratio of the 
reflection intensities for the young group in pre-activating and activating solution were 
0.0679 and 0.096 respectively. The ratio of the reflection intensities for the master cyclists 
in pre-activating and activating solution were 0.1076 and 0.1867 respectively. The 
reflection intensity ratios for the hip fracture patients in pre-activating and activating 
solution were 0.0726 and 0.1463 respectively. 
 The intensity profile of the MM1 reflection was increased during skinned fibre 
contraction compared to when the fibres were in a relaxed state in all groups studied. 
Based on the physical principles of X-ray diffraction, a higher reflection intensity is 
caused by a higher order of the molecules in a given sample. In the present study, the 
samples were sets of approximately thirty skinned muscle fibres from either young 
individuals, master cyclists or one hip fracture patient. Since the MM1 reflection 
corresponds to the 14.3nm axial repeat of the myosin filament head (Huxley and Brown, 
1967), an increased MM1 reflection suggests that a greater array of myosin heads are 
aligned in an ordered fashion during contraction, compared to a relaxed state. The MM1 
reflection intensity was similar between groups during contraction, indicating that the 







Figure 5.13. Low angle x-ray diffraction reflections from young participants (A & 
B), master cyclists (C & D), and one hip fracture patient (patient 1) (E & F).  
The age and gender of all participants are in  
Table 5.1. The sets of fibres in a relaxed state in pre-activating solution are in panels A, 
C and E. The diffraction patterns from the sets of fibres during isometric contractions in 
activating solution A are in panels B, D and F. The reflection intensity profile of the MM1 
reflection, pointed out by the black arrow in all panels, was increased during skinned fibre 
contraction in activating solution in all groups compared to when fibres were relaxed in 
pre-activating solution. The diffraction patterns from hip fracture patient skinned fibres 






































5.4 Discussion  
 
The main findings of the present study showed that neither age nor physical activity 
appear to affect skinned fibre specific force, but that specific force varied between 
individuals and was observably different between solutions. However, the skinned fibres 
tested exhibited markedly different trends between the cohorts studied, depending on the 
activating solutions used to study skinned fibres, despite statistically significant 
differences not being observed. This implies that the conclusion drawn from a given study 
regarding skinned fibre specific force could be dependent on the activating solution used. 
Furthermore, the present study’s findings support that skinned fibre specific force across 
different populations is modulated by myofibrillar protein content.  
The comparison of specific force and myosin content measurements between the 
three experimental groups studied in the present investigation was made using MHC I 
fibres, due to the low number of MHC IIA fibres in the elderly groups (Figure 5.3). 
Skinned fibre specific force from MHC I fibres was found to be variable within individual 
subjects in all groups studied (Figure 5.4). Despite the significant difference in specific 
force observed from the same fibres contracting in solution A compared to solution B, 
the variability in the specific force values did not differ substantially between the two 
solutions, as indicated by the range of values obtained. Specific force data were included 
based on the strict criteria of consistency of skinned fibre force production over five 
consecutive contractions, as opposed to a criteria which arbitrarily excluded force values. 
This may have increased the range of specific force values analysed, although three-fold 
variability in MHC I fibre specific force within the same study has also been observed 




5.4.1 The trends in mean specific force results measured in solutions A and B 
 
5.4.1.1 Solution A 
 
In the present study, mean MHC I skinned fibre specific force was similar between 
young, master cyclist and hip fracture patient groups, when fibres were tested in solution 
A. The observation that there was no significant difference between specific force from 
master cyclists and young individuals is consistent with previous findings that exercise 
maintains skinned fibre specific force in the elderly (D’Antona et al., 2007, Korhonen et 
al., 2006). However, specific force was not significantly lower in comparatively frail hip 
fracture patients compared to young participants. This finding contradicts the hypothesis 
that physical activity prevents skinned fibre specific force loss in the elderly and is 
consistent with previous work which reported that skinned fibre specific force was similar 
between mobility-limited (Reid et al., 2012) and wheelchair bound (Venturelli et al., 
2015) elderly cohorts.  
The physical activity profile of the hip fracture patients in the present study was not 
documented, but was assumed to be lower than the master cyclists’ physical activity 
profile, which had been carefully characterised as part of previous work (Pollock et al., 
2015). Therefore, if physical activity ameliorates specific force loss, the lack of a 
difference between master cyclists and hip fracture patients could potentially be due to 
the latter being a physically active cohort prior to requiring surgery, although this is 
unlikely given their history of major illness (Table 5.1). Overall, the lack of difference 
between the physically active and comparatively unhealthy elderly groups with the young 
cohort, suggests that neither ageing nor daily physical activity in the elderly affects 
specific force at the level of myofilament interaction, at least up to the age range studied. 
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An interesting point to consider is the amount of physical activity required to 
ameliorate the onset of specific force loss at the skinned fibre level. Several investigations 
have reported similar specific force values in physically inactive elderly compared to 
young cohorts, such as mobility-limited (Reid et al., 2012) or chronically wheel chair 
bound (Venturelli et al., 2015) individuals. In contrast, young and elderly individuals who 
have undergone an extreme duration of non-weight bearing have consistently exhibited 
specific force loss at the skinned fibre level (D'Antona et al., 2003, Trappe et al., 2004, 
Trappe et al., 2008, Larsson et al., 1996). This suggests that an extreme intervention such 
as the complete absence of weight bearing is required for a prolonged period of time to 
reduce the intrinsic force generating capacity of individual skeletal muscle fibres, as 
opposed to simply inducing functional changes associated with reductions in fibre CSA. 
Indeed, resistance training of long duration (Pansarasa et al., 2009, Parente et al., 2008), 
but not short duration (Trappe et al., 2000) has caused improvements in skinned fibre 
specific force, supporting that a sufficiently strong stimulus is required for long periods 
of time to induce changes to a muscle fibre’s intrinsic force generating potential. 
Therefore, perhaps even chronic inactivity in elderly individuals is not sufficient to mimic 
the effects of a complete absence of weight bearing, which is itself used to be a model of 
accelerated ageing. 
5.4.1.2 Solution B 
 
In contrast to the lack of a clear trend in specific force between groups in solution 
A, a trend was observed, albeit not statistically significant, for specific force to be highest 
in young individuals, followed by master cyclists, and lowest in the hip fracture patients 
when the same MHC I skinned fibres contracted in solution B. The trend suggests that 
specific force is relatively preserved in endurance trained compared to frail elderly 
individuals, supporting previous findings that physical activity modulates skinned fibre 
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specific force in the elderly (D'Antona et al., 2007). The lack of statistical significance is 
likely to be related to the variation in skinned fibre specific force observed within 
individuals. Another reason could be that the present study was underpowered. Indeed, 
almost double the number of MHC I fibres were tested in elderly compared to young 
individuals, due to the predominance of MHC I fibres in the elderly groups and relatively 
even proportion of MHC I and IIA fibres in the young group. Therefore, a higher number 
of MHC I fibres from young individuals may affect the statistical significance of the 
observed trend.   
Although not statistically significant, the clear difference in trend observed in 
specific force measured from the same fibres in solutions A and B suggests that different 
conclusions might be drawn from the same study depending on the activating solution 
used. This implies that different experimental solutions used in different studies are likely 
to have contributed to the equivocal results regarding the occurrence of specific force loss 
in sedentary elderly compared to young cohorts (Larsson et al., 1997, Yu et al., 2007, 
Ochala et al., 2007, Raue et al., 2009, Trappe et al., 2003, Hvid et al., 2011, Frontera et 
al., 2003, Frontera et al., 2000a) as well as the equivocal results regarding whether 
physical activity or inactivity in the elderly modulates specific force (D'Antona et al., 
2003, D'Antona et al., 2007, Power et al., 2016, Reid et al., 2012, Venturelli et al., 2015). 
Information detailing the chemical constituents of the activating solutions used by 
studies measuring specific force from human skinned fibres could be compiled from the 
studies included in the systematic review described in Chapter 2. 75% of data sets 
compiled in Chapter 2 used Imidazole as a pH buffer. In Chapter 4, Imidazole was shown 
to negatively affect skinned fibre specific force. The fact that the majority of the literature 
uses Imidazole suggests that this particular compound does not cause the equivocal results 
regarding the occurrence of age-related specific force loss. However, clearly the majority 
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of publications on human skinned fibres have studied fibres contracting sub-optimally, 
by using Imidazole as a pH buffer.  
The hypothesis that the experimental conditions during contractile measurements 
from skinned fibres can influence the conclusions drawn regarding specific force from a 
given data set, is demonstrated by the two different observations made in the same study 
by Callahan et al. (2014). MHC I and IIA Vastus Lateralis fibre specific force measured 
at 25°C was not significantly different between elderly osteoarthritic and healthy elderly 
controls. However, MHC IIA specific force was significantly lower in the osteoarthritic 
group when measured at 15°C, albeit from a separate set of fibres. Therefore, 
experimental conditions other than the activating solution used, such as temperature, 
might well affect the conclusions drawn from skinned fibre specific force measurements. 
In addition to experimental conditions affecting the conclusions drawn from a given 
study, it has been suggested that using CSA as a proxy to represent the sarcomeres in 
parallel in a single muscle fibre is inappropriate. Toth et al. (2012) observed no change 
in MHC I and IIA Vastus Lateralis specific force measured at 15°C and 25°C, following 
eighteen weeks of resistance training in elderly men and women, when skinned fibre P0 
was normalised to CSA. In contrast, normalising P0 to the myofibrillar fraction, calculated 
from EM images, revealed that specific force measured at 25°C was significantly 
increased in MHC I and IIA fibres following resistance training. However, the 
myofibrillar fraction was extrapolated using the EM data from a sub-set of the participants 
studied, so must be interpreted with caution. Even so, skinned fibre CSA measurements 
are also confounded by the variable effects of swelling which occurs due to chemical 
skinning (discussed in section 2.1.6), indicating that CSA measurements and 
subsequently, representations of sarcomeres in parallel, may be inaccurate. 
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5.4.2 The implications of the differences in force measured between solutions A and 
B 
 
The difference in force between solutions A and B measured in the same skinned 
fibres indicates that despite reaching a plateau in force production during an isometric 
contraction, specific force measured in solution A is clearly not maximal. This could have 
implications for other measurements taken relating to cross-bridge behaviour, such as 
stiffness measurements. However, force may still be proportional to stiffness in solution 
A, even if neither force nor stiffness measurements are maximal. An investigation into 
the relationship between skinned fibre stiffness and force in solutions A and B, given the 
relationship between the two variables in human skinned fibres (Ochala and Larsson, 
2008) could provide critical information for understanding the cause of the increase in 
specific force observed in solution B. 
A novel finding of the present study is that the trend in specific force from the same 
skinned fibres between young and elderly cohorts differs depending on the activating 
solution used. However, this trend was not statistically significant, which may be due to 
the variability in specific force measurements from each individual. Interestingly, the 
difference in skinned fibre specific force between solutions A and B had a tendency to be 
greater in young compared to elderly individuals. The fact that the specific force from the 
same fibres tends to increase more in fibres from young individuals contracting in solution 
B, compared to the hip fracture patients in particular, could suggest that skeletal muscle 
fibres from different cohorts exhibit differences in cross-bridge behaviour across the two 
activating solutions used (Figure 5.6). Indeed, specific force was approximately double 
(1.97 times) in solution B compared to in solution A in skinned fibres from young 
participants. In contrast, the increase in specific force from solution A to B was lower in 
master cyclists (1.65 times) and even lower in hip fracture patients (1.38 times), although 
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this trend was not statistically significant. The lack of statistical significance may be 
related to statistical power. Indeed, when either the individual data points from each group 
were compared using a one-way ANOVA, or an independent t-test was used to compare 
young individuals and hip fracture patients only, statistical significance was observed. 
Therefore, perhaps having five individuals per group, and subsequently five mean values 
to compare in a one-way ANOVA, means that the analysis is not sufficiently powered, 
causing the lack of significance. The potential mechanism underpinning the observed 
trends between specific force measured in solutions A and B is discussed below, in light 
of the MHC I skinned fibre myosin content and MM1 reflections obtained from low angle 
x-ray diffraction. 
 
5.4.3 Skinned fibre myosin content 
 
The linearity of the myosin standard curve (Figure 3.4), and the homogeneous 
effect of both batches of LSB within samples (Figure 5.7) and across different samples 
(Figure 5.8) indicates that any relative differences in myosin content between groups 
could be reliably detected. The mean MHC I skinned fibre myosin content was similar 
between young participants, master cyclists and hip fracture patients (Figure 5.10), which 
is consistent with the similar MHC I fibre specific force between the groups in solutions 
A and B (Figure 5.5). Therefore, the findings from the present study support previously 
published observations from skinned fibres (D'Antona et al., 2003) and homogenate 
muscle samples (Trappe et al., 2003) that differences in skinned fibre specific force 
between groups are dependent on differences in myofibrillar protein content. This is 
illustrated in Figure 5.11, where a clustering of data points is observed due to the 
similarities between specific force and myosin content between young and elderly 
cohorts. If specific force loss had been observed in the present study, an associated 
213 
 
reduction in skinned fibre myosin content, similar to that published by D'Antona et al. 
(2003) (see Figure 1.8) , would be expected. 
Interestingly, within individual subjects from a given experimental group the 
mean correlation between specific force and myosin content was considerably stronger in 
young participants, compared to master cyclists or hip fracture patients (Figure 5.12). 
However, the myosin content quantified for a given individual fibre does not differentiate 
between different parts of the myosin molecule, so this correlation is not necessarily 
indicative of the relationship between the behaviour of the available myosin heads 
forming cross-bridges, and specific force. Furthermore, measurements reflecting skinned 
fibre cross-bridge stiffness and behaviour were beyond the scope of the present study, 
meaning that direct assessments of how myosin may be behaving differently in young 
compared to elderly participants cannot be made. Therefore, the significance of the higher 
correlation between specific force and myosin content in skinned fibres is difficult to 
ascertain without further experiments. 
A technical point to make about the myosin content data, is that the accuracy of 
the myosin content normalised to skinned fibre volume could be improved by more 
accurate volume measurements. As described in section 3.8, skinned fibre volume was 
calculated from fibre length measured at x10 magnification using an eyepiece graticule, 
and depth and diameter measurements measured at x40 magnification. Geiger et al. 
(2000) also used light microscopy to measure skinned fibre volume, but corrected their 
measurements using a correction factor, calculated from the degree of error between their 
light microscope depth measurements compared to a confocal microscope. A separate 
experiment would need to be conducted to obtain the appropriate correction factor, but 
would be useful in confirming the accuracy of the trends in skinned fibre myosin content 
observed between groups in the present study.  
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5.4.3.1 The potential contribution of a reduced number of cross-bridges, or a 
difference in cross-bridge behaviour, to the observed trends. 
 
Specific force has been shown to be proportional to myofibrillar protein content 
as well as skinned fibre stiffness (D'Antona et al., 2003, Ochala and Larsson, 2008), 
implying that the number of available acto-myosin cross-bridges is dependent on 
myofibrillar protein content. Therefore, the fact that MHC I skinned fibre mean myosin 
content was similar between the experimental groups in the present study suggests that 
the number of available acto-myosin cross-bridges would have also been similar between 
groups. The non-significant increase in specific force from solution A to solution B which 
was greater in young participants compared to both elderly groups (Figure 5.6), is 
therefore unlikely to be due to a higher total number of available cross-bridges in skinned 
fibres from young people. 
Assuming that the total number of available cross-bridges is similar across the 
three groups tested in the present study, the trends in the relative force between solutions 
A and B in each experimental group are likely due to differences in cross-bridge 
behaviour. Indeed, the hypothesis that cross-bridge behaviour, as opposed to the number 
of cross-bridges, can modulate skinned fibre specific force has been supported by 
observations in humans. In spite of reduced myofibrillar protein content, an increased 
proportion of the available cross-bridges in a bound state during an isometric contraction, 
maintained MHC IIA Vastus Lateralis specific force in heart failure patients relative to 
age-matched controls (Miller et al., 2009). Therefore, the greater increase in specific force 
from solution A to B in young individuals compared to elderly groups may be due to a 
higher proportion of the available cross-bridges bound during an isometric contraction. 
Alternatively, previous studies have attributed specific force loss in elderly men (Ochala 
et al., 2007) and rats (Lowe et al., 2001) to a higher number of acto-myosin cross-bridges 
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in a low-force producing state. Therefore, the lower increase in specific force in solution 
B compared to solution A produced by the skinned fibres from elderly cohorts in the 
present study could be due to a higher number of cross-bridges in a low-force state. 
However, the lack of statistical significance in the ratio of specific force in solution B to 
solution A (Figure 5.6) between the different cohorts in the present study suggests that 
perhaps the differences in skinned fibre responses between groups were not 
physiologically significant. 
 
5.4.3.2 The potential implications of the X-ray diffraction results 
 
The MM1 X-ray diffraction intensity recordings presented in this study were 
obtained from sets of approximately thirty skinned fibres undergoing maximal activating 
contractions in solution A. X-ray diffraction experiments in humans are sparse (Li et al., 
2015, Ochala et al., 2011), making this a novel aspect of the present study. The increased 
intensity of the skinned fibre MM1 reflection, which represents the array of myosin 
filament heads spaced 14.3nm apart, during contraction in solution A compared to 
relaxation has been previously observed in human (Li et al., 2015) and mammalian 
skeletal muscle (Haselgrove, 1975, Huxley et al., 1982, Kraft et al., 2002). The increased 
MM1 reflection intensity during contraction therefore suggests that a higher number of 
myosin filament heads are in a bound state during contraction compared to relaxation, 
which is a logical assumption.  
A previous investigation which recorded the MM1 reflection intensity observed a 
higher degree of disorder in skinned fibres from elderly compared to young individuals 
(Li et al., 2015). In contrast, in the present study the MM1 reflection intensity during 
contraction did not differ between the cohorts studied, implying that the number of bound 
cross-bridges was not different between skinned fibres from all groups contracting in 
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solution A. However, MM1 reflection intensities from the present study are consistent 
with the specific force results obtained using skinned fibres from the same participants in 
solution A. This therefore supports previous observations that human skinned fibre 
specific force is dependent on the fibre stiffness (Ochala and Larsson, 2008).  
Due to the limited amount of human tissue and high number of samples required 
for X-ray diffraction, the MM1 reflection intensities could not be measured using fibres 
contracting in solution B. However, the difference in the degree of mean specific force 
increase in fibres contracting in solution A compared to solution B between the 
experimental groups studied (Figure 5.6), suggests that the MM1 reflection intensity from 
fibres contracting in solution B could be increased in young individuals compared to both 
elderly cohorts. This would imply a difference in the order of the array of myosin filament 
heads in skinned fibres from young compared to elderly groups and is an experiment for 
future work. 
 
5.4.4 Inclusion criteria for skinned fibre data 
 
An important point to consider with regard to the data presented in this study is 
the inclusion criteria utilised. Data were included if the coefficient of variation between 
a pair of contractions was 28% or less. 28% was selected because it was the value which 
allowed the inclusion of as many data points as possible without affecting the correlation 
(R2) between the mean specific force of a pair of contractions from a skinned fibre in 
solution A vs solution B. However, perhaps a more appropriate inclusion criteria would 
be to calculate a threshold for each individual participant included in the present study, 
as opposed to applying the same threshold across different individuals. This could 
potentially improve the accuracy with which skinned fibre specific force values are 
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reflective of a given individual, and could therefore potentially aid in revealing any 
significant trends, such as that observed in solution B (Figure 5.5). 
 
5.4.5 Summary and conclusions 
 
The present study’s findings support that skinned fibre specific force is modulated 
by myosin content. The difference in the relative increase in specific force in solution B 
compared to solution A between groups was not statistically significant, although this 
may be due to a lack of statistical power. Methodological factors such as the activating 
solutions used to elicit maximal isometric contractions from skinned fibres are likely to 
contribute to the equivocal results previously reported as to the occurrence of age-related 
specific force loss at the myofilament level. Furthermore, the observation that myosin 
loss seems to occur in some (D'Antona et al., 2003) but not all elderly cohorts (Trappe et 
al., 2003), irrespective of their daily level of physical activity, suggests that identifying 
individuals susceptible to degradation of myofibrillar protein could be an important 





6 General Discussion 
 
6.1 General Overview 
  
The initial aim of the present thesis was to assess the impact of physical activity on 
age-related specific force loss in human skinned muscle fibres, in relation to myosin 
protein content, cross-bridge behaviour, and positioning of the myosin head during 
contraction. However, prior to addressing this question, it became clear that there 
remained unanswered questions regarding the skinned fibre technique. Therefore, before 
work on human ageing was undertaken, investigations were carried out in order to 
identify methodological factors which could explain the high degree of variability in 
published specific force values. 
 
6.2 Systematic review: addressing the variance in published 
specific force values 
 
The measurement of specific force in vivo is complicated by a number of factors which 
must be accounted for with regard to measuring both P0 and PCSA. These are offset by 
using the chemically skinned fibre technique, which enables the study of a single skeletal 
muscle fibres in vitro. However, published skinned fibre specific force values vary greatly 
between studies, which contradicts the concept that a reliable experimental technique will 
yield consistent results across different laboratories, even allowing for the lower 
temperature at which skinned fibre experiments are conducted. Therefore, a systematic 
review of the skinned fibre literature was undertaken in order to assess the variability in 
published specific force results, and where possible, to identify factors causing the 
variability and quantify their effect. The main findings were that: 
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1. A high degree of greater than 8-fold variability was observed in specific force 
measured from fibres from the same population (i.e. young, healthy individuals), 
of the same MHC isoform expression, studied at the same temperature. 
2. The ratio of MHC IIA:MHC I fibre specific force was found to be consistent across 
62 studies which provided data for both fibre types. 
3. When 73 publications were grouped based on shared authorship, 4 main 
publication groups were observed. 
4. The published specific force data was relatively consistent within publication 
groups, compared to between groups. 
5. The specific force data as published were adjusted for three methodological factors 
(skinned fibre swelling, CSA measurement technique and sarcomere length) which 
accounted for 30% of the observed variability in published specific force values. 
 
6.3 The impact of two commonly used activating solutions on the 
skinned fibre contractile response 
 
The ability to control the experimental solutions surrounding a skinned fibre is an 
advantage of the technique. However, the activating solutions used to elicit force from 
skinned skeletal muscle fibres differ between groups of researchers, indicating that this 
could be a potential source of the variation in skinned fibre specific force values. This 
methodological difference could not be assessed using systematic review methodology. 
Therefore, experiments were carried out in order to quantify the effect of different 
activating solutions, one used by research groups which study human skinned fibres 
(Solution A) (Larsson and Moss, 1993, Trappe et al., 2003) and one used by local 
collaborators (solution B) (West et al., 2013), on skinned fibre force, and identify the 
cause of any observed differences. The main findings were that: 
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1. The contractile response of the same skinned fibres differed considerably 
depending on the activating solutions used. Specific force was significantly higher 
and time to half peak tension (t50) was significantly faster when fibres contracted 
in solution B. 
2. Specific force was significantly lower in an activating solution containing 
Imidazole, a pH buffer. 
3. A lower concentration of Cl- and the inclusion of glutathione were both 
individually found to be associated with a faster t50. 
 
6.4 The impact of physical activity on the development of age-
related specific force loss in human skinned fibres 
 
Having identified and probed differences between activating solutions, a different 
approach was taken towards investigating age-related specific force loss using skinned 
fibres. A three pronged approach was taken which: 1) Assessed specific force in two 
different activating solutions to identify differential responses to the two solutions. 2) 
Assessed the relationship between specific force and myosin content from the same 
skinned fibres. 3) Determine whether differences in the position of the myosin heads 
during contraction could account for any observed trends in specific force, using low-
angle X-ray diffraction experiments. These parameters were measured in skinned fibres 
from mixed sex cohorts of young, healthy individuals compared to comparatively frail 
hip fracture patients and physically active master cyclists who had been carefully 
characterised as part of previous work (Pollock et al., 2015). The hypothesis was that 
specific force loss would occur in the more frail hip fracture patients and not in the highly 
active cyclists. The main findings were that: 
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1. Physical activity did not affect the onset of specific-force loss at the myofilament 
level in elderly compared to young individuals. 
2. Skinned fibre specific force was proportionate to myosin content. 
3. The order of the array of myosin heads during contraction was maintained in 
skinned fibres from elderly individuals, when made to contract in solution A. 
4. Cross-bridge behaviour, as defined by the difference in specific force from the 
same fibres which contracted in solutions A and B, was not significantly different 
between young and elderly cohorts, although this may be due to a low statistical 
power. 
The relevance of the findings from the aforementioned studies, both with regard to 
methodological factors associated with the chemically skinned fibre technique and to the 
physiology of age-related specific force loss, will now be broadly discussed.  
The division of the majority of the published, human skinned fibre research into four 
publication groups is a novel observation. More importantly, the relative consistency of 
the data within each publication group, compared to across all four groups, supports that 
methodological differences are partially responsible for the dispersion of the data. That 
30% of the variability is caused by methodological factors supports this, but also 
highlights that the effect of other factors, both methodological and physiological, on the 
dispersion of the data have not been uncovered. The findings of the systematic review 
presented in Chapter 2 could benefit the skinned fibre field in the long-term by 
encouraging efforts to better understand which factors influence skinned fibre contraction 
which are not physiological, but methodological.  
That the skinned fibre contractile response is sensitive to the activating solutions used 
to elicit a contraction is clearly demonstrated in Chapter 4. Therefore, chemical 
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differences in activating solutions between publication groups are a likely source of the 
variance in published specific force values. One way of comprehensively determining the 
effect of the experimental solutions used by the different research groups on skinned fibre 
specific force and other contractile measurements would be via a multi-group 
collaborative study. Each publication group could send frozen aliquots of their solutions 
to one lab where their effects on the contractile response of skinned fibres could be 
compared using skinned fibres from the same biopsy sample. This would ensure that a 
consistent method is used, thereby isolating the effects of the different activating solutions 
on skinned fibre contraction. Furthermore, the differences in contractile response 
observed in the different activating solutions used in Chapter 4 suggest that other 
measurements of cross-bridge kinetics or stiffness are affected by the chemical 
composition of the solutions used.  
The findings presented in Chapter 4 also indicate that the optimal chemical 
compositions of the activating solutions used to study skinned fibres has not been 
determined. Initially, testing different pH buffers would be an obvious candidate to assess 
factors affecting force, since different pH buffers were found to have an effect on force 
in the present thesis. Logically, optimising the activating solutions used to study skinned 
skeletal muscle fibres would increase the probability that any observed differences in 
specific force at the myofilament level would be due to physiological differences between 
young or elderly cohorts, as opposed to methodological factors. 
The findings from Chapter 5 indicate that neither physical activity, nor age, affect 
specific force at the myofilament level. This observation was supported by measurements 
of skinned fibre myosin content and findings from preliminary X-ray diffraction 
experiments, that the order of the myosin heads during contraction was similar between 
all three groups. The association between specific force and myofibrillar protein content 
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was consistent with observations from previous studies (D'Antona et al., 2003, Trappe et 
al., 2003). The relatively consistent relationship observed between myofibrillar protein 
content and specific force contrasts with the equivocal observations regarding whether 
specific force loss occurs with advancing age. This suggests that supporting specific force 
results with data regarding skinned fibre myofibrillar protein content is critical for 
demonstrating a physiological basis for a given observed difference, or lack of difference, 
in specific force between different young and elderly cohorts. 
The significantly greater specific force in solution B compared to solution A in all 
groups, directly demonstrated a difference in cross-bridge behaviour between the two 
solutions, within groups. A non-significant trend was observed for the difference in 
specific force elicited by solution B compared to solution A to be greater in young than 
elderly groups. The lack of statistical significance may be due to a lack of statistical 
power, which if increased, may directly reveal a difference in cross-bridge behaviour 
between skinned fibres from young and elderly individuals. 
6.5 Summary and conclusions 
 
To conclude, the work in the present thesis has demonstrated that differences in 
published specific force values stem largely from the methodological practices of 
different publication groups. This variability is also likely to be contributed to by the 
experimental solutions used to elicit force from skinned skeletal muscle fibres. The work 
investigating the methodological factors affecting published skinned fibre specific force 
results is relevant to scientists using the skinned fibre technique in numerous contexts.  
The fact that physical activity was found to have no effect on specific force at the level 
of the myofilaments what somewhat surprising. That specific force was related to myosin 
content, suggests that myosin content can be maintained in skinned fibres of elderly 
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individuals. Taken altogether, the data are in general agreement with work from Trappe 
et al. (2003) and consistent with the mechanism proposed by  D'Antona et al. (2003) 
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Name:        
Address: 
Date of birth: 
Telephone no: 
If the answer is YES to any questions please give some details including 
dates where possible. 
1. Have you any history of heart trouble? 






2. Have you any history of problems with blood vessels? 






3. Have you any history of chest problems? 







4. Have you ever smoked? 





5. Do you suffer from diabetes? 





6. Have you any history of major illness now or in the last 20 yrs? 










8. Do you suffer from osteoarthritis or rheumatoid arthritis? 
(If YES please state joints affected and indicate mild, moderate or severe and 












10. Do you have any problems with your bones 




















14. Have you had any acute illness in the last six months? 

















17. Do you have any physical disabilities? 










19. Is there any other illness or condition that affects your general health or 






















Print name: __________________________  







8.2 Fibre typing cheetah muscle fibres 
 
The protocol used to differentiate between skinned fibres containing MHC I and 
MHC II myosin heavy chain isoforms, as seen in Figure 3.3, is outlined here. Fibre 
segments 1-3mm in length from gluteus, semitendinosus and longissimus muscle of the 
African cheetah were dissolved in 20µl of sample buffer (Laemmli, 1970) and heated at 
100⁰C for 3 minutes. Four microlitre samples were loaded into 0.75mm thick gels in a 
Hoefer ‘mighty small’ apparatus. A 4.5% stacking gel with a 7.5% separating gel 
containing 30% glycerol was used (Picquet, 2003). The gels were run using the method 
of Picquet (2003) with minor modifications. Over a 12 hour period a constant voltage of 
100V was set until the bromophenyl blue marker had migrated significantly (~2cm) into 
the separating gel, at which point the voltage was increased to 180V for the remainder of 
the run. Gels were subsequently silver stained (Morrissey, 1981) to reveal the myosin 
heavy chain bands. A sample of gluteus muscle, which contains both MHC I and MHC 
II fibres, underwent the same treatment as the single fibre segments and was used as a 
standard. Two clearly separated bands were seen in this standard which were assumed to 







8.1 Constituents of SDS PAGE gels used to fibre type skinned 




Stock solution Separating Gel (ml) 
100% Glycerol 3 
30% Acrylamide-bis (50:1) 2.667 
Tris 1.5M (pH 8.8) 1.333 
1M Glycine 1 
10% SDS 0.4 
Distilled water 1.495 
TEMED 0.005 
10% Ammonium persulfate. 0.1 
Total volume 10ml 
Table 8.1. The constituents and subsequent quantities required to make up the 8% 
separating gel used to fibre type skinned single skeletal muscle fibres in the present thesis 




Stock solution Stacking Gel (ml) 
100% Glycerol 3 
30% Acrylamide-bis (50:1) 1.333 
Tris 0.5M (pH 6.7) 1.4 
100mM EDTA (pH 7.0) 0.4 
10% SDS 0.4 
Distilled water 3.362 
TEMED 0.005 
10% Ammonium persulfate 0.100 
Total volume 10ml 
Table 8.2. The constituents and subsequent quantities required to make up the 4% 
separating gel used to fibre type skinned single skeletal muscle fibres in the present thesis 









Chemical Upper running buffer Lower running buffer 
Tris 3g 3g 
Glycine 14.4g 14.4g 
SDS 1g 1g 
Β-mercaptoethanol None 1% 
Table 8.3. Chemical constituents of upper and lower running buffer used to fibre type 





Laemmli sample buffer 
Chemical Quantity 
Tris-HCL pH 6.8 0.91g 
4% SDS 2g 
20% Glycerol 10ml 
10% β-mercaptoethanol 5ml 
0.002% bromophenol blue 1mg 
Distilled water 82ml 
Total volume 100ml 
Table 8.4. Ingredients and quantities to make up 100ml of Laemmli sample buffer 






8.2 Forest plots of the variance in published skinned fibre specific force 
 
 
Figure 8.1. A Forest Plot of mean published MHC I fibre specific force results measured at 12°C. 
The mean specific force was 120 kPa, and up to 8-fold variability was observed, the largest range of all the data sets outlined in Chapter 2. The χ2 was 




Figure 8.2. A Forest Plot of mean published MHC IIA fibre specific force results measured at 12°C. 







Figure 8.3. A Forest Plot of mean published MHC I fibre specific force results 
measured at 15°C. 
The mean specific force was 142 kPa. The χ2 was significant (p < 0.05) and the I2 of 99% 









Figure 8.4. A Forest Plot of mean published MHC I fibre specific force results measured at >18°C. 






Figure 8.5. A Forest Plot of mean published MHC IIA fibre specific force results measured at >18°C. 





8.3 Correlation between myosin content and skinned fibres from young and 
elderly experimental groups. 
 
The relationship between the myosin content and specific force measured in both 
solutions A and B from individual skinned fibres, for participants in each experimental 
group (Young controls; Master Cyclists; Hip fracture patients), is illustrated in Figure 8.6. 
Specific force was calculated assuming both a cylindrical and an elliptical skinned fibre 
CSA for the same skinned fibres, to determine whether the CSA shape assumed affects 
the correlation between skinned fibre specific force and myosin content.  
As can be seen in Figure 1 A and B, the correlation between specific force 
measured in solution A and myosin content from individual fibres is weak in all groups, 
when either a cylindrical or elliptical fibre shape is assumed to calculate specific force. 
In both Figures 1 A and B the correlation is strongest in young individuals compared to 
both elderly groups. In Figure 1 C and D the correlations between specific force measured 
in solution B and myosin content were weak in all experimental groups, but strongest in 
the young group, while no correlation at all was observed in skinned fibres from master 
cyclists. 
The correlations between myosin content and skinned fibre specific force from 
individual fibres were weak (Figure 8.6), which suggests that little mechanistic 
information can be gained from this comparison at the skinned fibre level. However, 
previous studies have demonstrated that myofibrillar protein content (Trappe et al., 2003) 
and thick filament density (Widrick et al., 1997) differences (or lack thereof) between 
experimental groups mirror the trends in specific force between the same groups. Specific 
force was also shown to be proportional to the ratio of myosin:actin in skinned fibres from 
healthy controls and AQM patients (Ochala and Larsson, 2008). These findings suggest 
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that more detailed information regarding myofibrillar protein content (i.e. actin as well as 
myosin) may be required in order to observe stronger correlations between protein content 
and specific force from individual skinned fibres. The relationship between mean myosin 
content and specific force of a given experimental group from the present study (Chapter 
5) was consistent with that observed by D’Antona et al. (2003). However, a comparison 
of the correlation between individual skinned fibre specific force and myosin content 




































A. MHC I SF (cylindrical CSA) vs Myosin Content
YO MHC I SF vs
Myosin sol A
MC MHC I SF vs
Myosin Sol A

























B. MHC I SF (ellipticalCSA) vs Myosin Content
YO MHC I SF vs
Myosin sol A
MC MHC I SF vs
Myosin Sol A






Figure 8.6. Mean specific force from individual MHC I skinned fibres, plotted against the myosin 
content of the same fibre. Experimental groups are denoted as blue dots (Healthy, young group), 
orange dots (Elderly master cyclists) and grey dots (hip fracture patients). Specific force values 
measured in solutions A (A and B) and B (C and D) were calculated assuming both cylindrical 
(A and C) and elliptical (B and D) cross-sectional shapes for the same skinned fibres. The 
correlation (R2) was weak in all cases, but was higher in young compared to elderly groups. When 
an elliptical cross-sectional shape was assumed (B) the correlation between specific force 
measured in solution A and myosin content was noticeably higher in master cyclists compared to 
hip fracture patients, which was not the case when a cylindrical cross-sectional shape was 
assumed. In solution B, there was no correlation between skinned fibre specific force and myosin 
























C. MHC I SF (cylindrical CSA) vs Myosin Content
YO MHC I SF vs
Myosin sol B
MC MHC I SF vs
Myosin Sol B



























D. MHC I SF (ellpitical CSA) vs Myosin Content
YO MHC I SF vs
Myosin sol B
MC MHC I SF vs
Myosin Sol B




8.4 Matlab code used in the present thesis 
 
8.4.1 Script file used to calculate the baseline, P0 and t50 of a given skinned fibre 




close all hidden 
  
Dir='enter file name here\';  
excelfile=[Dir 'Matlab output.xlsx']; 
DirStructure=dir(Dir); 
Title={DirStructure.name}; 
% Go through the files one at a time by using a for loop. 
for i= 3:length(Title); 
    figure; set(gcf, 'windowstyle', 'docked', 'color', 'w') 
    File=Title{i}; 
    Data=dlmread([Dir File]); 
    Time=Data(:,1); 
    Force=Data(:,2); 
     
    % smooth the raw data before plotting 
    Smooth=smooth(medfilt1(Force, 7),50); 
    %plot(Time,Force,'c', Time, Smooth, 'b'); 
    plot(Time, Smooth, 'b'); 
    ylim([min(Smooth(10000:end)) max(Smooth(10000:end))]) 
     
    %Select start/end of candidate signal 
    [T1, Thresh]=ginput(2);    
     
    %Select the minima of the signal as a starting point 
    SelectedTimeIdx = find(Time>T1(1),1,'first'); 
    ROI = Smooth(SelectedTimeIdx:SelectedTimeIdx+1000); 
    [~,LocalMinimaIdx] = min(ROI); %Find minima of valley (starting 
point) 
    Start_Pt = (SelectedTimeIdx + LocalMinimaIdx); 
    End_Pt=round(T1(2)*1000); 
    hold on 
    plot(Time(Start_Pt), Smooth(Start_Pt),'dr') 
     
    Force_trace=Smooth(Start_Pt:End_Pt); 
    Time_scale=Time(Start_Pt:End_Pt); 
    Time_scale=Time_scale-Time_scale(1); 
     
    % reject the 1st few data points 
    min_point = 300; %Remove signal artifact (right after starting 
point) 
    BL1=min(Force_trace(min_point:end)); 
    col='rcgy' 
    figure; set(gcf, 'windowstyle', 'docked', 'color', 'w') 
    % find the point where the slope has a zero y-intercept 
    for j=1:100 
        
        if (BL1<0) 
            min_point = ceil(min_point*1.005);             
            BL1=min(Force_trace(min_point:end)); 
        end 
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        cla 
        Force_trace=Force_trace-BL1; 
        Peak1=max(Force_trace(min_point:end-30)); 
        Extrapolation_point=Peak1*0.10; 
        D=Force_trace<Extrapolation_point; 
        T2=find(D,1,'last'); 
        [SlpBL2]=polyfit(Time_scale(min_point:T2), 
Force_trace(min_point:T2),1); 
        Slope=SlpBL2(1); 
        BL2=SlpBL2(2); 
        
        plot(Time_scale, Force_trace) 
        hold on 
        plot([0, Time_scale(T2)], [BL2, 
Time_scale(T2)*Slope+BL2],col(1)) 
     
              
        disp(['round number ' int2str(j) ' baseline is ' 
num2str(BL2)]) 
        disp(['Min point: ' num2str(min_point)]) 
       if abs(BL2)<1e-10 
          break 
       end 
       BL1=BL2; 
       drawnow 
    end 
% Plot original signal Overlayed with Starting Point (green) and 
baseline (red)     
% h_signalOverlay = figure; 
% plot(Smooth); 







% hold off; 
  
% Calculate final signals 
figure;set(gcf, 'windowstyle', 'docked', 'color', 'w') 
SMT=smooth(Force_trace, 2000); 
TimeScaleFinal = Time_scale(min_point:end); 
SignalFinal = SMT(min_point:end); 
  
  
%Calculate zero point by extrapolating the line from 10% of peak point 
P0=max(SMT(300:end-30)); 
pc10Max = P0 * 0.10; 









% Adjust signals to zero intercept 
SMT = SMT - yIntercept; 
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SignalFinal = SignalFinal - yIntercept; 
  
%Plot new signals 
x=[-100 100]; plot(x,(Slope.*x),'r--') 




%Find half width maxima 
P0=max(SignalFinal(300:end-30)); 
halfMax = P0/2; 




% Maxima of signal 





Time_half_P0 = TimeScaleFinal(halfMaxIdx); 
title([Dir File], 'interpreter', 'none') 
xlabel([' P0 : ' num2str(P0,4), ' Time to half P0 : ' 
num2str(Time_half_P0,4)]) 
  
%Axis resizing to view full signal 
expandAxes = 1.20; 
axis(expandAxes .* [min(Time_scale) max(Time_scale) min(SMT) 
max(SMT)]) 
  
xlswrite(excelfile, [P0, Time_half_P0],'sheet1', ['E' int2str(i+10)]) 
xlswrite(excelfile, {[Dir File]},'sheet1', ['C' int2str(i+10)]) 
end 
 




close all hidden 
  
Dir='C:\Users\test\Desktop\Thesis\Ageing study\Investigation into 
ageing - skinned fibre force\Young, healthy participants\ASYC-6\ASYC-6 
Fibre 15\'; 
excelfile=[Dir 'Matlab output.xlsx']; 
DirStructure=dir(Dir); 
Title={DirStructure.name}; 
% Go through the files one at a time by using a for loop. 
for i= 3:length(Title); 
    h_fig = figure; set(gcf, 'windowstyle', 'docked', 'color', 'w') 
    File=Title{i}; 
    Data=dlmread([Dir File]); 
    Time=Data(:,1); 
    Force=Data(:,2); 
     
    % smooth the raw data before plotting 
    Smooth=smooth(medfilt1(Force, 7),30); 
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    %plot(Time,Force,'c', Time, Smooth, 'b'); 
    plot(Time, Smooth, 'b'); 
    ylim([min(Smooth(10000:end)) max(Smooth(10000:end))]) 
     
    %Select start/end of candidate signal 
    zoom reset; %set default zoom level 
    zoom on; 
    figure(h_fig); %bring figure in focus 
    pause(); % you can zoom with your mouse and when your image is 
okay, you press any key 
    zoom off; % to escape the zoom mode 
    [Tstart]=ginput(2); %select starting region 
    zoom out; 
    zoom on; 
    pause(); 
    zoom off; 
    [Tend] =ginput(2); %select end region 
    zoom out; 
     
    %Find the mean of the selected start region 
    SelectedTimeStart1Idx = find(Time>Tstart(1),1,'first'); 
    SelectedTimeStart2Idx = find(Time>Tstart(2),1,'first'); 
    startSignal = Smooth(SelectedTimeStart1Idx:SelectedTimeStart2Idx); 
    meanStart = mean(startSignal); 
    %Select the closet point to that mean 
    [~,meanStartIdx] = min(abs(startSignal-meanStart));  
    %normalises the values around 'zero mean' and get the absolute 
values of those (so it doesn't matter if they're positive or negative) 
and then find the lowest point, so you get teh closest point around 
the mean. 
    %meanstartIdx specifies the location of your signal (e.g. it's the 
10th 
    % element of the signal) and then sets the signal around that 
point. 
     
    %Same for end region 
    SelectedTimeEnd1Idx = find(Time>Tend(1),1,'first'); 
    SelectedTimeEnd2Idx = find(Time>Tend(2),1,'first'); 
    endSignal =  Smooth(SelectedTimeEnd1Idx:SelectedTimeEnd2Idx); 
    meanEnd =  mean(endSignal); 
    [~,meanEndIdx] = min(abs(endSignal-meanEnd)); 
     
    %meanStartIdx =  find(startSignal>meanStart,1,'first'); 
    %meanEndIdx =  find(endSignal>meanEnd,1,'first'); 
     
    Start_Pt = meanStartIdx + (SelectedTimeStart1Idx-1);  
    End_Pt = meanEndIdx + (SelectedTimeEnd1Idx-1); 
     
    hold on 
    plot(Time(Start_Pt), Smooth(Start_Pt),'dr') 
    plot(Time(End_Pt), Smooth(End_Pt),'dm') 
  
    Force_trace=Smooth(Start_Pt:End_Pt); 
    Time_scale=Time(Start_Pt:End_Pt); 
    % Plot original signal Overlayed with Starting Point (green) and 
baseline (red) 
    % h_signalOverlay = figure; 
    % plot(Smooth); 
    % hold on; 
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    % 
figure(h_signalOverlay);plot(Start_Pt:End_Pt,Smooth(Start_Pt:End_Pt),'
g') 
    % 
figure(h_signalOverlay);plot(Start_Pt+min_point:End_Pt,Smooth(Start_Pt
+min_point:End_Pt),'r') 
    % hold off; 
     
    % Calculate final signals 
    figure;set(gcf, 'windowstyle', 'docked', 'color', 'w') 
    smoothSpan = 100; 
    buffer=ceil(smoothSpan/2)+1; 
    SMT=smooth(Force_trace, smoothSpan); 
    TimeScaleFinal = Time_scale(buffer:end-buffer); 
    SignalFinal = SMT(buffer:end-buffer); 
    min_point = 1; 
    TimeScaleFinal=TimeScaleFinal-TimeScaleFinal(1); 
    SignalFinal = SignalFinal - SignalFinal(1);     
    %%% Calculate zero point by extrapolating the line from 10% of 
peak point 
    %P0=max(SignalFinal(300:end-30)); 
    %pc10Max = P0 * 0.10; 
    %[pc10MaxIdx] = find(SignalFinal>=pc10Max,1,'first'); 
    %[SlpBL2]=polyfit(TimeScaleFinal(1:pc10MaxIdx), 
SignalFinal(1:pc10MaxIdx),1); 
    %Slope=SlpBL2(1); 
    %yIntercept=SlpBL2(2); 
    %xIntercept = -yIntercept/Slope; 
    %hold on 
    %grid on 
    %%% Adjust signals to zero intercept 
    %SignalFinal = SignalFinal - yIntercept; 
    %%% Plot new signals 
    %x=[-100 100]; plot(x,(Slope.*x),'r--') 
     
    plot(TimeScaleFinal,SignalFinal,'b','LineWidth',2) 
     
     
    %Find half width maxima 
    P0=max(SignalFinal); 
    halfMax = P0/2; 
    [halfMaxIdx] = find(SignalFinal>=halfMax,1,'first'); 
    line([TimeScaleFinal(halfMaxIdx) TimeScaleFinal(halfMaxIdx)],[-100 
100],'Color','r'); 
     
    % Maxima of signal 
    [fullMaxIdx] = find(SignalFinal>=P0,1,'first'); 
    line([-100 100],[SignalFinal(fullMaxIdx) 
SignalFinal(fullMaxIdx)],'Color','r'); 
     
     
    Time_half_P0 = TimeScaleFinal(halfMaxIdx); 
    title([Dir File], 'interpreter', 'none') 
    xlabel([' P0 : ' num2str(P0,4), ' Time to half P0 : ' 
num2str(Time_half_P0,4)]) 
     
    %Axis resizing to view full signal 
    expandAxes = 1.20; 




     
    xlswrite(excelfile, [P0, Time_half_P0],'sheet1', ['E' 
int2str(i+10)]) 




8.4.3 Script file used to calculate the chemical composition of solution B and 
modified activating solutions described in chapters 4 and 5. 
 
clear;  
close all hidden;  
clc 
load SolCalcDat.mat MetsList LigsList NoteList Labels  
load LastTab1.mat ForTable1 
Tab=  xlsread('SolCalcData.xlsx','Data', 'D9:O19'); 
DHTab=xlsread('SolCalcData.xlsx','Data', 'D22:O32'); 
SS=get(0,'ScreenSize'); 
if SS(4)<950; sc=SS(4)/1020; FS=[10,8]; else sc=1; FS=[12, 10]; end 
TabUD=[{Tab} {MetsList} {LigsList} {DHTab} {NoteList}]; 
B=3; % border width 
WFr=1010; HFr=920*sc; % Overall figure width and weight 
W1=440; W2=560; % Widths of the 2 columns 
H1=380*sc; H2=265*sc; H3=260*sc; H4=100*sc; H5=320*sc; % Hts of the 5 
tables (1 and 5 are in the left column) 
HL1=(HFr - H1 - H5)/2-B;  
HL2=(HFr - H2 - H3 - H4)/3-2*B;  
fh=figure('Position',[10 10 WFr HFr],.... 




    [B     H5+4*B             W1        H1].... 
    [W1+10 H4+H3+150+6*B      W2        H2].... 
    [W1+10 H4+70+5*B          W2        H3].... 
    [W1+10 2*B                W2        H4].... 
    [B     B                  W1/2      H5]}; 
  
APs={.... 
    [B     H5+H1+2*B            W1     145*sc].... 
    [W1+10 H4+H3+150+H2         W2     140*sc].... 
    [W1+10 H4+70+H3+3*B         W2      80*sc].... 
    [W1+10 H4+2*B               W2      60*sc].... 
    [W1/2  B                    W1/2+B  H5]..... 
    [B     860     W1      55]}; %AP(6) is for the main heading ah6 
  
              %% Heading  
ah6=annotation('textbox', 'Units', 'pixels',.... 
               'Position', APs{6},..... 
               'BackgroundColor', [1 1 1],.......... 
               'VerticalAlignment', 'top',.... 
               'EdgeColor', [0 0 0], 'LineWidth', 3,...... 
               'FitBoxToText', 'off',.... 
               'String', Labels(51:52),.... 
               'FontSize', FS(2),..... 
               'FontWeight', 'Demi');                 
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              %% user input table (Table 1) 
  
htab1=uitable('Data', BlankCells(ForTable1), ..... 
              'RowName',[], ..... 
              'ColumnName',{'Ligand' 'Notes' 'Required|Value'  
'in|units' '' 'Stock|Conc mM' 'K+|ratio' 'Na+|ratio' 'Cl-
|ratio'},..... 
              'ColumnWidth', {115 35 55 40  2 55 35 35 48}, ..... 
              'Position',PPs{1} ,..... 
              'FontSize',FS(2),..... 
              'ColumnEditable', [false,false, true 
false,true,true,true],..... 
              'CellEditCallback', @FillTables, ..... %  does temp 
change 
              'CellSelectionCallback', @ShowNote, ..... 
              'BackgroundColor', [0.9 0.95 1; 1 1 1],.......... 
              'UserData', TabUD); 
rh1=annotation('rectangle', 'Units', 'pixels',.... 
               'Position',PPs{1},.... 
               'Color', [0 0 1], 'LineWidth', 3);  
ah1=annotation('textbox', 'Units', 'pixels',.... 
               'Position', APs{1},...... 
               'FontSize', FS(2),..... 
               'BackgroundColor', [0.9 0.95 1],.......... 
               'VerticalAlignment', 'top',.... 
               'EdgeColor', [0 0 1], 'LineWidth', 3,...... 
               'FitBoxToText', 'off',.... 
               'String', Labels(1:5));   
            
           %% K value Table (Table2) 
            
htab2=uitable('Data', BlankCells2([LigsList num2cell(Tab)]), ..... 
              'RowName',[], ..... 
              'ColumnName',[{'Ligand'} ; MetsList], ..... 
              'FontSize',FS(2),..... 
              'ColumnWidth', {115 50 41 41 41 41 41 41 41 41 2 41 2}, 
..... 
              'BackgroundColor', [1 0.95 0.95; 1 1 1],.......... 
              'Position',PPs{2} , ..... 
              'CellSelectionCallback', @ShowDetail,..... 
              'UserData', TabUD);   
rh2=annotation('rectangle', 'Units', 'pixels',..... 
               'Position',PPs{2},.... 
               'Color', [1 0 0], 'LineWidth', 3);           
ah2=annotation('textbox',  'Units', 'pixels',.... 
               'Position', APs{2},...... 
               'FontSize', FS(2),...... 
               'BackgroundColor', [1 0.95 0.95],.......... 
               'VerticalAlignment', 'top',.... 
               'EdgeColor', [1 0 0], 'LineWidth', 3,...... 
               'FitBoxToText', 'off',.... 
               'String', Labels(11:14));     
           
       
          %% Solution ligand distribution table (Table 3) 
           
htab3=uitable('RowName',[],.....  
              'ColumnName',[{'Ligand (L)'}; {'L'}; MetsList], ..... 
              'FontSize',10,.....FS(2) 
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              'ColumnWidth', {100 44 44 38 38 38 44 38 38 38 38 1 38 
1}, ..... 
              'BackgroundColor', [0.9,1,1; 1 1 1],.......... 
              'Position', PPs{3} ); 
rh3=annotation('rectangle', 'Units', 'pixels',.... 
               'Position',PPs{3},..... 
               'Color', [0 1 1], 'LineWidth', 3);          
ah3=annotation('textbox',  'Units', 'pixels',.... 
               'Position', APs{3},...... 
               'FontSize', FS(2),..... 
               'BackgroundColor', [0.9,1,1],.......... 
               'EdgeColor', [0 1 1], 'LineWidth', 3,...... 
               'FitBoxToText', 'off',.... 
               'String', Labels(21:24));   
          
          
            %% Solution other ions table (Table 4)          
htab4=uitable('RowName', {'Free (mM)' 'Bound (mM)' 'Total (mM)'},....          
               'ColumnName', {'Ca'  'Mg'  'K' 'Na' 'Cl' 
'Ionic|Strength'},... 
               'FontSize',FS(2),..... 
               'ColumnWidth', {60}, ..... 
               'BackgroundColor', [1,0.94,1; 1 1 1],.......... 
               'Position',PPs{4} ); 
rh4=annotation('rectangle', 'Units', 'pixels',.... 
               'Position',PPs{4},.... 
               'Color', [0.7 0 0.7], 'LineWidth', 3);   
           
ah4=annotation('textbox',  'Units', 'pixels',.... 
               'Position', APs{4},...... 
               'FontSize', FS(2),..... 
               'BackgroundColor', [1,0.94,1],.......... 
               'EdgeColor', [0.7  0 0.7], 'LineWidth', 3,...... 
               'FitBoxToText', 'off',.... 
               'String', Labels(31:36));       
           
              %% Recipe table (Table 5)      
               
htab5=uitable('ColumnName', {'Component' 'Volume (ml)'},..... 
              'RowName', [],..... 
              'ColumnWidth', {120 80 }, ..... 
              'Position',PPs{5} ,..... 
              'FontSize', FS(2),.... 
              'BackgroundColor', [0.9 1 0.9; 1 1 1],.......... 
              'ButtonDownFcn', @PrntTabs,.... 
              'CellSelectionCallback', @Res2TextFile); 
            
ah5=annotation('textbox',  'Units', 'pixels',.... 
               'Position',APs{5},...... 
               'FontSize', FS(2),..... 
               'BackgroundColor', [0.9 1 0.9],.......... 
               'VerticalAlignment', 'top',.... 
               'EdgeColor', [0 1 0], 'LineWidth', 3,...... 
               'FitBoxToText', 'off',.... 
               'String', Labels(41:46));      
rh5=annotation('rectangle', 'Units', 'pixels',.... 
               'Position',PPs{5}-[0 0 B 0],..... 
               'Color', [0 1 0], 'LineWidth', 3);       




              'Position',  [B+W1/2 B W1/2-B H5/5],.... 
              'ColumnEditable', true,.... 
              'FontSize', FS(2),.... 
              'ColumnWidth', {200},.... 
              
'Data',{'....................Name...................';date}); 
           
FillTables(htab1, [1 1]) % show the default solution          
